data_2yt9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2yt9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.84 0.353 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -134.73 118.61 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.2 t -53.86 135.72 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.39 29.88 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.72 -43.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 9.0 p -118.32 -35.55 3.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.84 27.37 6.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -89.11 138.68 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.75 143.8 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -129.03 132.54 47.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.8 ptt-85 -58.81 -28.49 66.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -136.99 -178.25 5.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.9 -33.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -57.48 -51.53 69.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -57.48 -26.67 61.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 27.3 tp -84.37 -26.38 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -38.88 90.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -26.17 54.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -71.55 -50.25 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -53.13 -29.58 31.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 24.0 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.59 0.709 . . . . 0.0 110.948 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.77 -43.82 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 -0.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -119.1 97.78 5.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.951 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.5 t -112.85 156.51 22.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.1 t -82.38 129.29 63.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -19.29 36.29 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.27 -66.28 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.69 -69.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.29 -11.92 5.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.42 169.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.04 132.27 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.23 146.93 48.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.43 25.88 10.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 151.39 31.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -89.21 -15.52 33.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -77.48 -24.2 50.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mmt-85 -90.55 -59.72 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.65 -31.91 27.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.7 t -64.26 -43.22 95.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.88 -20.92 41.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.16 -49.42 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -52.05 -36.57 50.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -30.12 24.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 9.2 mptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -43.12 2.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.719 2.279 . . . . 0.0 112.33 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.97 133.94 55.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.27 146.96 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -52.22 159.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.34 48.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -75.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.6 p -77.12 -17.09 58.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.11 59.16 7.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -85.94 -75.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.35 126.98 2.78 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.13 138.93 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.4 t -52.03 -55.24 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.15 160.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -48.21 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.333 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.84 -32.36 44.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -63.91 -35.52 80.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.81 -34.27 64.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.55 -35.98 81.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.36 58.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -70.19 -50.19 42.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.764 0.316 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 50.3 mt -51.72 -33.34 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.56 -24.62 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -75.76 -66.85 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.73 -62.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.799 0.333 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.66 128.13 40.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.71 133.47 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -97.48 29.75 3.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.16 -43.57 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 24.2 p -116.26 -27.32 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 92.13 37.09 6.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -101.28 134.72 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.32 143.39 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -125.08 159.44 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -84.22 -27.22 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -137.49 -176.83 4.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 18.7 m -90.3 -30.42 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.83 -44.7 88.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.66 -25.96 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 52.2 tp -82.44 -29.74 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.26 -45.23 77.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -26.05 68.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -81.71 -43.15 18.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -51.95 -37.92 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.559 0.695 . . . . 0.0 110.905 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.71 -48.03 0.29 Allowed 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 -1.799 . . . . 0.0 112.393 -0.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -114.25 96.59 5.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 p -113.38 155.57 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 19.2 t -82.48 129.36 63.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.659 0.743 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -28.46 25.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.82 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.52 -68.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.62 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 168.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -126.47 132.49 51.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.26 140.07 53.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.07 23.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.44 151.32 30.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -89.23 -9.08 52.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.17 -24.48 37.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.29 -56.85 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -53.21 -34.82 58.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 17.2 t -65.74 -30.09 70.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -92.77 -20.79 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -84.07 -46.54 11.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.69 -52.81 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -64.15 -30.12 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -26.58 39.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -46.69 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -110.79 136.41 49.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.1 147.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.159 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.86 159.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.57 -6.4 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 16.8 t -109.98 -75.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.26 -16.88 59.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.75 57.47 8.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -84.21 -76.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.67 128.8 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -128.63 140.2 51.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.3 t -52.01 -57.86 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.45 160.51 26.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.353 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -31.1 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.7 tp -72.52 -37.89 68.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.81 -31.7 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -79.53 -33.47 34.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -64.02 -48.13 77.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.3 mt -51.61 -32.94 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -91.58 -24.03 19.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -66.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.8 -60.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.342 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -112.39 129.09 56.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 6.5 t -59.97 138.77 57.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.8 28.88 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.0 mt -132.54 -41.37 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.1 p -116.94 -33.09 4.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.42 29.49 7.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.66 138.57 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.737 0.304 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 44.4 mm -89.34 144.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -128.29 137.84 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -67.1 -31.29 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.17 151.65 49.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.7 t -72.3 -29.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -58.3 -37.77 75.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -78.36 -27.06 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 38.4 tp -71.54 -28.17 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.26 -55.97 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -55.15 -33.96 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -68.08 -50.56 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -53.67 -32.12 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.505 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.592 0.711 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.74 -40.05 1.19 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.313 -0.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -123.64 96.7 5.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.7 t -113.14 156.77 22.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.8 t -82.36 129.36 63.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -19.88 35.47 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.717 2.278 . . . . 0.0 112.366 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 69.7 t -91.63 -64.49 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.8 m -69.08 -69.05 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.67 -10.98 6.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 164.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.71 55.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.33 139.22 53.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.74 28.0 5.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.16 144.72 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -89.27 -9.14 51.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.62 -24.17 33.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -92.65 -58.72 2.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -51.91 -35.06 44.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 3.4 t -61.5 -33.66 74.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -91.27 -20.98 21.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -80.74 -39.37 27.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.04 -51.1 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -58.12 -36.04 72.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 1.5 t -52.09 -30.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 3.0 mptt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -47.1 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -109.13 135.63 49.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.05 147.03 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.73 159.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -92.85 -6.41 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.66 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -76.83 -16.67 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 57.82 8.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.506 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -84.38 -76.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.57 128.89 2.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.91 139.46 52.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -53.59 39.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.832 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -105.23 160.68 25.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -47.74 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.703 2.269 . . . . 0.0 112.387 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.9 -33.1 55.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -63.82 -31.74 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.76 -36.86 56.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -60.23 -36.43 77.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.15 57.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -65.98 -48.08 72.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.9 mt -51.92 -35.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -91.61 -16.98 26.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -83.35 -66.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.71 -63.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.854 0.359 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -132.85 119.92 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.7 t -55.37 133.1 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.23 29.06 2.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.4 -40.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.9 p -118.19 -39.96 3.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.44 26.0 5.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 134.77 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.6 mm -89.3 137.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -121.72 128.07 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.443 ' H ' ' NE ' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -58.72 -27.06 64.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.01 172.54 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 -34.82 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.18 -30.88 62.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -80.98 -26.05 36.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.916 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.71 -25.95 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -73.68 -53.09 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -54.07 -29.94 46.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.3 ptpt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.553 0.692 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.76 -45.6 0.41 Allowed 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 -1.782 . . . . 0.0 112.372 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.13 100.12 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 14.9 p -113.32 155.68 24.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 21.0 t -82.4 129.41 63.31 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -31.54 20.02 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.337 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.72 -66.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 22.2 m -67.05 -67.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.29 -11.93 6.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 168.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 132.35 50.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 25.38 5.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.08 42.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -89.24 -22.3 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -54.83 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -55.72 -58.93 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -53.62 -33.83 56.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -66.44 -29.26 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -93.85 -20.77 19.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.61 -46.64 11.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.85 -53.43 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -63.33 -30.35 71.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -26.69 40.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.47 136.71 53.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.92 146.67 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.79 158.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.49 -6.33 50.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.98 -75.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 29.2 p -76.27 -17.11 59.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 62.25 4.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -89.31 -76.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.858 0.361 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.8 134.14 3.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -136.95 135.83 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -54.69 26.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.82 160.43 26.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.577 0.703 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.65 2.233 . . . . 0.0 112.366 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.54 -35.8 61.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -60.1 -28.81 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 54.4 tp -84.48 -30.44 25.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.77 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -82.75 -33.75 23.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -60.88 -46.9 88.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.8 mt -51.55 -33.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -23.41 19.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.69 -61.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.62 118.99 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.09 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 35.1 t -52.71 133.04 36.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 30.58 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.14 -39.83 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 19.9 p -121.33 -35.97 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 106.06 24.85 6.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -93.64 139.06 31.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.19 143.77 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.73 129.28 42.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -33.06 71.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -129.99 150.9 51.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 61.9 t -79.2 -37.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -53.15 -31.16 41.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -36.69 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 42.1 tp -57.67 -36.32 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.06 -55.85 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -58.76 -34.3 71.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -67.16 -59.49 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -54.48 -28.82 47.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.77 -42.46 0.75 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.394 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -124.35 100.33 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.54 156.91 22.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.43 129.36 63.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -19.57 35.79 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.08 -66.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 28.2 m -65.05 -69.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.64 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.14 172.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -129.39 135.25 48.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.59 146.99 47.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 22.47 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 158.71 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -89.26 -22.11 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.48 -32.67 68.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.04 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -51.8 -32.59 31.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.824 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 77.3 p -66.79 -47.62 71.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -75.64 -18.89 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -83.78 -54.02 5.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.52 -60.03 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -51.88 -38.33 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -30.01 24.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.582 0.706 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.44 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -116.81 137.51 52.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 146.53 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.57 158.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -92.52 -6.39 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.95 -75.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.33 -17.05 59.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.66 61.9 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.448 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -89.06 -76.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 137.17 136.45 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -140.17 140.12 35.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.72 -56.92 14.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.97 160.57 26.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -48.07 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.66 -37.08 62.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -59.32 -25.9 64.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.87 -37.1 18.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.962 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -55.13 -38.63 68.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.73 -42.01 32.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -51.97 -48.96 64.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.85 -29.35 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.59 -20.91 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -84.36 -66.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 99.6 t -72.92 -55.45 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.26 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.2 t -56.12 133.58 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.27 27.48 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.46 -39.08 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.66 -40.23 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.31 25.7 5.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.26 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.334 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.6 mm -99.64 143.99 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -127.14 141.56 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.824 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -26.28 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -136.33 173.56 11.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.05 -31.43 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.26 -27.24 68.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 -40.63 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.3 -27.94 69.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -64.83 -54.58 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -26.88 56.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -81.28 -42.05 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -54.38 -35.69 63.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.571 0.701 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.64 -48.76 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.371 -0.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -123.64 99.81 6.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.27 156.68 22.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 22.5 t -84.75 129.43 56.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.575 0.702 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.9 19.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.703 2.269 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.51 -67.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.53 -67.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 121.98 12.9 5.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 165.45 23.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -116.7 135.26 53.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.21 133.97 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.33 24.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.45 143.5 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -21.27 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.91 -19.43 61.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -95.33 -59.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -51.86 -34.25 40.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.1 t -65.01 -34.43 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.37 -20.42 24.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -82.8 -45.38 14.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.47 -58.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -53.91 -37.26 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.97 24.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.613 0.72 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -47.51 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.724 2.282 . . . . 0.0 112.311 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -109.6 135.86 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.11 146.59 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -52.06 159.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -92.54 -6.49 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.85 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.842 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.31 -17.03 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.92 55.65 11.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -82.24 -76.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 131.2 128.89 3.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.499 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -128.55 142.05 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 8.1 t -52.04 -57.5 9.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -100.81 160.6 26.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -47.87 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.316 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.55 -38.18 66.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.42 -31.03 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 60.2 tp -80.86 -36.01 31.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.65 -32.45 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -80.86 -39.83 12.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -53.05 -48.33 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.833 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.61 -28.16 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -91.56 -15.14 29.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -93.71 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.71 -65.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -100.47 118.71 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.5 t -52.39 134.0 34.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.9 27.06 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.95 -38.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 8.1 p -120.18 -35.48 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 31.47 5.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.59 139.62 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 36.5 mm -87.87 141.97 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -125.66 132.78 52.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -34.76 69.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 154.43 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.67 -33.15 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -53.26 -32.68 49.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -38.36 27.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 50.6 tp -53.25 -37.99 62.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -52.72 -49.43 65.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -65.63 -26.56 67.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -75.54 -58.89 3.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -55.23 -28.64 54.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 18.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.491 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.2 Cg_endo -69.83 -39.64 1.29 Allowed 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.343 -0.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -124.02 101.61 7.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 68.9 p -112.07 152.96 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.1 t -82.37 129.08 64.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.0 37.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.98 -54.4 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.32 -69.09 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.42 -9.98 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 166.9 0.69 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 130.61 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -118.53 158.78 24.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 22.81 12.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.79 133.28 15.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -79.17 -22.79 44.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -74.11 -22.16 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -61.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -51.75 -30.08 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 t -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -92.62 -21.0 20.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -81.02 -26.57 36.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.91 -61.15 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -51.93 -35.64 46.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.7 t -52.07 -30.05 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 6.8 mptt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.555 0.693 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -45.86 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.673 2.249 . . . . 0.0 112.371 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.07 137.23 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.99 147.07 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.76 159.1 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -92.92 -6.41 48.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.37 -75.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.08 -16.85 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.97 58.37 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -85.07 -76.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.84 129.32 2.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.02 140.4 51.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -57.16 10.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.44 160.6 25.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -47.5 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -29.81 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -67.04 -37.5 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 tp -71.52 -36.59 71.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -57.83 -36.46 72.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.56 -36.5 48.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -61.33 -37.84 84.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.5 -22.74 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -19.85 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.03 -66.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.2 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.058 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -90.76 138.97 31.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.12 140.17 52.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.76 26.18 4.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.69 -51.67 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.9 p -108.54 -25.08 11.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.84 43.03 5.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -111.24 131.8 54.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 5.1 mp -85.93 146.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -128.21 127.46 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -53.34 -32.44 49.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.15 160.15 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.15 -39.44 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -54.46 -33.31 59.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -75.98 -26.0 56.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.2 -27.5 53.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -67.54 -50.78 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -24.85 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.6 -53.66 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -62.73 -22.17 66.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.571 0.701 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.65 -46.48 0.36 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.367 -0.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -122.81 98.06 5.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 29.7 p -113.59 155.57 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.42 129.46 63.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -30.14 22.87 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.371 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.86 -65.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.7 m -69.04 -67.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.44 -11.08 6.43 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.11 169.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -125.29 133.85 52.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -125.61 135.76 52.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 23.11 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.48 151.58 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -89.28 -11.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.6 -23.83 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.863 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.31 -56.14 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -53.94 -35.56 61.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.7 t -65.94 -26.93 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.4 -21.25 18.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -84.74 -45.86 11.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.86 -51.96 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -65.39 -31.79 73.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -30.22 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.18 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.73 2.286 . . . . 0.0 112.307 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.07 129.09 51.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.27 147.44 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.81 158.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -6.42 49.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.55 -16.88 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.68 59.36 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -86.53 -76.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.78 133.1 3.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -135.05 143.18 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.2 m -52.03 -61.12 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.3 160.58 27.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.734 2.289 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.96 -31.45 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -66.44 -29.88 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 57.7 tp -82.01 -32.15 30.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.81 -40.43 88.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.58 -40.98 58.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -52.03 -47.25 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 21.2 mt -51.74 -32.29 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -23.33 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -66.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.21 -62.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -98.16 116.35 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.6 134.2 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 27.35 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.36 -39.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.31 -40.56 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.77 25.83 5.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.517 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.32 140.33 29.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.82 143.91 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.48 139.52 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -69.81 -26.22 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.75 167.21 22.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.3 t -84.06 -38.19 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.56 -28.65 47.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -43.88 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.0 tp -55.47 -31.63 62.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.36 -57.06 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -54.5 -30.02 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -74.82 -49.0 22.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.49 -35.49 65.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.568 0.699 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.72 -43.88 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.368 -0.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -121.02 99.05 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.36 156.88 22.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.0 t -82.35 129.38 63.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.06 35.42 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.628 2.219 . . . . 0.0 112.313 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 65.4 t -91.34 -64.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.9 m -69.46 -69.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.98 -10.22 6.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 165.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.0 136.35 53.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -128.54 133.85 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.67 25.75 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.54 142.54 23.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -85.02 -20.72 30.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.21 -17.3 61.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -97.92 -59.72 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -51.8 -33.77 37.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 5.6 t -63.81 -34.83 78.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.72 -20.6 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -81.38 -43.83 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.25 -52.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -61.05 -34.18 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.11 -30.0 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.624 0.725 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -47.97 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.659 2.239 . . . . 0.0 112.313 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.54 131.37 43.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.4 147.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.75 159.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -92.92 -6.41 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.8 m -109.78 -75.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.7 p -76.77 -16.62 59.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 53.94 16.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.48 -75.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 129.33 126.37 2.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.11 144.35 50.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -56.95 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -101.79 160.6 26.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.654 2.236 . . . . 0.0 112.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.17 -38.24 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.77 -35.05 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -59.48 -45.19 92.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.25 -34.71 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -62.9 -34.0 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.891 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.35 -28.36 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.58 -17.47 25.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -95.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.96 -66.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.03 121.4 41.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.69 131.77 35.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.92 26.73 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.17 -40.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.59 -38.91 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.86 26.82 5.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 137.96 32.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 141.64 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -126.02 143.38 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -68.25 -33.43 74.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.18 149.15 52.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 79.9 t -78.25 -31.57 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -38.39 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 48.7 tp -53.26 -36.56 61.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -52.67 -46.39 67.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -65.6 -27.36 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -76.18 -58.19 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -57.09 -27.19 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.7 mttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.74 -48.88 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.351 -0.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.67 101.5 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.0 t -108.6 150.58 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.82 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.31 128.5 67.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.35 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.6 t -105.51 -64.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.1 -69.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 131.64 -14.14 5.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.43 166.84 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -124.0 140.29 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.01 148.5 46.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.13 25.41 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 142.29 21.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -7.69 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.68 -25.14 28.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -90.75 -56.39 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.74 -30.98 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 t -65.31 -36.2 83.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.03 -12.33 36.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -91.62 -36.8 13.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 90.4 t -76.94 -51.5 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -64.77 -27.71 69.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -25.58 46.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -47.18 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.1 136.27 48.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 6.7 t -52.37 159.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -93.71 -6.46 46.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 m -109.53 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.38 -14.78 59.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.83 52.47 20.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -74.96 -76.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 126.68 116.03 2.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -114.95 143.48 45.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -54.94 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.51 160.1 27.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -41.58 4.13 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.258 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.55 -17.03 59.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -86.6 -9.53 55.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.3 -40.66 10.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -65.02 -35.41 81.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.32 72.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.67 -43.88 45.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 45.3 mt -51.5 -31.19 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -91.81 -33.13 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.34 -67.0 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.01 -62.61 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.857 0.361 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.94 112.59 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.2 t -53.95 133.61 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.62 29.23 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -132.19 -44.2 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.7 p -114.87 -32.46 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.34 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -96.82 142.32 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.12 131.81 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -117.25 131.87 56.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -61.0 -26.65 67.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.04 171.83 13.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 72.8 t -86.66 -36.48 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.76 -27.12 58.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -26.24 30.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.7 tp -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.99 -50.8 67.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.75 -26.58 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -70.87 -55.23 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -53.62 -32.42 51.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.602 0.715 . . . . 0.0 110.939 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.77 -45.97 0.39 Allowed 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.33 -0.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.37 98.34 6.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 157.28 21.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.3 t -82.43 129.33 63.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -22.58 31.81 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.719 2.279 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.02 -68.17 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 32.6 m -63.04 -69.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.74 -12.35 5.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.81 169.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 131.92 50.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -120.83 142.68 49.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -98.16 25.37 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.41 158.24 42.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -23.31 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -69.03 -53.91 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -60.61 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -51.92 -34.04 39.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.2 t -65.12 -34.56 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -88.84 -20.74 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -82.27 -47.57 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.12 -53.52 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -62.53 -31.98 72.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -27.8 35.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.54 0.686 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -44.31 2.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.32 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 137.23 51.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.14 145.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.23 159.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.38 -6.39 50.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -111.08 -75.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -75.28 -16.55 60.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.02 45.84 32.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -71.27 -75.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 127.51 121.16 2.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -122.57 141.81 51.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.54 -57.02 11.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.844 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -97.94 160.74 27.72 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.674 0.749 . . . . 0.0 110.831 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.34 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -37.26 61.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -56.91 -28.42 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 42.1 tp -86.94 -36.35 18.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -59.24 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.66 98.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.514 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.73 -41.22 61.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.11 -41.94 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -9.73 49.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -71.8 -50.5 29.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.84 -50.65 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -118.34 127.41 53.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.05 135.65 57.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 28.51 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.3 -46.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.0 p -112.45 -33.07 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.51 32.4 6.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -98.16 134.79 40.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.3 mm -87.44 145.97 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -129.79 131.52 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -61.32 -29.52 69.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.23 163.31 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 41.1 t -79.16 -31.19 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.5 -29.05 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -82.93 -25.87 31.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 44.6 tp -78.08 -25.85 47.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.99 -54.08 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -25.85 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -72.91 -54.12 9.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -52.37 -39.67 61.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.938 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.521 0.677 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.7 -42.42 0.75 Allowed 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.349 -0.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -123.59 97.99 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.96 157.25 20.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -82.33 129.13 64.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.61 37.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.237 . . . . 0.0 112.355 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.9 -66.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 29.1 m -64.75 -69.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.65 -12.95 5.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.04 171.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.333 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -128.97 135.43 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.92 148.22 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -104.99 23.53 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 155.27 37.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -19.39 25.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -74.22 -24.68 59.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -88.86 -59.92 2.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -51.6 -32.91 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -64.67 -48.31 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.49 -19.91 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -80.35 -48.98 12.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.91 -59.08 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -52.51 -37.16 56.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.5 t -52.97 -29.09 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.812 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.61 0.719 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -46.11 1.33 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.54 132.85 53.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 146.89 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.169 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.86 159.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.96 -6.38 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.5 m -109.52 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.18 -16.73 58.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 57.65 8.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -83.92 -76.1 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.13 128.14 2.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -128.25 139.82 52.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.6 t -52.01 -54.65 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 160.6 25.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.17 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -53.4 -34.89 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -61.41 -31.79 71.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.85 -31.47 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.04 -37.29 86.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.42 -34.16 54.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -63.94 -36.92 85.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.74 0.305 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 79.0 mt -72.8 -25.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -20.53 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -96.86 -64.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.13 -68.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -109.08 132.63 53.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.3 t -69.85 133.87 47.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.89 26.26 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.12 -38.59 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.76 -36.47 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.35 -17.82 23.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -51.99 132.2 32.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.332 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.65 147.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -131.76 125.06 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -62.83 -34.49 77.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.17 155.7 33.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.12 -27.15 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.96 -43.97 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -34.36 77.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.14 -30.69 71.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.5 -57.14 14.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -57.23 -30.59 64.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -69.33 -56.29 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -51.94 -32.83 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.81 -42.79 0.7 Allowed 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.626 -1.823 . . . . 0.0 112.317 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.05 99.55 6.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 154.79 28.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 26.7 t -82.42 129.67 62.22 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.83 24.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.296 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 96.7 t -84.75 -72.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 48.6 m -56.46 -67.78 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.03 4.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.55 170.67 13.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -121.84 133.64 54.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -128.78 139.54 52.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 26.6 6.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.27 151.33 30.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -89.25 -16.52 31.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.5 -24.08 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -90.43 -59.67 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.56 -32.72 29.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.5 t -64.27 -46.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -78.56 -20.43 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -79.93 -49.68 11.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.01 -58.73 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -51.98 -37.66 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -28.21 32.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.558 0.694 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -47.37 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.64 135.65 49.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 146.93 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -52.05 159.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.24 -6.4 47.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -75.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.1 p -77.65 -17.0 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.38 58.63 7.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -85.34 -75.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.35 128.72 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -128.6 139.27 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 m -51.93 -55.55 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 160.6 25.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 -47.09 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -54.39 -33.26 58.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -62.35 -36.16 81.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 64.9 tp -72.17 -29.9 64.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.95 -44.81 95.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.82 -35.65 91.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -63.11 -34.63 78.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.02 -25.94 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.47 -17.76 25.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -100.37 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 89.3 t -68.31 -67.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.842 0.353 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -106.4 128.9 54.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 8.5 t -62.1 134.91 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 26.19 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.28 -39.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -121.71 -38.8 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.88 30.18 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.38 137.05 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.97 147.98 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -133.09 135.95 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.26 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.05 158.12 45.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.91 -25.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.08 -34.07 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -77.94 -34.56 51.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 24.1 tp -60.87 -35.26 76.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -55.7 -42.41 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -66.82 -46.65 74.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -61.22 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -51.92 -31.0 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.567 0.699 . . . . 0.0 110.872 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.1 Cg_endo -69.75 -48.9 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.358 -0.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -123.68 100.0 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.91 157.58 21.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -84.08 129.27 59.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -24.39 29.83 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.673 2.248 . . . . 0.0 112.358 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.17 -65.02 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.2 m -69.37 -69.1 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.24 -11.34 5.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 167.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.11 121.01 33.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -110.67 136.86 49.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 24.26 5.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 153.18 33.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -89.19 -18.94 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.07 -25.45 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt-85 -88.46 -59.39 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.66 -33.74 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.8 t -64.88 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -88.56 -20.55 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -82.11 -46.8 13.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.88 -52.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -25.55 45.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 5.4 mptt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.561 0.696 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -38.42 7.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.47 136.31 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.8 145.87 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.097 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.94 159.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -6.52 50.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.4 m -111.35 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -74.9 -16.43 60.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.93 43.28 30.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -68.26 -76.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 126.26 120.82 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -121.63 143.35 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -53.77 45.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.46 160.67 25.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -48.37 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.725 2.284 . . . . 0.0 112.31 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -53.15 -37.47 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -56.88 -26.47 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.9 -35.52 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -59.38 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.78 -39.75 98.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.76 -41.41 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.735 0.303 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 8.2 mt -54.21 -41.75 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.31 -9.54 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.83 -52.81 15.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.04 -51.33 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.41 118.08 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.24 133.51 52.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -96.0 26.59 4.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.2 -38.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.0 p -119.72 -41.23 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.63 22.81 6.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.25 137.41 32.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.321 . . . . 0.0 110.86 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.62 138.34 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -122.5 128.39 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -58.23 -29.5 65.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.29 171.45 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 -36.82 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -52.29 -42.29 63.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -26.2 62.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 41.7 tp -77.63 -26.11 50.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -67.6 -53.7 25.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -26.17 67.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.73 -54.64 8.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -53.4 -34.79 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 39.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.91 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.5 mttt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.54 0.686 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.75 -41.39 0.92 Allowed 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.722 -1.783 . . . . 0.0 112.35 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -124.96 98.41 5.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.8 t -112.47 156.38 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.41 129.19 64.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.62 37.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.723 2.282 . . . . 0.0 112.34 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -94.82 -65.0 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.56 -69.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.64 -12.41 5.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.39 168.38 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -126.9 134.81 50.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.1 144.46 49.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.52 23.5 10.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.53 155.82 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -89.29 -20.9 23.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.69 -24.71 61.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -88.66 -59.75 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.7 -33.57 34.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.834 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.7 t -64.79 -46.51 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.838 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -77.49 -19.81 55.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -81.2 -51.06 8.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.16 -54.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -58.72 -35.8 73.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -30.07 24.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.565 0.698 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -118.5 138.17 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 146.56 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.94 159.04 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.75 -6.52 48.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.27 -75.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -76.9 -17.27 59.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.0 61.98 4.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -89.19 -76.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.78 133.29 3.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -136.47 137.06 39.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -55.87 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.16 160.57 26.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.62 0.724 . . . . 0.0 110.838 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.22 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.335 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -34.73 58.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -62.14 -30.4 71.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 69.0 tp -80.28 -33.59 37.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -61.16 -41.81 97.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -68.68 -35.61 80.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -62.96 -46.3 88.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 8.0 mt -51.44 -35.17 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.63 -21.17 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.8 -66.94 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.19 -59.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.841 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -85.84 123.91 31.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -57.45 135.89 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -96.62 30.62 2.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.81 -41.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.51 -33.57 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.74 24.55 7.3 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 129.59 43.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.7 148.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.68 132.67 48.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.31 -27.0 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.19 175.44 9.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.2 -27.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.77 -44.19 96.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.9 -25.85 67.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.92 -25.8 37.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -64.77 -44.58 89.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.02 62.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -76.97 -48.38 18.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -52.41 -35.42 51.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.929 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.51 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 2.6 mtmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.72 -43.76 0.58 Allowed 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.344 -0.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -120.92 102.17 8.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 6.1 p -113.88 153.39 29.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -82.36 129.45 63.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.633 0.73 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -20.82 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.248 . . . . 0.0 112.331 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.74 -69.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.03 -68.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.88 18.33 3.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 172.18 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -124.38 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -127.39 138.62 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.72 25.71 4.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 152.38 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -14.18 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -32.99 50.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.24 -57.81 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -51.87 -32.75 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 81.1 p -65.9 -48.88 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.32 -18.45 60.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -83.1 -51.33 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.4 -58.79 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -31.59 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -25.17 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.594 0.711 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.36 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.304 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.25 135.95 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.93 146.38 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -52.09 159.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -92.68 -6.44 49.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 -75.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.4 p -76.88 -17.27 59.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 62.13 4.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.11 -76.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.341 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.46 135.57 3.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.15 135.71 34.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.345 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -57.17 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 160.58 27.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -47.88 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.87 -32.73 54.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -61.51 -30.3 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.34 -36.24 34.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.953 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.73 -38.77 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.39 -34.76 63.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -65.99 -49.07 69.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.862 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.7 mt -51.62 -32.37 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -91.68 -24.9 19.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -77.19 -66.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.3 -63.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.84 127.36 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.81 134.32 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -98.45 31.71 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.12 -45.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.2 p -114.02 -34.07 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.53 27.74 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.478 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -96.54 134.2 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 31.0 mm -87.47 147.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -131.6 131.01 42.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -32.47 70.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 170.66 15.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.82 -28.22 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -55.02 -45.88 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -46.39 75.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 tp -52.13 -30.33 25.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -53.7 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -62.12 -31.76 72.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -70.43 -51.4 29.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -52.21 -31.07 30.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.96 179.905 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.499 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.9 mttt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.74 -47.53 0.31 Allowed 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.343 -0.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -117.87 98.31 6.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.86 157.49 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.1 t -82.35 129.15 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -15.3 36.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.0 -65.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.74 -69.52 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.52 -12.81 5.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 168.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -124.92 132.86 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.9 134.92 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -95.66 25.31 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.12 151.68 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -89.26 -17.49 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -23.12 56.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -91.35 -59.33 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -51.73 -33.9 36.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.2 t -65.08 -35.39 80.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -88.46 -20.1 25.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -82.52 -45.64 14.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.14 -53.2 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -34.54 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 4.1 t -51.98 -30.13 23.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.55 0.69 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.09 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.346 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -119.43 137.86 53.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.35 146.57 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.73 158.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.24 -6.31 50.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -75.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.6 p -75.8 -17.37 59.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.38 60.95 5.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -88.84 -76.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.63 135.31 3.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -136.73 137.94 40.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 40.6 p -52.24 -47.93 65.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -110.41 160.52 28.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.6 64.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -57.82 -25.85 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 45.6 tp -87.71 -27.69 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.88 -38.55 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.24 45.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.515 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -60.89 -41.4 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 6.5 mt -53.88 -41.94 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.91 -9.03 47.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.98 -49.22 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.88 -51.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.31 119.67 23.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.3 t -54.9 133.81 48.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.34 29.6 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.69 -40.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 23.8 p -117.28 -30.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.59 6.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -99.56 141.31 32.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.4 mm -93.66 143.7 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -128.93 128.34 43.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -29.53 70.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.53 155.05 49.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.76 -29.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -55.4 -32.22 62.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -82.98 -37.42 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 tp -63.07 -31.73 72.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.52 -39.95 92.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -73.95 -26.88 60.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -76.82 -48.07 19.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -53.06 -32.5 47.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 28.9 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.509 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.582 0.706 . . . . 0.0 110.899 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.77 -47.66 0.3 Allowed 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.314 -0.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -117.24 98.89 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 57.2 p -112.85 155.8 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.37 129.26 64.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.61 36.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.244 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.99 -64.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.54 -69.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.27 -11.67 5.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 169.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -127.91 133.7 49.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.8 145.61 48.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 23.83 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 154.97 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -89.22 -19.52 25.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -24.89 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.66 -59.79 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -51.63 -33.13 31.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 t -64.79 -47.19 79.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.57 -20.37 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -80.61 -51.88 8.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.71 -55.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -56.89 -36.86 70.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.12 -30.07 24.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.533 0.682 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.88 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.743 2.295 . . . . 0.0 112.35 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -97.34 130.25 44.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.89 147.29 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.76 159.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -92.74 -6.35 49.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.7 m -110.34 -75.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.37 -16.31 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.99 50.67 26.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -76.49 -76.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.331 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 128.13 127.14 2.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -54.68 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 160.67 25.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.28 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.31 -36.44 61.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -59.08 -32.75 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 64.6 tp -77.23 -35.26 55.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.86 -28.17 69.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -84.34 -31.56 24.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -64.56 -47.57 78.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 48.0 mt -51.69 -34.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -21.52 20.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.44 -66.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.57 -61.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.841 0.353 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.93 140.63 30.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 18.8 t -74.43 140.85 44.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.96 28.49 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.93 -46.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.2 p -112.55 -31.38 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.78 26.09 10.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.46 135.07 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.01 145.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -126.34 147.22 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -65.46 -42.95 91.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -123.28 169.98 10.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.08 -29.8 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -63.51 -45.68 89.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -26.13 68.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.99 -27.81 43.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.942 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -49.71 73.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -24.96 67.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -74.33 -54.58 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -51.9 -30.18 23.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.577 0.703 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.6 Cg_endo -69.77 -48.39 0.27 Allowed 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.658 -1.809 . . . . 0.0 112.345 -0.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -115.11 103.72 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 47.7 p -115.24 155.46 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.858 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 11.9 t -82.34 129.18 64.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.62 29.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.36 -57.29 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.4 m -76.83 -69.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.39 -12.21 6.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 171.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.89 133.64 47.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.49 141.58 51.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 23.96 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 152.73 32.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 -13.74 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.88 -22.77 49.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -59.03 2.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -51.6 -33.47 33.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 t -65.02 -48.53 73.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -75.42 -19.79 59.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -81.36 -49.69 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.77 -60.08 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -52.02 -35.24 46.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 -28.9 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.57 0.7 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -48.41 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.24 . . . . 0.0 112.349 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.64 138.41 52.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.77 146.5 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.132 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.78 158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -92.3 -6.5 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -110.07 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.2 p -75.84 -17.37 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.61 61.09 5.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -88.62 -76.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.75 135.58 3.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.91 139.75 39.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -49.93 68.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.31 160.56 26.59 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.31 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -53.55 -37.88 63.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.17 -26.25 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 55.8 tp -88.36 -26.29 22.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -61.63 -49.8 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -67.44 -39.72 91.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -51.87 -41.14 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 6.9 mt -53.84 -42.2 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -9.11 50.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 -43.47 54.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.03 -50.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.23 134.22 54.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.065 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.82 133.56 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.03 28.11 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.24 -39.83 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 25.8 p -120.1 -33.3 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.65 35.18 4.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -104.55 138.14 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.31 148.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.62 129.82 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -29.21 46.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -141.67 -179.85 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.33 -28.15 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -55.72 -58.6 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -56.9 -29.4 62.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.831 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 40.7 tp -75.76 -27.55 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.63 -49.61 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -25.91 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -71.71 -44.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -58.3 -25.65 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.863 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.518 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 1.4 mttp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.594 0.711 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.4 Cg_endo -69.81 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.353 -0.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.96 103.29 10.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 92.5 p -109.0 156.37 19.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.6 t -82.35 128.83 65.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -10.84 29.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.734 2.289 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.38 -67.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 57.7 m -59.57 -68.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.82 17.67 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.25 172.82 8.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.366 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 139.51 50.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -127.76 131.4 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 23.64 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.58 138.98 18.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -81.53 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.73 -23.38 29.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.55 -56.75 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.68 -31.44 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -63.44 -54.79 31.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -73.59 -19.32 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -79.19 -47.74 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 96.0 t -67.19 -57.41 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -52.03 -36.24 49.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.2 t -53.15 -28.8 27.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.546 0.688 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -46.84 1.08 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.88 136.09 50.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.45 147.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.79 158.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -92.3 -6.43 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.35 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -75.82 -17.08 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.78 56.27 10.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -83.23 -76.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.38 128.58 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.449 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.97 142.02 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 p -51.99 -50.42 61.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.98 160.61 26.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.63 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.78 -38.22 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.45 -27.83 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 56.9 tp -82.23 -33.22 29.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.12 -40.16 88.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.88 -36.11 61.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.03 -44.66 94.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.53 -38.02 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -21.38 23.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -64.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 52.3 t -84.54 -59.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.4 m 59.99 33.18 21.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 8.9 p -144.51 74.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -108.8 65.12 0.25 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.61 174.98 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.862 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.2 m -91.61 117.15 29.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.47 -175.67 38.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.51 166.01 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.353 . . . . 0.0 111.122 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -134.73 118.61 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.2 t -53.86 135.72 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.39 29.88 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.72 -43.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 9.0 p -118.32 -35.55 3.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.84 27.37 6.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -89.11 138.68 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.75 143.8 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -129.03 132.54 47.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.8 ptt-85 -58.81 -28.49 66.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -136.99 -178.25 5.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.9 -33.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -57.48 -51.53 69.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -57.48 -26.67 61.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 27.3 tp -84.37 -26.38 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -38.88 90.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -26.17 54.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -71.55 -50.25 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -53.13 -29.58 31.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 24.0 mt -76.39 -32.83 58.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -29.59 62.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.97 149.27 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.18 160.15 14.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -111.68 79.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 54.22 85.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.941 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -178.33 159.57 1.15 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.59 0.709 . . . . 0.0 110.948 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.77 -43.82 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 -0.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -119.1 97.78 5.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.951 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.5 t -112.85 156.51 22.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.1 t -82.38 129.29 63.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -19.29 36.29 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.27 -66.28 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.69 -69.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.29 -11.92 5.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.42 169.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.04 132.27 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.23 146.93 48.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.43 25.88 10.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 151.39 31.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -89.21 -15.52 33.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -77.48 -24.2 50.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mmt-85 -90.55 -59.72 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.65 -31.91 27.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.7 t -64.26 -43.22 95.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.88 -20.92 41.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.16 -49.42 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -52.05 -36.57 50.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -30.12 24.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -85.95 -43.7 12.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.9 t0 60.89 77.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -96.46 93.92 1.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.5 160.34 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.82 -34.28 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 75.07 -110.71 3.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -61.27 160.51 22.81 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -43.12 2.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.719 2.279 . . . . 0.0 112.33 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.97 133.94 55.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.27 146.96 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -52.22 159.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.34 48.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -75.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.6 p -77.12 -17.09 58.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.11 59.16 7.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -85.94 -75.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.35 126.98 2.78 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.13 138.93 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.4 t -52.03 -55.24 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.15 160.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -48.21 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.333 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.84 -32.36 44.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -63.91 -35.52 80.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.81 -34.27 64.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.55 -35.98 81.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.36 58.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -70.19 -50.19 42.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.764 0.316 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 50.3 mt -51.72 -33.34 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.56 -24.62 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -75.76 -66.85 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.73 -62.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -82.7 -169.89 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.0 t 63.37 92.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -172.8 68.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 170.81 15.68 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -32.9 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.3 8.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.503 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 86.3 p -154.71 161.48 41.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.87 168.94 15.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.835 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -145.71 -165.28 11.27 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.1 p -173.5 179.98 1.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 3.8 m -112.96 60.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -179.93 175.65 46.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.93 159.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.173 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.66 128.13 40.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.71 133.47 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -97.48 29.75 3.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.16 -43.57 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 24.2 p -116.26 -27.32 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 92.13 37.09 6.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -101.28 134.72 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.32 143.39 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -125.08 159.44 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -84.22 -27.22 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -137.49 -176.83 4.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 18.7 m -90.3 -30.42 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.83 -44.7 88.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.66 -25.96 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 52.2 tp -82.44 -29.74 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.26 -45.23 77.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -26.05 68.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -81.71 -43.15 18.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -51.95 -37.92 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 52.5 mt -58.68 -33.22 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.8 m -63.46 -27.58 69.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -78.97 66.59 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.08 149.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 129.29 56.57 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -170.5 50.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.947 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -177.14 159.58 1.44 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.905 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.71 -48.03 0.29 Allowed 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 -1.799 . . . . 0.0 112.393 -0.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -114.25 96.59 5.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 p -113.38 155.57 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 19.2 t -82.48 129.36 63.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.659 0.743 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -28.46 25.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.82 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.52 -68.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.62 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 168.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -126.47 132.49 51.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.26 140.07 53.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.07 23.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.44 151.32 30.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -89.23 -9.08 52.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.17 -24.48 37.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.29 -56.85 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -53.21 -34.82 58.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 17.2 t -65.74 -30.09 70.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -92.77 -20.79 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -84.07 -46.54 11.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.69 -52.81 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -64.15 -30.12 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -26.58 39.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -88.45 -46.06 9.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.94 101.04 10.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 76.6 121.28 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.9 p -177.04 109.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.62 150.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.11 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -131.41 -97.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 160.6 60.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -46.69 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -110.79 136.41 49.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.1 147.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.159 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.86 159.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.57 -6.4 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 16.8 t -109.98 -75.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.26 -16.88 59.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.75 57.47 8.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -84.21 -76.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.67 128.8 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -128.63 140.2 51.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.3 t -52.01 -57.86 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.45 160.51 26.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.353 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -31.1 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.7 tp -72.52 -37.89 68.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.81 -31.7 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -79.53 -33.47 34.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -64.02 -48.13 77.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.3 mt -51.61 -32.94 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -91.58 -24.03 19.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -66.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.8 -60.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -79.11 -170.42 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.9 m 51.94 70.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -151.93 172.46 31.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 95.09 0.54 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.723 2.282 . . . . 0.0 112.32 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.53 106.28 15.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.13 139.43 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.474 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 52.7 p -156.34 136.62 12.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 14.9 p -176.7 106.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 134.63 122.43 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.29 125.81 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p -160.85 127.89 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -139.84 146.45 17.96 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.25 141.25 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 111.149 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -112.39 129.09 56.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 6.5 t -59.97 138.77 57.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.8 28.88 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.0 mt -132.54 -41.37 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.1 p -116.94 -33.09 4.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.42 29.49 7.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.66 138.57 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.737 0.304 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 44.4 mm -89.34 144.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -128.29 137.84 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -67.1 -31.29 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.17 151.65 49.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.7 t -72.3 -29.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -58.3 -37.77 75.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -78.36 -27.06 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 38.4 tp -71.54 -28.17 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.26 -55.97 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -55.15 -33.96 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -68.08 -50.56 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -53.67 -32.12 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 2.9 mt -70.39 -32.93 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 3.3 t -70.59 -28.36 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.38 -59.04 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.3 m -78.05 143.42 37.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -145.81 165.8 27.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.533 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -103.61 82.24 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.951 0.405 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.505 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER -172.33 159.61 4.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.592 0.711 . . . . 0.0 110.896 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.74 -40.05 1.19 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.313 -0.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -123.64 96.7 5.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.7 t -113.14 156.77 22.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.8 t -82.36 129.36 63.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -19.88 35.47 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.717 2.278 . . . . 0.0 112.366 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 69.7 t -91.63 -64.49 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.8 m -69.08 -69.05 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.67 -10.98 6.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 164.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.71 55.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.33 139.22 53.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.74 28.0 5.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.16 144.72 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -89.27 -9.14 51.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.62 -24.17 33.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -92.65 -58.72 2.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -51.91 -35.06 44.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 3.4 t -61.5 -33.66 74.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -91.27 -20.98 21.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -80.74 -39.37 27.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.04 -51.1 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -58.12 -36.04 72.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 1.5 t -52.09 -30.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -88.99 -48.33 7.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.28 175.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 108.62 46.45 0.97 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.71 177.53 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 64.8 t -127.13 101.1 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -75.85 -90.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -77.32 160.59 75.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -47.1 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -109.13 135.63 49.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.05 147.03 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.73 159.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -92.85 -6.41 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.66 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -76.83 -16.67 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 57.82 8.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.506 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -84.38 -76.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.57 128.89 2.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.91 139.46 52.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -53.59 39.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.832 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -105.23 160.68 25.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -47.74 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.703 2.269 . . . . 0.0 112.387 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.9 -33.1 55.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -63.82 -31.74 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.76 -36.86 56.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -60.23 -36.43 77.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.15 57.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -65.98 -48.08 72.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.9 mt -51.92 -35.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -91.61 -16.98 26.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -83.35 -66.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.71 -63.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -78.59 59.26 2.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.34 133.92 48.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -168.61 -73.98 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -23.25 30.94 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 0.0 112.296 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 30.7 t -102.72 149.38 24.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 m -131.14 -172.14 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 CA-C-O 119.161 -0.8 . . . . 0.0 112.488 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 50.6 p -138.42 146.36 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.28 155.67 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 135.82 110.89 1.09 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.37 117.38 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.827 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 53.8 p -74.44 164.96 25.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 175.34 165.28 31.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.72 170.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.12 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -132.85 119.92 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.7 t -55.37 133.1 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.23 29.06 2.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.4 -40.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.9 p -118.19 -39.96 3.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.44 26.0 5.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 134.77 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.6 mm -89.3 137.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -121.72 128.07 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.443 ' H ' ' NE ' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -58.72 -27.06 64.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.01 172.54 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 -34.82 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.18 -30.88 62.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -80.98 -26.05 36.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.916 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.71 -25.95 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -73.68 -53.09 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -54.07 -29.94 46.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -37.23 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 20.2 m -74.78 -32.16 61.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -52.44 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 96.5 p -132.73 138.58 47.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -133.85 179.79 17.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -133.38 79.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 110.895 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.3 ptpt -174.1 159.54 2.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.553 0.692 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.76 -45.6 0.41 Allowed 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 -1.782 . . . . 0.0 112.372 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.13 100.12 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 14.9 p -113.32 155.68 24.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 21.0 t -82.4 129.41 63.31 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -31.54 20.02 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.337 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.72 -66.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 22.2 m -67.05 -67.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.29 -11.93 6.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 168.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 132.35 50.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 25.38 5.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.08 42.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -89.24 -22.3 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -54.83 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -55.72 -58.93 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -53.62 -33.83 56.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -66.44 -29.26 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -93.85 -20.77 19.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.61 -46.64 11.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.85 -53.43 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -63.33 -30.35 71.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -26.69 40.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -88.19 -49.21 7.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 179.89 1.0 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.56 7.52 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.5 t -165.85 151.46 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.879 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.62 145.85 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.77 -108.42 2.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -55.81 157.48 7.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.47 136.71 53.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.92 146.67 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.79 158.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.49 -6.33 50.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.98 -75.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 29.2 p -76.27 -17.11 59.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 62.25 4.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -89.31 -76.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.858 0.361 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.8 134.14 3.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -136.95 135.83 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -54.69 26.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.82 160.43 26.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.577 0.703 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.65 2.233 . . . . 0.0 112.366 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.54 -35.8 61.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -60.1 -28.81 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 54.4 tp -84.48 -30.44 25.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.77 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -82.75 -33.75 23.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -60.88 -46.9 88.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.8 mt -51.55 -33.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -23.41 19.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.69 -61.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -81.64 -173.23 4.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.7 m 58.19 178.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 127.34 178.08 15.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 102.58 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.722 2.281 . . . . 0.0 112.301 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.2 p -164.2 113.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.894 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.8 m -94.91 162.88 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.159 -0.8 . . . . 0.0 112.44 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.99 -39.18 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 6.7 t 55.79 88.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.31 -144.7 15.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t 57.08 -179.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.83 -173.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.05 -139.05 2.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 28.2 m -92.22 149.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.13 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.62 118.99 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.09 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 35.1 t -52.71 133.04 36.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 30.58 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.14 -39.83 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 19.9 p -121.33 -35.97 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 106.06 24.85 6.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -93.64 139.06 31.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.19 143.77 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.73 129.28 42.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -33.06 71.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -129.99 150.9 51.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 61.9 t -79.2 -37.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -53.15 -31.16 41.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -36.69 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 42.1 tp -57.67 -36.32 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.06 -55.85 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -58.76 -34.3 71.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -67.16 -59.49 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -54.48 -28.82 47.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 14.3 mt -69.32 -29.79 67.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.36 -26.17 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -51.93 -74.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 6.2 p -123.26 123.92 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -179.91 -52.24 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -90.42 96.56 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -178.29 159.55 1.16 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.77 -42.46 0.75 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.394 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -124.35 100.33 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.54 156.91 22.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.43 129.36 63.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -19.57 35.79 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.08 -66.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 28.2 m -65.05 -69.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.64 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.14 172.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -129.39 135.25 48.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.59 146.99 47.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 22.47 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 158.71 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -89.26 -22.11 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.48 -32.67 68.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.04 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -51.8 -32.59 31.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.824 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 77.3 p -66.79 -47.62 71.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -75.64 -18.89 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -83.78 -54.02 5.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.52 -60.03 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -51.88 -38.33 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -30.01 24.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -83.96 -36.58 23.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.41 86.34 3.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 164.12 98.71 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.51 157.59 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 110.833 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 28.3 t -85.31 -66.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 97.69 -113.85 4.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -69.26 157.38 89.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.44 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -116.81 137.51 52.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 146.53 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.57 158.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -92.52 -6.39 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.95 -75.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.33 -17.05 59.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.66 61.9 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.448 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -89.06 -76.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 137.17 136.45 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -140.17 140.12 35.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.72 -56.92 14.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.97 160.57 26.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -48.07 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.66 -37.08 62.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -59.32 -25.9 64.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.87 -37.1 18.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.962 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -55.13 -38.63 68.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.73 -42.01 32.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -51.97 -48.96 64.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.85 -29.35 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.59 -20.91 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -84.36 -66.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 99.6 t -72.92 -55.45 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -91.45 45.96 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.13 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -174.82 71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 172.27 12.91 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.722 2.281 . . . . 0.0 112.348 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 30.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 p -130.8 157.58 42.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.528 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.35 169.25 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.15 151.88 50.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 164.34 178.6 37.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.17 174.06 6.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.5 m -103.25 -176.82 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -177.25 91.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.509 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 33.1 m -92.48 159.49 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.26 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.2 t -56.12 133.58 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.27 27.48 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.46 -39.08 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.66 -40.23 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.31 25.7 5.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.26 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.334 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.6 mm -99.64 143.99 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -127.14 141.56 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.824 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -26.28 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -136.33 173.56 11.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.05 -31.43 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.26 -27.24 68.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 -40.63 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.3 -27.94 69.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -64.83 -54.58 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -26.88 56.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -81.28 -42.05 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -54.38 -35.69 63.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 5.9 mt -67.9 -25.99 65.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -26.44 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -75.43 81.42 2.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.37 168.08 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -52.31 146.16 16.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.453 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 -169.64 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 110.86 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -134.07 159.34 72.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.571 0.701 . . . . 0.0 110.903 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.64 -48.76 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.371 -0.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -123.64 99.81 6.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.27 156.68 22.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 22.5 t -84.75 129.43 56.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.575 0.702 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.9 19.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.703 2.269 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.51 -67.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.53 -67.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 121.98 12.9 5.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 165.45 23.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -116.7 135.26 53.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.21 133.97 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.33 24.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.45 143.5 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -21.27 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.91 -19.43 61.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -95.33 -59.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -51.86 -34.25 40.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.1 t -65.01 -34.43 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.37 -20.42 24.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -82.8 -45.38 14.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.47 -58.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -53.91 -37.26 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.97 24.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -83.14 -31.98 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -130.56 101.05 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -88.77 -125.08 2.43 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.8 m -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.879 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 9.6 m -135.89 146.74 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -78.33 -94.15 0.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 160.66 9.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.613 0.72 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -47.51 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.724 2.282 . . . . 0.0 112.311 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -109.6 135.86 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.11 146.59 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -52.06 159.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -92.54 -6.49 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.85 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.842 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.31 -17.03 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.92 55.65 11.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -82.24 -76.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 131.2 128.89 3.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.499 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -128.55 142.05 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 8.1 t -52.04 -57.5 9.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -100.81 160.6 26.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -47.87 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.316 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.55 -38.18 66.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.42 -31.03 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 60.2 tp -80.86 -36.01 31.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.65 -32.45 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -80.86 -39.83 12.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -53.05 -48.33 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.833 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.61 -28.16 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -91.56 -15.14 29.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -93.71 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.71 -65.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -84.32 54.7 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.7 t -91.21 -172.97 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.6 173.17 22.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 118.45 5.69 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.367 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.0 t -150.97 105.73 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.91 172.83 11.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.901 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.516 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 65.1 m -148.2 83.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -171.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -87.68 -157.46 31.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.515 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.93 127.46 47.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.835 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.4 t -165.81 137.04 3.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 170.11 -169.38 42.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.08 140.68 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -100.47 118.71 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.5 t -52.39 134.0 34.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.9 27.06 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.95 -38.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 8.1 p -120.18 -35.48 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 31.47 5.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.59 139.62 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 36.5 mm -87.87 141.97 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -125.66 132.78 52.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -34.76 69.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 154.43 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.67 -33.15 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -53.26 -32.68 49.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -38.36 27.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 50.6 tp -53.25 -37.99 62.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -52.72 -49.43 65.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -65.63 -26.56 67.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -75.54 -58.89 3.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -55.23 -28.64 54.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 18.4 mt -68.98 -27.43 65.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 21.8 m -83.51 -26.75 29.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -52.47 -33.06 42.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -37.52 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.98 -125.81 7.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 57.62 74.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.491 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -176.53 159.53 1.66 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.2 Cg_endo -69.83 -39.64 1.29 Allowed 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.343 -0.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -124.02 101.61 7.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 68.9 p -112.07 152.96 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.1 t -82.37 129.08 64.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.0 37.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.98 -54.4 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.32 -69.09 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.42 -9.98 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 166.9 0.69 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 130.61 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -118.53 158.78 24.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 22.81 12.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.79 133.28 15.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -79.17 -22.79 44.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -74.11 -22.16 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -61.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -51.75 -30.08 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 t -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -92.62 -21.0 20.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -81.02 -26.57 36.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.91 -61.15 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -51.93 -35.64 46.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.7 t -52.07 -30.05 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -79.7 -42.35 24.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.34 116.09 9.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -158.18 36.24 0.52 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.536 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.8 m -155.56 179.51 9.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.03 141.71 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -133.44 -76.1 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -58.98 160.67 10.56 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.555 0.693 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -45.86 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.673 2.249 . . . . 0.0 112.371 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.07 137.23 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.99 147.07 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.76 159.1 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -92.92 -6.41 48.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.37 -75.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.08 -16.85 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.97 58.37 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -85.07 -76.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.84 129.32 2.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.02 140.4 51.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -57.16 10.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.44 160.6 25.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -47.5 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -29.81 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -67.04 -37.5 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 tp -71.52 -36.59 71.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -57.83 -36.46 72.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.56 -36.5 48.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -61.33 -37.84 84.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.5 -22.74 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -19.85 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.03 -66.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.2 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.058 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -82.15 67.07 8.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.79 121.33 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -174.16 -166.75 32.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 134.56 28.3 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.354 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.94 -72.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -83.39 176.56 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.512 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 3.4 m 62.58 46.88 5.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 13.6 p -153.81 142.72 21.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 167.71 104.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 29.4 t -78.93 136.63 37.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.3 t -162.59 112.53 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.95 71.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.13 131.49 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -90.76 138.97 31.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.12 140.17 52.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.76 26.18 4.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.69 -51.67 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.9 p -108.54 -25.08 11.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.84 43.03 5.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -111.24 131.8 54.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 5.1 mp -85.93 146.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -128.21 127.46 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -53.34 -32.44 49.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.15 160.15 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.15 -39.44 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -54.46 -33.31 59.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -75.98 -26.0 56.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.2 -27.5 53.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -67.54 -50.78 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -24.85 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.6 -53.66 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -62.73 -22.17 66.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.43 -64.92 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.67 -41.07 8.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 51.44 38.75 22.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.0 p -95.31 -58.86 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.03 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -139.85 74.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER -173.88 159.6 2.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.571 0.701 . . . . 0.0 110.884 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.65 -46.48 0.36 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.367 -0.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -122.81 98.06 5.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 29.7 p -113.59 155.57 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.42 129.46 63.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -30.14 22.87 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.371 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.86 -65.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.7 m -69.04 -67.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.44 -11.08 6.43 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.11 169.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -125.29 133.85 52.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -125.61 135.76 52.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 23.11 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.48 151.58 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -89.28 -11.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.6 -23.83 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.863 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.31 -56.14 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -53.94 -35.56 61.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.7 t -65.94 -26.93 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.4 -21.25 18.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -84.74 -45.86 11.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.86 -51.96 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -65.39 -31.79 73.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -30.22 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -80.21 -36.22 35.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.73 119.66 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -142.18 50.09 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 94.1 p -165.08 118.86 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.3 -58.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 94.68 -88.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 155.15 41.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.18 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.73 2.286 . . . . 0.0 112.307 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.07 129.09 51.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.27 147.44 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.81 158.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -6.42 49.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.55 -16.88 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.68 59.36 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -86.53 -76.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.78 133.1 3.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -135.05 143.18 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.2 m -52.03 -61.12 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.3 160.58 27.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.734 2.289 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.96 -31.45 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -66.44 -29.88 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 57.7 tp -82.01 -32.15 30.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.81 -40.43 88.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.58 -40.98 58.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -52.03 -47.25 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 21.2 mt -51.74 -32.29 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -23.33 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -66.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.21 -62.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -82.7 -171.88 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.5 t 61.86 81.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -179.42 -179.62 48.76 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -28.33 25.49 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.708 2.272 . . . . 0.0 112.293 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 28.8 t -68.69 101.83 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.3 m -158.53 104.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.847 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.485 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.27 113.33 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.795 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.2 172.55 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -135.86 152.48 21.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.39 156.71 29.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.895 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 75.9 p -129.6 156.38 44.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.34 171.0 12.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.02 128.5 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -98.16 116.35 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.6 134.2 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 27.35 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.36 -39.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.31 -40.56 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.77 25.83 5.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.517 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.32 140.33 29.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.82 143.91 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.48 139.52 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -69.81 -26.22 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.75 167.21 22.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.3 t -84.06 -38.19 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.56 -28.65 47.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -43.88 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.0 tp -55.47 -31.63 62.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.36 -57.06 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -54.5 -30.02 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -74.82 -49.0 22.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.49 -35.49 65.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 8.9 mt -72.65 -25.99 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 5.9 t -86.21 -26.12 25.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -34.06 40.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.72 165.12 31.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 112.07 22.31 5.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.506 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -153.11 92.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -179.27 159.53 0.95 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.568 0.699 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.72 -43.88 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.368 -0.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -121.02 99.05 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.36 156.88 22.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.0 t -82.35 129.38 63.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.06 35.42 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.628 2.219 . . . . 0.0 112.313 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 65.4 t -91.34 -64.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.9 m -69.46 -69.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.98 -10.22 6.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 165.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.0 136.35 53.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -128.54 133.85 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.67 25.75 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.54 142.54 23.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -85.02 -20.72 30.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.21 -17.3 61.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -97.92 -59.72 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -51.8 -33.77 37.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 5.6 t -63.81 -34.83 78.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.72 -20.6 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -81.38 -43.83 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.25 -52.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -61.05 -34.18 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.11 -30.0 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -82.64 -41.36 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.66 127.47 32.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -152.43 -40.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 47.3 t -146.61 -70.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 98.36 -91.02 1.08 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -79.3 153.72 76.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.624 0.725 . . . . 0.0 110.83 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -47.97 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.659 2.239 . . . . 0.0 112.313 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.54 131.37 43.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.4 147.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.75 159.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -92.92 -6.41 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.8 m -109.78 -75.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.7 p -76.77 -16.62 59.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 53.94 16.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.48 -75.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 129.33 126.37 2.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.11 144.35 50.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -56.95 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -101.79 160.6 26.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.654 2.236 . . . . 0.0 112.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.17 -38.24 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.77 -35.05 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -59.48 -45.19 92.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.25 -34.71 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -62.9 -34.0 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.891 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.35 -28.36 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.58 -17.47 25.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -95.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.96 -66.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -83.64 55.35 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.97 -37.56 11.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -163.4 -165.87 21.27 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.389 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 8.3 t -162.07 74.87 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -174.29 153.57 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.189 -0.784 . . . . 0.0 112.493 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 12.1 p -122.18 149.33 43.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.922 0.391 . . . . 0.0 110.824 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.79 166.89 16.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.812 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -160.43 128.79 2.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.16 169.15 21.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.855 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 4.7 p -168.15 134.64 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 178.57 139.28 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.22 147.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.03 121.4 41.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.69 131.77 35.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.92 26.73 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.17 -40.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.59 -38.91 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.86 26.82 5.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 137.96 32.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 141.64 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -126.02 143.38 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -68.25 -33.43 74.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.18 149.15 52.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 79.9 t -78.25 -31.57 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -38.39 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 48.7 tp -53.26 -36.56 61.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -52.67 -46.39 67.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -65.6 -27.36 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -76.18 -58.19 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -57.09 -27.19 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.63 -29.16 70.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.48 -26.2 23.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -52.01 118.77 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.6 t -179.23 93.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -134.01 105.97 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -179.22 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.7 mttt -153.41 161.07 30.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.74 -48.88 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.351 -0.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.67 101.5 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.0 t -108.6 150.58 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.82 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.31 128.5 67.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.35 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.6 t -105.51 -64.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.1 -69.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 131.64 -14.14 5.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.43 166.84 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -124.0 140.29 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.01 148.5 46.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.13 25.41 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 142.29 21.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -7.69 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.68 -25.14 28.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -90.75 -56.39 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.74 -30.98 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 t -65.31 -36.2 83.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.03 -12.33 36.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -91.62 -36.8 13.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 90.4 t -76.94 -51.5 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -64.77 -27.71 69.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -25.58 46.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.33 -26.41 55.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.24 -29.8 24.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -158.77 93.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.6 -38.82 2.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.374 . . . . 0.0 110.858 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.13 148.66 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -54.13 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 160.6 37.91 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -47.18 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.1 136.27 48.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 6.7 t -52.37 159.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -93.71 -6.46 46.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 m -109.53 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.38 -14.78 59.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.83 52.47 20.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -74.96 -76.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 126.68 116.03 2.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -114.95 143.48 45.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -54.94 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.51 160.1 27.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -41.58 4.13 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.258 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.55 -17.03 59.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -86.6 -9.53 55.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.3 -40.66 10.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -65.02 -35.41 81.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.32 72.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.67 -43.88 45.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 45.3 mt -51.5 -31.19 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -91.81 -33.13 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.34 -67.0 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.01 -62.61 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.35 -176.46 6.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.79 156.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.76 173.28 13.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 79.45 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.7 p -80.94 175.09 10.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.36 103.69 16.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.508 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.24 -170.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 2.1 t 62.36 166.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.71 101.29 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -132.35 36.13 3.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.877 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.98 84.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -148.27 155.18 26.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.34 138.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 111.1 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.94 112.59 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.2 t -53.95 133.61 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.62 29.23 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -132.19 -44.2 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.7 p -114.87 -32.46 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.34 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -96.82 142.32 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.12 131.81 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -117.25 131.87 56.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -61.0 -26.65 67.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.04 171.83 13.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 72.8 t -86.66 -36.48 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.76 -27.12 58.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -26.24 30.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.7 tp -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.99 -50.8 67.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.75 -26.58 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -70.87 -55.23 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -53.62 -32.42 51.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 29.1 mt -64.69 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 36.1 m -86.43 -26.63 24.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -67.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.48 113.17 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -151.35 -77.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -120.02 81.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.918 0.389 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -166.34 159.55 12.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.77 -45.97 0.39 Allowed 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.33 -0.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.37 98.34 6.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 157.28 21.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.3 t -82.43 129.33 63.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -22.58 31.81 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.719 2.279 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.02 -68.17 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 32.6 m -63.04 -69.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.74 -12.35 5.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.81 169.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 131.92 50.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -120.83 142.68 49.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -98.16 25.37 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.41 158.24 42.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -23.31 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -69.03 -53.91 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -60.61 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -51.92 -34.04 39.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.2 t -65.12 -34.56 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -88.84 -20.74 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -82.27 -47.57 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.12 -53.52 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -62.53 -31.98 72.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -27.8 35.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -88.61 -35.78 16.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -54.25 130.35 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -173.64 39.43 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.462 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.9 t -168.56 -172.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.27 60.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -51.75 -28.47 23.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.91 160.5 27.13 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.54 0.686 . . . . 0.0 110.912 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -44.31 2.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.32 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 137.23 51.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.14 145.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.23 159.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.38 -6.39 50.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -111.08 -75.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -75.28 -16.55 60.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.02 45.84 32.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -71.27 -75.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 127.51 121.16 2.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -122.57 141.81 51.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.54 -57.02 11.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.844 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -97.94 160.74 27.72 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.674 0.749 . . . . 0.0 110.831 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.34 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -37.26 61.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -56.91 -28.42 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 42.1 tp -86.94 -36.35 18.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -59.24 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.66 98.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.514 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.73 -41.22 61.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.11 -41.94 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -9.73 49.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -71.8 -50.5 29.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.84 -50.65 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -79.23 58.66 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.3 t -104.34 -28.1 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.13 -170.38 54.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 150.74 68.77 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.8 t -101.38 -36.84 8.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.5 p -118.66 -47.48 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.126 -0.819 . . . . 0.0 112.533 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.8 104.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.833 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.06 86.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -136.95 -124.28 2.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.429 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.5 p 54.94 -171.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.22 172.45 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -137.24 137.42 8.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.95 148.79 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -118.34 127.41 53.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.05 135.65 57.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 28.51 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.3 -46.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.0 p -112.45 -33.07 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.51 32.4 6.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -98.16 134.79 40.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.3 mm -87.44 145.97 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -129.79 131.52 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -61.32 -29.52 69.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.23 163.31 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 41.1 t -79.16 -31.19 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.5 -29.05 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -82.93 -25.87 31.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 44.6 tp -78.08 -25.85 47.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.99 -54.08 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -25.85 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -72.91 -54.12 9.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -52.37 -39.67 61.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.88 -30.78 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.22 -26.74 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -28.9 43.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 9.8 t -109.26 123.99 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -66.53 -161.36 1.08 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -177.7 177.16 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.902 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER 64.18 155.43 0.12 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.521 0.677 . . . . 0.0 110.896 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.7 -42.42 0.75 Allowed 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.349 -0.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -123.59 97.99 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.96 157.25 20.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -82.33 129.13 64.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.61 37.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.237 . . . . 0.0 112.355 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.9 -66.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 29.1 m -64.75 -69.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.65 -12.95 5.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.04 171.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.333 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -128.97 135.43 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.92 148.22 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -104.99 23.53 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 155.27 37.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -19.39 25.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -74.22 -24.68 59.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -88.86 -59.92 2.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -51.6 -32.91 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -64.67 -48.31 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.49 -19.91 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -80.35 -48.98 12.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.91 -59.08 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -52.51 -37.16 56.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.5 t -52.97 -29.09 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -83.1 -30.55 27.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.812 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -52.02 103.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 132.19 -151.5 19.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.1 t -108.46 -40.89 4.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 22.6 t 62.92 70.31 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -98.7 -37.4 4.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 160.59 26.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.61 0.719 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -46.11 1.33 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.54 132.85 53.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 146.89 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.169 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -51.86 159.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.96 -6.38 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.5 m -109.52 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.18 -16.73 58.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 57.65 8.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -83.92 -76.1 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.13 128.14 2.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -128.25 139.82 52.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.6 t -52.01 -54.65 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 160.6 25.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.17 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -53.4 -34.89 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -61.41 -31.79 71.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.85 -31.47 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.04 -37.29 86.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.42 -34.16 54.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -63.94 -36.92 85.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.74 0.305 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 79.0 mt -72.8 -25.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -20.53 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -96.86 -64.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.13 -68.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -86.49 54.66 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -32.23 21.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 164.72 74.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 160.09 50.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -56.52 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.21 144.84 32.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.161 -0.8 . . . . 0.0 112.52 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 80.1 p -143.44 141.33 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 31.6 m -156.9 144.04 18.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -94.69 -156.69 32.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.5 m -132.93 101.56 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 110.891 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.18 163.71 12.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 138.95 172.12 12.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.431 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.33 141.35 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -109.08 132.63 53.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.3 t -69.85 133.87 47.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.89 26.26 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.12 -38.59 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.76 -36.47 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.35 -17.82 23.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -51.99 132.2 32.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.332 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.65 147.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -131.76 125.06 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -62.83 -34.49 77.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.17 155.7 33.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.12 -27.15 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.96 -43.97 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -34.36 77.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.14 -30.69 71.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.5 -57.14 14.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -57.23 -30.59 64.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -69.33 -56.29 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -51.94 -32.83 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.33 -32.47 66.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 45.4 m -72.42 -39.42 67.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -52.89 -62.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 29.8 m -90.18 168.45 11.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 130.79 -19.38 4.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.5 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.12 82.28 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -169.47 159.55 7.3 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.81 -42.79 0.7 Allowed 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.626 -1.823 . . . . 0.0 112.317 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.05 99.55 6.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 154.79 28.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 26.7 t -82.42 129.67 62.22 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.83 24.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.296 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 96.7 t -84.75 -72.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 48.6 m -56.46 -67.78 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.03 4.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.55 170.67 13.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -121.84 133.64 54.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -128.78 139.54 52.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 26.6 6.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.27 151.33 30.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -89.25 -16.52 31.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.5 -24.08 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -90.43 -59.67 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.56 -32.72 29.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.5 t -64.27 -46.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -78.56 -20.43 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -79.93 -49.68 11.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.01 -58.73 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -51.98 -37.66 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -28.21 32.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -89.57 -50.95 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 t0 72.2 -69.45 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 107.43 27.1 5.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 8.6 t -89.53 69.98 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.881 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.72 -25.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 151.28 -120.1 1.06 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 160.58 80.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.558 0.694 . . . . 0.0 110.932 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -47.37 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.64 135.65 49.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 146.93 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -52.05 159.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.24 -6.4 47.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -75.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.1 p -77.65 -17.0 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.38 58.63 7.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -85.34 -75.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.35 128.72 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -128.6 139.27 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 m -51.93 -55.55 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 160.6 25.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 -47.09 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -54.39 -33.26 58.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -62.35 -36.16 81.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 64.9 tp -72.17 -29.9 64.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.95 -44.81 95.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.82 -35.65 91.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -63.11 -34.63 78.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.02 -25.94 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.47 -17.76 25.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -100.37 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 89.3 t -68.31 -67.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -89.38 50.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.2 t -76.29 134.92 39.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -104.56 175.85 22.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 167.39 24.54 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.665 2.243 . . . . 0.0 112.377 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -118.53 -44.03 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.6 m 53.66 73.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.134 -0.815 . . . . 0.0 112.503 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.5 t -174.57 152.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 110.815 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.94 139.19 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 106.77 150.75 17.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.05 169.84 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 t -171.79 149.65 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 178.84 150.53 8.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.33 136.33 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.115 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -106.4 128.9 54.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 8.5 t -62.1 134.91 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 26.19 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.28 -39.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -121.71 -38.8 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.88 30.18 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.38 137.05 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.97 147.98 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -133.09 135.95 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.26 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.05 158.12 45.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.91 -25.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.08 -34.07 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -77.94 -34.56 51.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 24.1 tp -60.87 -35.26 76.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -55.7 -42.41 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -66.82 -46.65 74.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -61.22 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -51.92 -31.0 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 1.9 mt -89.77 -25.97 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.4 m -62.46 -25.85 68.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.84 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -57.39 179.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.23 92.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 129.96 -147.15 17.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -169.23 1.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.879 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -137.57 159.47 69.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.699 . . . . 0.0 110.872 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.1 Cg_endo -69.75 -48.9 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.358 -0.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -123.68 100.0 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.91 157.58 21.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -84.08 129.27 59.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -24.39 29.83 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.673 2.248 . . . . 0.0 112.358 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.17 -65.02 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.2 m -69.37 -69.1 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.24 -11.34 5.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 167.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.11 121.01 33.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -110.67 136.86 49.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 24.26 5.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 153.18 33.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -89.19 -18.94 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.07 -25.45 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt-85 -88.46 -59.39 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.66 -33.74 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.8 t -64.88 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -88.56 -20.55 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -82.11 -46.8 13.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.88 -52.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -25.55 45.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -83.95 -25.17 30.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.79 148.59 5.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -59.3 -171.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 6.3 t -61.99 167.99 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.828 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.84 -25.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 68.16 -92.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.478 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -92.52 160.54 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.561 0.696 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -38.42 7.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.47 136.31 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.8 145.87 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.097 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.94 159.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -6.52 50.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.4 m -111.35 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -74.9 -16.43 60.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.93 43.28 30.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -68.26 -76.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 126.26 120.82 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -121.63 143.35 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -53.77 45.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.46 160.67 25.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -48.37 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.725 2.284 . . . . 0.0 112.31 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -53.15 -37.47 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -56.88 -26.47 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.9 -35.52 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -59.38 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.78 -39.75 98.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.76 -41.41 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.735 0.303 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 8.2 mt -54.21 -41.75 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.31 -9.54 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.83 -52.81 15.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.04 -51.33 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -78.1 59.39 2.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 33.5 t -97.43 122.23 40.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 168.92 174.74 37.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.492 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -39.88 5.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 6.5 t -169.91 120.29 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.2 m -148.27 31.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 6.7 p -87.91 131.8 34.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 162.96 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.871 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -174.37 39.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.531 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.29 117.84 31.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.22 146.93 15.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -144.54 163.9 27.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 29.3 m -98.63 161.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.41 118.08 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.24 133.51 52.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -96.0 26.59 4.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.2 -38.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.0 p -119.72 -41.23 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.63 22.81 6.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.25 137.41 32.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.321 . . . . 0.0 110.86 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.62 138.34 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -122.5 128.39 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -58.23 -29.5 65.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.29 171.45 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 -36.82 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -52.29 -42.29 63.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -26.2 62.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 41.7 tp -77.63 -26.11 50.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -67.6 -53.7 25.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -26.17 67.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.73 -54.64 8.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -53.4 -34.79 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 39.7 mt -57.93 -28.34 64.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.8 m -77.43 -37.76 50.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -52.57 -51.22 60.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.3 m -111.37 123.39 50.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -79.06 -141.71 2.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -179.24 172.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.958 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.5 mttt 64.19 155.48 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.54 0.686 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.75 -41.39 0.92 Allowed 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.722 -1.783 . . . . 0.0 112.35 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -124.96 98.41 5.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.8 t -112.47 156.38 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.41 129.19 64.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.62 37.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.723 2.282 . . . . 0.0 112.34 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -94.82 -65.0 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.56 -69.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.64 -12.41 5.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.39 168.38 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -126.9 134.81 50.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.1 144.46 49.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.52 23.5 10.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.53 155.82 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -89.29 -20.9 23.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.69 -24.71 61.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -88.66 -59.75 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.7 -33.57 34.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.834 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.7 t -64.79 -46.51 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.838 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -77.49 -19.81 55.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -81.2 -51.06 8.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.16 -54.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -58.72 -35.8 73.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -30.07 24.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -86.4 -47.99 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.13 -58.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 68.8 -160.49 52.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.7 112.74 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 110.9 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.34 116.07 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.101 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -108.42 -69.26 0.66 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -90.29 157.51 44.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -118.5 138.17 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 146.56 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.94 159.04 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.75 -6.52 48.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.27 -75.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -76.9 -17.27 59.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.0 61.98 4.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -89.19 -76.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.78 133.29 3.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -136.47 137.06 39.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -55.87 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.16 160.57 26.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.62 0.724 . . . . 0.0 110.838 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.22 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.335 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -34.73 58.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -62.14 -30.4 71.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 69.0 tp -80.28 -33.59 37.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -61.16 -41.81 97.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -68.68 -35.61 80.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -62.96 -46.3 88.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 8.0 mt -51.44 -35.17 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.63 -21.17 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.8 -66.94 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.19 -59.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -78.59 -172.26 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 39.1 m 53.73 76.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -70.82 -167.2 7.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.515 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 125.72 12.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.34 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -67.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.91 -175.56 3.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.454 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.33 134.0 9.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.888 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 8.1 t -135.58 162.08 33.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -164.99 162.79 35.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.8 p -164.71 179.2 6.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.6 p -169.71 157.78 7.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.11 133.09 3.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 30.8 m -90.87 126.32 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -85.84 123.91 31.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -57.45 135.89 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -96.62 30.62 2.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.81 -41.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.51 -33.57 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.74 24.55 7.3 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 129.59 43.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.7 148.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.68 132.67 48.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.31 -27.0 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.19 175.44 9.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.2 -27.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.77 -44.19 96.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.9 -25.85 67.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.92 -25.8 37.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -64.77 -44.58 89.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.02 62.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -76.97 -48.38 18.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -52.41 -35.42 51.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.86 -31.05 62.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 22.3 t -64.44 -34.13 77.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -52.52 123.09 10.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.8 p -175.01 155.9 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 140.77 -156.98 25.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.508 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.54 178.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.413 . . . . 0.0 110.856 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.51 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 2.6 mtmm 64.12 155.5 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.72 -43.76 0.58 Allowed 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.344 -0.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -120.92 102.17 8.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 6.1 p -113.88 153.39 29.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -82.36 129.45 63.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.633 0.73 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -20.82 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.248 . . . . 0.0 112.331 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.74 -69.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.03 -68.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.88 18.33 3.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 172.18 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -124.38 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -127.39 138.62 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.72 25.71 4.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 152.38 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -14.18 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -32.99 50.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.24 -57.81 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -51.87 -32.75 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 81.1 p -65.9 -48.88 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.32 -18.45 60.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -83.1 -51.33 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.4 -58.79 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -31.59 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -25.17 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -89.33 9.2 26.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.82 -59.3 4.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.28 -127.21 34.7 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.95 -53.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.878 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 60.4 t 51.99 86.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -86.93 -148.37 12.83 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -53.05 157.42 2.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.711 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.36 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.304 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.25 135.95 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.93 146.38 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.0 t -52.09 159.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -92.68 -6.44 49.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 -75.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.4 p -76.88 -17.27 59.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 62.13 4.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.11 -76.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.341 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.46 135.57 3.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.15 135.71 34.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.345 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -57.17 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 160.58 27.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -47.88 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.87 -32.73 54.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -61.51 -30.3 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.34 -36.24 34.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.953 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.73 -38.77 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.39 -34.76 63.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -65.99 -49.07 69.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.862 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.7 mt -51.62 -32.37 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -91.68 -24.9 19.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -77.19 -66.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.3 -63.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -83.23 -169.88 2.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 t 62.67 179.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.23 -179.39 25.98 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 128.69 16.42 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.704 2.27 . . . . 0.0 112.373 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.94 -65.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 60.2 p -70.93 113.46 8.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.465 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.53 155.74 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 0.0 110.84 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 12.9 t -159.22 157.74 31.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -161.96 110.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 75.3 m -161.35 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.861 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 75.7 m -142.99 94.49 2.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -158.99 132.26 3.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.483 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.85 144.09 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.84 127.36 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.81 134.32 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -98.45 31.71 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.12 -45.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.2 p -114.02 -34.07 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.53 27.74 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.478 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -96.54 134.2 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 31.0 mm -87.47 147.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -131.6 131.01 42.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -32.47 70.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 170.66 15.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.82 -28.22 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -55.02 -45.88 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -46.39 75.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 tp -52.13 -30.33 25.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -53.7 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -62.12 -31.76 72.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -70.43 -51.4 29.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -52.21 -31.07 30.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 4.5 mt -72.3 -38.38 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.96 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 48.2 t -66.04 -29.45 69.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.22 -48.92 77.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.5 p 54.96 -171.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 174.56 115.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.52 167.24 1.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.499 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.9 mttt 64.19 155.43 0.12 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.74 -47.53 0.31 Allowed 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.343 -0.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -117.87 98.31 6.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.86 157.49 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.1 t -82.35 129.15 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -15.3 36.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.0 -65.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.74 -69.52 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.52 -12.81 5.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 168.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -124.92 132.86 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.9 134.92 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -95.66 25.31 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.12 151.68 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -89.26 -17.49 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -23.12 56.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -91.35 -59.33 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -51.73 -33.9 36.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.2 t -65.08 -35.39 80.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -88.46 -20.1 25.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -82.52 -45.64 14.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.14 -53.2 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -34.54 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 4.1 t -51.98 -30.13 23.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -86.42 -45.15 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.2 t70 63.19 164.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 175.49 -169.79 42.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.491 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 6.3 t 58.8 -171.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.53 89.72 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -94.27 -18.72 35.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.469 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -79.52 157.35 74.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.55 0.69 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.09 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.346 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -119.43 137.86 53.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.35 146.57 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.73 158.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.24 -6.31 50.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -75.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.6 p -75.8 -17.37 59.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.38 60.95 5.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -88.84 -76.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.63 135.31 3.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -136.73 137.94 40.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 40.6 p -52.24 -47.93 65.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -110.41 160.52 28.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.6 64.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -57.82 -25.85 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 45.6 tp -87.71 -27.69 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.88 -38.55 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.24 45.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.515 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -60.89 -41.4 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 6.5 mt -53.88 -41.94 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.91 -9.03 47.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.98 -49.22 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.88 -51.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -82.28 56.17 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 t -115.87 132.95 56.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.09 -72.97 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -34.8 13.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.7 p -164.53 164.38 21.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.7 t -148.98 121.11 8.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.154 -0.803 . . . . 0.0 112.484 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 41.8 t -161.76 152.13 17.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 130.67 36.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.842 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 176.62 57.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.1 t -170.94 -173.55 1.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.369 . . . . 0.0 110.872 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.48 165.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 141.06 80.76 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.65 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.31 119.67 23.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.3 t -54.9 133.81 48.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.34 29.6 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.69 -40.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 23.8 p -117.28 -30.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.59 6.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -99.56 141.31 32.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.4 mm -93.66 143.7 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -128.93 128.34 43.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -29.53 70.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.53 155.05 49.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.76 -29.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -55.4 -32.22 62.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -82.98 -37.42 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 tp -63.07 -31.73 72.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.52 -39.95 92.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -73.95 -26.88 60.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -76.82 -48.07 19.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -53.06 -32.5 47.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 28.9 mt -60.3 -33.59 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.14 -26.75 65.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.807 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -76.54 86.09 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.71 95.17 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 173.66 -168.71 41.67 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . 0.459 ' H ' ' NE ' ' A' ' 398' ' ' ARG . 1.1 tt0 63.26 170.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.509 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER 64.07 155.49 0.12 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.582 0.706 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.77 -47.66 0.3 Allowed 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.314 -0.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -117.24 98.89 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 57.2 p -112.85 155.8 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.37 129.26 64.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.61 36.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.244 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.99 -64.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.54 -69.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.27 -11.67 5.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 169.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . 0.459 ' NE ' ' H ' ' A' ' 387' ' ' GLU . 1.4 mpt_? -127.91 133.7 49.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.8 145.61 48.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 23.83 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 154.97 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -89.22 -19.52 25.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -24.89 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.66 -59.79 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -51.63 -33.13 31.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 t -64.79 -47.19 79.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.57 -20.37 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -80.61 -51.88 8.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.71 -55.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -56.89 -36.86 70.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.12 -30.07 24.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -84.9 -38.67 19.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.33 172.72 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -131.75 -38.43 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.3 m -94.52 122.15 36.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.14 -26.57 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 109.25 -86.83 0.46 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -82.49 153.67 68.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.533 0.682 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.88 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.743 2.295 . . . . 0.0 112.35 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -97.34 130.25 44.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.89 147.29 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.1 t -51.76 159.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -92.74 -6.35 49.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.7 m -110.34 -75.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.37 -16.31 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.99 50.67 26.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -76.49 -76.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.331 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 128.13 127.14 2.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -54.68 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 160.67 25.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.28 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.31 -36.44 61.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -59.08 -32.75 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 64.6 tp -77.23 -35.26 55.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.86 -28.17 69.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -84.34 -31.56 24.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -64.56 -47.57 78.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 48.0 mt -51.69 -34.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -21.52 20.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.44 -66.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.57 -61.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -77.59 -170.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p 63.14 22.68 13.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.76 171.07 32.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 85.27 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.92 27.04 3.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 79.3 p -139.99 -51.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.481 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 2.1 m -146.98 -43.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.45 157.1 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -141.94 36.95 1.63 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 64.6 p -152.25 101.84 2.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 0.0 110.854 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.67 124.1 1.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.829 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.15 151.77 23.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.47 131.17 46.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.93 140.63 30.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 18.8 t -74.43 140.85 44.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.96 28.49 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.93 -46.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.2 p -112.55 -31.38 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.78 26.09 10.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.46 135.07 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.01 145.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -126.34 147.22 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -65.46 -42.95 91.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -123.28 169.98 10.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.08 -29.8 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -63.51 -45.68 89.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -26.13 68.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.99 -27.81 43.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.942 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -49.71 73.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -24.96 67.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -74.33 -54.58 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -51.9 -30.18 23.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 18.8 mt -72.01 -36.7 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.45 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -51.98 137.94 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.86 100.98 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 153.77 90.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -179.37 167.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.912 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER 64.08 155.69 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 0.0 110.883 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.6 Cg_endo -69.77 -48.39 0.27 Allowed 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.658 -1.809 . . . . 0.0 112.345 -0.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -115.11 103.72 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 47.7 p -115.24 155.46 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.858 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 11.9 t -82.34 129.18 64.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.62 29.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.36 -57.29 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.4 m -76.83 -69.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.39 -12.21 6.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 171.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.89 133.64 47.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.49 141.58 51.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 23.96 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 152.73 32.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 -13.74 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.88 -22.77 49.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -59.03 2.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -51.6 -33.47 33.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 t -65.02 -48.53 73.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -75.42 -19.79 59.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -81.36 -49.69 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.77 -60.08 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -52.02 -35.24 46.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 -28.9 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -82.61 -48.8 10.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.08 -172.94 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 113.24 -41.84 2.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 5.5 t -66.55 152.98 44.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 40.2 t -91.12 90.66 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -113.9 -82.16 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -63.35 157.49 63.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.57 0.7 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -48.41 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.24 . . . . 0.0 112.349 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.64 138.41 52.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.77 146.5 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.132 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.78 158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -92.3 -6.5 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -110.07 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.2 p -75.84 -17.37 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.61 61.09 5.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -88.62 -76.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 136.75 135.58 3.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.91 139.75 39.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -49.93 68.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.31 160.56 26.59 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.31 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -53.55 -37.88 63.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.17 -26.25 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 55.8 tp -88.36 -26.29 22.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -61.63 -49.8 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -67.44 -39.72 91.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -51.87 -41.14 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 6.9 mt -53.84 -42.2 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -9.11 50.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 -43.47 54.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.03 -50.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -79.31 58.57 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.76 172.67 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -112.07 172.09 14.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.49 69.01 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.38 -60.33 3.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.0 t -135.84 131.97 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.497 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.52 177.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 0.0 110.866 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 7.9 m -153.98 170.43 21.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -157.14 82.19 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 73.2 m -108.66 -43.79 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.5 m 63.17 -179.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 153.17 -166.15 31.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.28 148.54 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.23 134.22 54.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.065 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.82 133.56 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.03 28.11 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.24 -39.83 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 25.8 p -120.1 -33.3 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.65 35.18 4.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -104.55 138.14 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.31 148.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.62 129.82 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -29.21 46.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -141.67 -179.85 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.33 -28.15 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -55.72 -58.6 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -56.9 -29.4 62.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.831 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 40.7 tp -75.76 -27.55 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.63 -49.61 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -25.91 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -71.71 -44.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -58.3 -25.65 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.57 -46.37 12.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -16.4 62.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.54 124.17 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.4 p -145.92 -42.44 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.35 79.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.55 165.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 110.905 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.518 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 1.4 mttp 64.18 155.58 0.12 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.594 0.711 . . . . 0.0 110.896 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.4 Cg_endo -69.81 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.353 -0.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.96 103.29 10.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 92.5 p -109.0 156.37 19.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.6 t -82.35 128.83 65.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -10.84 29.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.734 2.289 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.38 -67.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 57.7 m -59.57 -68.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.82 17.67 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.25 172.82 8.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.366 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 139.51 50.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -127.76 131.4 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 23.64 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.58 138.98 18.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -81.53 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.73 -23.38 29.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.55 -56.75 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -51.68 -31.44 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -63.44 -54.79 31.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -73.59 -19.32 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -79.19 -47.74 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 96.0 t -67.19 -57.41 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -52.03 -36.24 49.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.2 t -53.15 -28.8 27.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -84.64 -42.11 15.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -102.85 50.11 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 153.26 111.29 0.45 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 16.8 t 58.08 82.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.875 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.07 -69.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.72 -116.45 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.27 160.68 8.83 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.546 0.688 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -46.84 1.08 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.88 136.09 50.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.45 147.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 7.2 t -51.79 158.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -92.3 -6.43 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.35 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -75.82 -17.08 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.78 56.27 10.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -83.23 -76.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 132.38 128.58 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.449 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.97 142.02 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 p -51.99 -50.42 61.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.98 160.61 26.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.63 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.78 -38.22 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.45 -27.83 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 56.9 tp -82.23 -33.22 29.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.12 -40.16 88.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.88 -36.11 61.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.03 -44.66 94.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.53 -38.02 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -21.38 23.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -64.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 52.3 t -84.54 -59.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -80.56 -175.19 5.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.21 160.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -175.19 -176.04 43.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 82.76 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.665 2.243 . . . . 0.0 112.344 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.82 121.84 15.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 -61.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.483 -179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.49 HG21 HD22 ' A' ' 377' ' ' LEU . 35.4 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.84 0.353 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -134.73 118.61 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.2 t -53.86 135.72 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.39 29.88 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.72 -43.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 9.0 p -118.32 -35.55 3.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.84 27.37 6.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -89.11 138.68 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.75 143.8 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 377' ' ' LEU . 51.2 m-85 -129.03 132.54 47.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.8 ptt-85 -58.81 -28.49 66.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -136.99 -178.25 5.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.9 -33.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -57.48 -51.53 69.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -57.48 -26.67 61.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 362' ' ' VAL . 27.3 tp -84.37 -26.38 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -38.88 90.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -76.6 -26.17 54.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -71.55 -50.25 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -53.13 -29.58 31.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 379' ' ' ARG . 24.0 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.59 0.709 . . . . 0.0 110.948 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.77 -43.82 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 -0.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -119.1 97.78 5.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.951 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.5 t -112.85 156.51 22.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.1 t -82.38 129.29 63.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -19.29 36.29 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.27 -66.28 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.69 -69.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.29 -11.92 5.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.42 169.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.04 132.27 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.23 146.93 48.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.43 25.88 10.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 151.39 31.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -89.21 -15.52 33.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -77.48 -24.2 50.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mmt-85 -90.55 -59.72 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.65 -31.91 27.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.7 t -64.26 -43.22 95.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.88 -20.92 41.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' HIS . . . . . 0.401 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 81.1 t60 -80.16 -49.42 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 405' ' ' MET . 98.2 t -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -52.05 -36.57 50.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -30.12 24.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' HIS . . . . . 0.401 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 26.9 m-70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 9.2 mptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -43.12 2.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.719 2.279 . . . . 0.0 112.33 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.97 133.94 55.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -127.27 146.96 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.684 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.22 159.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.34 48.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -75.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.6 p -77.12 -17.09 58.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.11 59.16 7.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -85.94 -75.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 126.98 2.78 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.52 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.13 138.93 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.4 t -52.03 -55.24 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.15 160.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -48.21 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.333 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.84 -32.36 44.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -63.91 -35.52 80.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.684 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.6 tp -73.81 -34.27 64.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.55 -35.98 81.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.36 58.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -70.19 -50.19 42.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.764 0.316 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 50.3 mt -51.72 -33.34 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.56 -24.62 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -75.76 -66.85 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.73 -62.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.799 0.333 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.66 128.13 40.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.71 133.47 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -97.48 29.75 3.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.16 -43.57 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 24.2 p -116.26 -27.32 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 92.13 37.09 6.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -101.28 134.72 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.32 143.39 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 41.8 m-85 -125.08 159.44 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -84.22 -27.22 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -137.49 -176.83 4.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 18.7 m -90.3 -30.42 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.83 -44.7 88.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.66 -25.96 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 371' ' ' PHE . 52.2 tp -82.44 -29.74 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.26 -45.23 77.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -26.05 68.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -81.71 -43.15 18.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -51.95 -37.92 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.559 0.695 . . . . 0.0 110.905 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.71 -48.03 0.29 Allowed 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 -1.799 . . . . 0.0 112.393 -0.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -114.25 96.59 5.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 p -113.38 155.57 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 19.2 t -82.48 129.36 63.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.659 0.743 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -28.46 25.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.82 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.52 -68.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.62 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 168.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -126.47 132.49 51.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.26 140.07 53.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.07 23.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.44 151.32 30.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -89.23 -9.08 52.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.17 -24.48 37.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.29 -56.85 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.564 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -53.21 -34.82 58.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 17.2 t -65.74 -30.09 70.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -92.77 -20.79 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -84.07 -46.54 11.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 405' ' ' MET . 93.9 t -62.69 -52.81 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -64.15 -30.12 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -26.58 39.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -46.69 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -110.79 136.41 49.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.1 147.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.159 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.86 159.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.57 -6.4 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 443' ' ' HIS . 16.8 t -109.98 -75.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.26 -16.88 59.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.75 57.47 8.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -84.21 -76.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.67 128.8 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -128.63 140.2 51.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.3 t -52.01 -57.86 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.45 160.51 26.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.353 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -31.1 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 422' ' ' CYS . 59.7 tp -72.52 -37.89 68.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.81 -31.7 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -79.53 -33.47 34.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -64.02 -48.13 77.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.3 mt -51.61 -32.94 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -91.58 -24.03 19.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -66.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.8 -60.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 424' ' ' SER . 19.7 m80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.513 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.0 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.342 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -112.39 129.09 56.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 6.5 t -59.97 138.77 57.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.8 28.88 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.0 mt -132.54 -41.37 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.1 p -116.94 -33.09 4.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.42 29.49 7.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.66 138.57 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.737 0.304 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 44.4 mm -89.34 144.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -128.29 137.84 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -67.1 -31.29 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.17 151.65 49.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.7 t -72.3 -29.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -58.3 -37.77 75.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -78.36 -27.06 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.513 HD22 ' CG1' ' A' ' 362' ' ' VAL . 38.4 tp -71.54 -28.17 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.26 -55.97 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -55.15 -33.96 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -68.08 -50.56 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -53.67 -32.12 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.592 0.711 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.74 -40.05 1.19 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.313 -0.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -123.64 96.7 5.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.7 t -113.14 156.77 22.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.8 t -82.36 129.36 63.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -19.88 35.47 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.717 2.278 . . . . 0.0 112.366 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 69.7 t -91.63 -64.49 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.8 m -69.08 -69.05 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.67 -10.98 6.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 164.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.71 55.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.33 139.22 53.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.74 28.0 5.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.16 144.72 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -89.27 -9.14 51.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.62 -24.17 33.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -92.65 -58.72 2.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.623 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.3 ppp? -51.91 -35.06 44.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 3.4 t -61.5 -33.66 74.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -91.27 -20.98 21.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -80.74 -39.37 27.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 405' ' ' MET . 96.9 t -68.04 -51.1 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -58.12 -36.04 72.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 1.5 t -52.09 -30.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 3.0 mptt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -47.1 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -109.13 135.63 49.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.05 147.03 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.668 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.73 159.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -92.85 -6.41 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.66 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -76.83 -16.67 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 57.82 8.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.506 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -84.38 -76.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.57 128.89 2.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.91 139.46 52.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -53.59 39.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.832 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -105.23 160.68 25.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -47.74 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.703 2.269 . . . . 0.0 112.387 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.9 -33.1 55.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -63.82 -31.74 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 422' ' ' CYS . 58.2 tp -76.76 -36.86 56.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -60.23 -36.43 77.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.15 57.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.459 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -65.98 -48.08 72.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.9 mt -51.92 -35.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -91.61 -16.98 26.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -83.35 -66.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 438' ' ' HIS . 97.6 t -74.71 -63.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.556 HG21 HD22 ' A' ' 377' ' ' LEU . 26.9 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.854 0.359 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -132.85 119.92 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.4 ' SG ' HD12 ' A' ' 366' ' ' ILE . 3.7 t -55.37 133.1 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.23 29.06 2.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ILE . . . . . 0.4 HD12 ' SG ' ' A' ' 364' ' ' CYS . 2.3 mp -131.4 -40.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.9 p -118.19 -39.96 3.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.44 26.0 5.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 134.77 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.6 mm -89.3 137.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.4 ' CD1' HD13 ' A' ' 377' ' ' LEU . 58.7 m-85 -121.72 128.07 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.498 ' H ' ' NE ' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -58.72 -27.06 64.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.01 172.54 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 -34.82 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.18 -30.88 62.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -80.98 -26.05 36.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.916 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 362' ' ' VAL . 40.6 tp -76.71 -25.95 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -73.68 -53.09 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -54.07 -29.94 46.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.3 ptpt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.553 0.692 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.76 -45.6 0.41 Allowed 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 -1.782 . . . . 0.0 112.372 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.13 100.12 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 14.9 p -113.32 155.68 24.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 21.0 t -82.4 129.41 63.31 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -31.54 20.02 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.337 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.72 -66.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 22.2 m -67.05 -67.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.29 -11.93 6.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 168.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 132.35 50.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 25.38 5.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.08 42.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -89.24 -22.3 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -54.83 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -55.72 -58.93 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -53.62 -33.83 56.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -66.44 -29.26 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -93.85 -20.77 19.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' HIS . . . . . 0.45 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 77.1 t60 -84.61 -46.64 11.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 405' ' ' MET . 93.5 t -62.85 -53.43 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -63.33 -30.35 71.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -26.69 40.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' HIS . . . . . 0.45 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 31.5 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.47 136.71 53.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.538 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.92 146.67 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.643 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.79 158.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.49 -6.33 50.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.98 -75.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 29.2 p -76.27 -17.11 59.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 62.25 4.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -89.31 -76.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.858 0.361 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.538 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.8 134.14 3.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -136.95 135.83 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -54.69 26.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.82 160.43 26.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.577 0.703 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.65 2.233 . . . . 0.0 112.366 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.54 -35.8 61.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -60.1 -28.81 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 422' ' ' CYS . 54.4 tp -84.48 -30.44 25.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.1 t30 -63.77 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -82.75 -33.75 23.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -60.88 -46.9 88.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 436' ' ' ASN . 5.8 mt -51.55 -33.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -23.41 19.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.69 -61.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 374' ' ' VAL . 28.2 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.62 118.99 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.09 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 35.1 t -52.71 133.04 36.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 30.58 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.14 -39.83 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 19.9 p -121.33 -35.97 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 106.06 24.85 6.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -93.64 139.06 31.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.19 143.77 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.59 ' CD1' HD13 ' A' ' 377' ' ' LEU . 40.9 m-85 -130.73 129.28 42.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -33.06 71.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -129.99 150.9 51.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 362' ' ' VAL . 61.9 t -79.2 -37.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -53.15 -31.16 41.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -36.69 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 371' ' ' PHE . 42.1 tp -57.67 -36.32 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.06 -55.85 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.619 ' HA ' HD12 ' A' ' 382' ' ' LEU . 81.6 mtt180 -58.76 -34.3 71.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -67.16 -59.49 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -54.48 -28.82 47.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 379' ' ' ARG . 14.3 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.77 -42.46 0.75 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.394 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -124.35 100.33 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.54 156.91 22.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.43 129.36 63.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -19.57 35.79 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.08 -66.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 28.2 m -65.05 -69.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.64 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.14 172.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -129.39 135.25 48.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.59 146.99 47.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 22.47 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 158.71 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -89.26 -22.11 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.48 -32.67 68.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.04 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.551 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.8 -32.59 31.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.824 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 77.3 p -66.79 -47.62 71.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -75.64 -18.89 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -83.78 -54.02 5.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 405' ' ' MET . 95.5 t -60.52 -60.03 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -51.88 -38.33 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -30.01 24.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.582 0.706 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.44 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -116.81 137.51 52.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.54 146.53 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.646 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.57 158.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -92.52 -6.39 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.95 -75.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.33 -17.05 59.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.66 61.9 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.448 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -89.06 -76.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 137.17 136.45 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.488 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -140.17 140.12 35.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.72 -56.92 14.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.97 160.57 26.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -48.07 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.66 -37.08 62.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -25.9 64.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 422' ' ' CYS . 62.6 tp -86.87 -37.1 18.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -55.13 -38.63 68.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.73 -42.01 32.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.6 t60 -51.97 -48.96 64.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.85 -29.35 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.59 -20.91 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -84.36 -66.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.6 t -72.92 -55.45 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.26 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.2 t -56.12 133.58 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.27 27.48 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.46 -39.08 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.66 -40.23 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.31 25.7 5.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.26 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.334 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.6 mm -99.64 143.99 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 377' ' ' LEU . 52.9 m-85 -127.14 141.56 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -26.28 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -136.33 173.56 11.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.05 -31.43 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.26 -27.24 68.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 -40.63 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.51 HD22 ' CG2' ' A' ' 362' ' ' VAL . 38.9 tp -63.3 -27.94 69.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -64.83 -54.58 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.425 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -56.59 -26.88 56.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -81.28 -42.05 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -54.38 -35.69 63.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.9 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.571 0.701 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.64 -48.76 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.371 -0.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -123.64 99.81 6.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.27 156.68 22.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 22.5 t -84.75 129.43 56.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.575 0.702 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.9 19.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.703 2.269 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.51 -67.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.53 -67.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 121.98 12.9 5.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 165.45 23.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -116.7 135.26 53.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.21 133.97 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.33 24.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.45 143.5 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -21.27 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.91 -19.43 61.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -95.33 -59.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.86 -34.25 40.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.1 t -65.01 -34.43 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.37 -20.42 24.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -82.8 -45.38 14.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 94.5 t -65.47 -58.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -53.91 -37.26 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.97 24.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.613 0.72 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -47.51 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.724 2.282 . . . . 0.0 112.311 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -109.6 135.86 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.11 146.59 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.593 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.06 159.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -92.54 -6.49 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.85 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.842 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.31 -17.03 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.92 55.65 11.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -82.24 -76.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 131.2 128.89 3.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.499 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -128.55 142.05 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 8.1 t -52.04 -57.5 9.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -100.81 160.6 26.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -47.87 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.316 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.55 -38.18 66.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -31.03 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 422' ' ' CYS . 60.2 tp -80.86 -36.01 31.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.65 -32.45 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -80.86 -39.83 12.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -53.05 -48.33 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.833 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.61 -28.16 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -91.56 -15.14 29.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -93.71 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.71 -65.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 377' ' ' LEU . 7.2 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 370' ' ' ILE . . . -100.47 118.71 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.5 t -52.39 134.0 34.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.9 27.06 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.95 -38.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 8.1 p -120.18 -35.48 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 31.47 5.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.59 139.62 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 363' ' ' ALA . 36.5 mm -87.87 141.97 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 38.8 m-85 -125.66 132.78 52.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -34.76 69.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 154.43 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.67 -33.15 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -53.26 -32.68 49.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -38.36 27.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.517 HD22 ' CG1' ' A' ' 362' ' ' VAL . 50.6 tp -53.25 -37.99 62.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -52.72 -49.43 65.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 382' ' ' LEU . 70.4 mtt180 -65.63 -26.56 67.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -75.54 -58.89 3.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -55.23 -28.64 54.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.2 Cg_endo -69.83 -39.64 1.29 Allowed 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.343 -0.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -124.02 101.61 7.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 68.9 p -112.07 152.96 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.1 t -82.37 129.08 64.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.0 37.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.98 -54.4 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.32 -69.09 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.42 -9.98 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 166.9 0.69 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 130.61 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -118.53 158.78 24.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 22.81 12.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.79 133.28 15.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -79.17 -22.79 44.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -74.11 -22.16 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -61.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.619 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.4 ppp? -51.75 -30.08 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 t -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -92.62 -21.0 20.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -81.02 -26.57 36.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 405' ' ' MET . 98.8 t -83.91 -61.15 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -51.93 -35.64 46.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.7 t -52.07 -30.05 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 6.8 mptt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.555 0.693 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -45.86 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.673 2.249 . . . . 0.0 112.371 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.07 137.23 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.99 147.07 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.143 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.1 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -92.92 -6.41 48.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.37 -75.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.08 -16.85 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.97 58.37 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -85.07 -76.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.84 129.32 2.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.02 140.4 51.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -57.16 10.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.44 160.6 25.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -47.5 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -29.81 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -67.04 -37.5 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.657 HD11 ' HA ' ' A' ' 422' ' ' CYS . 65.7 tp -71.52 -36.59 71.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -57.83 -36.46 72.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.56 -36.5 48.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.669 ' CE1' HG21 ' A' ' 442' ' ' VAL . 22.9 t60 -61.33 -37.84 84.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.5 -22.74 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -19.85 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.03 -66.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.669 HG21 ' CE1' ' A' ' 438' ' ' HIS . 96.4 t -59.2 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.058 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.673 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.7 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -90.76 138.97 31.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.12 140.17 52.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.76 26.18 4.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.69 -51.67 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.9 p -108.54 -25.08 11.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.84 43.03 5.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -111.24 131.8 54.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -85.93 146.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.6 m-85 -128.21 127.46 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -53.34 -32.44 49.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.15 160.15 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.15 -39.44 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -54.46 -33.31 59.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -75.98 -26.0 56.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.673 HD22 ' CG2' ' A' ' 362' ' ' VAL . 45.3 tp -77.2 -27.5 53.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -67.54 -50.78 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -64.01 -24.85 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.6 -53.66 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -62.73 -22.17 66.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.571 0.701 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.65 -46.48 0.36 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.367 -0.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -122.81 98.06 5.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 29.7 p -113.59 155.57 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.42 129.46 63.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -30.14 22.87 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.371 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.86 -65.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.7 m -69.04 -67.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.44 -11.08 6.43 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.11 169.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -125.29 133.85 52.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -125.61 135.76 52.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 23.11 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.48 151.58 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -89.28 -11.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.6 -23.83 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.863 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.31 -56.14 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.7 ppp? -53.94 -35.56 61.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.7 t -65.94 -26.93 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.4 -21.25 18.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -84.74 -45.86 11.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 405' ' ' MET . 88.2 t -62.86 -51.96 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -65.39 -31.79 73.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -30.22 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.18 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.73 2.286 . . . . 0.0 112.307 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.07 129.09 51.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.27 147.44 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.557 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.81 158.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -6.42 49.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.55 -16.88 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.68 59.36 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -86.53 -76.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.78 133.1 3.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -135.05 143.18 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.2 m -52.03 -61.12 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.3 160.58 27.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.734 2.289 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.96 -31.45 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -66.44 -29.88 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.7 tp -82.01 -32.15 30.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.81 -40.43 88.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.58 -40.98 58.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.432 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.3 t60 -52.03 -47.25 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.811 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 21.2 mt -51.74 -32.29 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -23.33 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -66.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 438' ' ' HIS . 49.0 t -77.21 -62.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.624 HG11 HD22 ' A' ' 377' ' ' LEU . 21.9 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -98.16 116.35 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.6 134.2 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 27.35 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.36 -39.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.31 -40.56 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.77 25.83 5.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.517 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.32 140.33 29.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.82 143.91 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.48 139.52 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -69.81 -26.22 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.75 167.21 22.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 362' ' ' VAL . 22.3 t -84.06 -38.19 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.56 -28.65 47.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -43.88 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.624 HD22 HG11 ' A' ' 362' ' ' VAL . 23.0 tp -55.47 -31.63 62.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.36 -57.06 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -54.5 -30.02 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -74.82 -49.0 22.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.49 -35.49 65.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.568 0.699 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.72 -43.88 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.368 -0.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -121.02 99.05 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.36 156.88 22.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.0 t -82.35 129.38 63.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.06 35.42 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.628 2.219 . . . . 0.0 112.313 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 65.4 t -91.34 -64.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.9 m -69.46 -69.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.98 -10.22 6.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 165.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.0 136.35 53.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -128.54 133.85 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.67 25.75 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.54 142.54 23.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -85.02 -20.72 30.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.21 -17.3 61.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -97.92 -59.72 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.6 ppp? -51.8 -33.77 37.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 5.6 t -63.81 -34.83 78.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.72 -20.6 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -81.38 -43.83 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 405' ' ' MET . 98.3 t -65.25 -52.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.136 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -61.05 -34.18 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.11 -30.0 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.624 0.725 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -47.97 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.659 2.239 . . . . 0.0 112.313 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.54 131.37 43.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.4 147.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.75 159.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -92.92 -6.41 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.8 m -109.78 -75.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.7 p -76.77 -16.62 59.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 53.94 16.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.48 -75.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 129.33 126.37 2.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.11 144.35 50.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -56.95 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -101.79 160.6 26.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.654 2.236 . . . . 0.0 112.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.17 -38.24 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -79.77 -35.05 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -59.48 -45.19 92.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.25 -34.71 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.629 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.9 t60 -62.9 -34.0 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.35 -28.36 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.58 -17.47 25.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -95.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.629 HG21 ' CE1' ' A' ' 438' ' ' HIS . 74.2 t -67.96 -66.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.03 121.4 41.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.69 131.77 35.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.92 26.73 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.17 -40.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.59 -38.91 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.86 26.82 5.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 137.96 32.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 141.64 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -126.02 143.38 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -68.25 -33.43 74.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.18 149.15 52.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 79.9 t -78.25 -31.57 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -38.39 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 48.7 tp -53.26 -36.56 61.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -52.67 -46.39 67.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 382' ' ' LEU . 1.2 mtt-85 -65.6 -27.36 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -76.18 -58.19 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -57.09 -27.19 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 379' ' ' ARG . 10.1 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.7 mttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.74 -48.88 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.351 -0.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.67 101.5 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.0 t -108.6 150.58 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.82 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.31 128.5 67.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.35 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.6 t -105.51 -64.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.1 -69.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 131.64 -14.14 5.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.43 166.84 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -124.0 140.29 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.01 148.5 46.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.13 25.41 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 142.29 21.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -7.69 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.68 -25.14 28.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -90.75 -56.39 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.74 -30.98 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 t -65.31 -36.2 83.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.03 -12.33 36.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -91.62 -36.8 13.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 405' ' ' MET . 90.4 t -76.94 -51.5 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -64.77 -27.71 69.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -25.58 46.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -47.18 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.1 136.27 48.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.5 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.122 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.538 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.7 t -52.37 159.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -93.71 -6.46 46.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 m -109.53 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.38 -14.78 59.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.83 52.47 20.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -74.96 -76.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.5 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.68 116.03 2.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.481 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -114.95 143.48 45.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -54.94 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.51 160.1 27.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -41.58 4.13 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.258 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.55 -17.03 59.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -86.6 -9.53 55.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 422' ' ' CYS . 19.3 tp -93.3 -40.66 10.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.493 ' HA ' HD12 ' A' ' 439' ' ' ILE . 1.2 p-10 -65.02 -35.41 81.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.32 72.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 442' ' ' VAL . 18.8 t60 -75.67 -43.88 45.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 436' ' ' ASN . 45.3 mt -51.5 -31.19 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -91.81 -33.13 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -67.0 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.8 t -76.01 -62.61 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.696 HG11 HD22 ' A' ' 377' ' ' LEU . 22.0 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.857 0.361 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.94 112.59 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.2 t -53.95 133.61 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.62 29.23 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -132.19 -44.2 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.7 p -114.87 -32.46 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.34 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -96.82 142.32 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.12 131.81 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 377' ' ' LEU . 49.9 m-85 -117.25 131.87 56.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -61.0 -26.65 67.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.04 171.83 13.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.68 HG22 HG21 ' A' ' 362' ' ' VAL . 72.8 t -86.66 -36.48 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.76 -27.12 58.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -26.24 30.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.696 HD22 HG11 ' A' ' 362' ' ' VAL . 16.7 tp -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.99 -50.8 67.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.4 OUTLIER -63.75 -26.58 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -70.87 -55.23 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -53.62 -32.42 51.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 379' ' ' ARG . 29.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.602 0.715 . . . . 0.0 110.939 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.77 -45.97 0.39 Allowed 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.33 -0.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.37 98.34 6.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 157.28 21.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.3 t -82.43 129.33 63.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -22.58 31.81 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.719 2.279 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.02 -68.17 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 32.6 m -63.04 -69.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.74 -12.35 5.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.81 169.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 131.92 50.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -120.83 142.68 49.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -98.16 25.37 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.41 158.24 42.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -23.31 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -69.03 -53.91 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -60.61 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.92 -34.04 39.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.2 t -65.12 -34.56 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -88.84 -20.74 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' HIS . . . . . 0.437 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 79.0 t60 -82.27 -47.57 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 96.2 t -62.12 -53.52 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -62.53 -31.98 72.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -27.8 35.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' HIS . . . . . 0.437 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 29.7 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.54 0.686 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -44.31 2.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.32 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 137.23 51.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.497 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -131.14 145.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.718 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.23 159.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.38 -6.39 50.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -111.08 -75.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -75.28 -16.55 60.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.02 45.84 32.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -71.27 -75.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.497 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 127.51 121.16 2.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -122.57 141.81 51.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.54 -57.02 11.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.844 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -97.94 160.74 27.72 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.674 0.749 . . . . 0.0 110.831 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.34 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -37.26 61.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -28.42 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 422' ' ' CYS . 42.1 tp -86.94 -36.35 18.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.601 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.32 -59.24 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.66 98.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.514 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.73 -41.22 61.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.4 mt -54.11 -41.94 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -9.73 49.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -71.8 -50.5 29.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.84 -50.65 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -118.34 127.41 53.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.05 135.65 57.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 28.51 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.3 -46.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.0 p -112.45 -33.07 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.51 32.4 6.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -98.16 134.79 40.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.3 mm -87.44 145.97 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.484 ' CD1' HD13 ' A' ' 377' ' ' LEU . 50.2 m-85 -129.79 131.52 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -61.32 -29.52 69.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.23 163.31 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 41.1 t -79.16 -31.19 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.5 -29.05 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -82.93 -25.87 31.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.6 tp -78.08 -25.85 47.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.99 -54.08 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.744 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.5 OUTLIER -59.11 -25.85 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -72.91 -54.12 9.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -52.37 -39.67 61.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 379' ' ' ARG . 12.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.521 0.677 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.7 -42.42 0.75 Allowed 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.349 -0.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -123.59 97.99 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.96 157.25 20.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -82.33 129.13 64.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.61 37.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.237 . . . . 0.0 112.355 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.9 -66.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 29.1 m -64.75 -69.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.65 -12.95 5.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.04 171.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.333 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -128.97 135.43 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.92 148.22 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -104.99 23.53 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 155.27 37.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -19.39 25.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -74.22 -24.68 59.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -88.86 -59.92 2.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.6 -32.91 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -64.67 -48.31 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.49 -19.91 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -80.35 -48.98 12.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 405' ' ' MET . 97.5 t -64.91 -59.08 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -52.51 -37.16 56.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.5 t -52.97 -29.09 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.812 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.61 0.719 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -46.11 1.33 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.54 132.85 53.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.66 146.89 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.169 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.68 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.86 159.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.96 -6.38 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.5 m -109.52 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.18 -16.73 58.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 57.65 8.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -83.92 -76.1 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.13 128.14 2.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -128.25 139.82 52.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.6 t -52.01 -54.65 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 160.6 25.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.17 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -53.4 -34.89 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -61.41 -31.79 71.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 422' ' ' CYS . 63.5 tp -77.85 -31.47 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.04 -37.29 86.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.42 -34.16 54.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.655 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -63.94 -36.92 85.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.74 0.305 . . . . 0.0 110.804 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 79.0 mt -72.8 -25.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -20.53 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -96.86 -64.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.655 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -66.13 -68.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -109.08 132.63 53.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.3 t -69.85 133.87 47.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.89 26.26 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.12 -38.59 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.76 -36.47 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.35 -17.82 23.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -51.99 132.2 32.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.332 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.65 147.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 377' ' ' LEU . 53.2 m-85 -131.76 125.06 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -62.83 -34.49 77.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.17 155.7 33.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.12 -27.15 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.96 -43.97 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -34.36 77.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.7 tp -66.14 -30.69 71.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.5 -57.14 14.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.609 ' HA ' HD12 ' A' ' 382' ' ' LEU . 9.6 mtt180 -57.23 -30.59 64.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -69.33 -56.29 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -51.94 -32.83 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 379' ' ' ARG . 7.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.81 -42.79 0.7 Allowed 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.626 -1.823 . . . . 0.0 112.317 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.05 99.55 6.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 154.79 28.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 26.7 t -82.42 129.67 62.22 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.83 24.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.296 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 96.7 t -84.75 -72.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 48.6 m -56.46 -67.78 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.03 4.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.55 170.67 13.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -121.84 133.64 54.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -128.78 139.54 52.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 26.6 6.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.27 151.33 30.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -89.25 -16.52 31.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.5 -24.08 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -90.43 -59.67 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.589 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.56 -32.72 29.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.5 t -64.27 -46.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -78.56 -20.43 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -79.93 -49.68 11.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 405' ' ' MET . 95.3 t -63.01 -58.73 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -51.98 -37.66 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -28.21 32.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.558 0.694 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -47.37 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.64 135.65 49.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.06 146.93 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.05 159.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.24 -6.4 47.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -75.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.1 p -77.65 -17.0 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.38 58.63 7.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -85.34 -75.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 128.72 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -128.6 139.27 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 m -51.93 -55.55 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 160.6 25.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 -47.09 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -54.39 -33.26 58.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -36.16 81.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.627 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.9 tp -72.17 -29.9 64.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.95 -44.81 95.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.82 -35.65 91.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.641 ' CE1' HG21 ' A' ' 442' ' ' VAL . 32.3 t60 -63.11 -34.63 78.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.02 -25.94 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.47 -17.76 25.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -100.37 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -68.31 -67.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 377' ' ' LEU . 7.5 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.842 0.353 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -106.4 128.9 54.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 8.5 t -62.1 134.91 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 26.19 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.28 -39.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -121.71 -38.8 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.88 30.18 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.38 137.05 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.97 147.98 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -133.09 135.95 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.26 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.05 158.12 45.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.91 -25.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.08 -34.07 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -77.94 -34.56 51.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 362' ' ' VAL . 24.1 tp -60.87 -35.26 76.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -55.7 -42.41 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -66.82 -46.65 74.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -61.22 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -51.92 -31.0 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.567 0.699 . . . . 0.0 110.872 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.1 Cg_endo -69.75 -48.9 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.358 -0.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -123.68 100.0 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.91 157.58 21.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -84.08 129.27 59.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -24.39 29.83 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.673 2.248 . . . . 0.0 112.358 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.17 -65.02 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.2 m -69.37 -69.1 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.24 -11.34 5.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 167.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.11 121.01 33.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -110.67 136.86 49.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 24.26 5.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 153.18 33.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -89.19 -18.94 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.07 -25.45 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt-85 -88.46 -59.39 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.66 -33.74 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.8 t -64.88 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -88.56 -20.55 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -82.11 -46.8 13.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 405' ' ' MET . 90.5 t -62.88 -52.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -25.55 45.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 5.4 mptt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.561 0.696 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -38.42 7.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.47 136.31 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.8 145.87 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.097 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.686 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.94 159.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -6.52 50.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.4 m -111.35 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -74.9 -16.43 60.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.93 43.28 30.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -68.26 -76.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.26 120.82 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -121.63 143.35 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -53.77 45.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.46 160.67 25.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -48.37 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.725 2.284 . . . . 0.0 112.31 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -53.15 -37.47 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.88 -26.47 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 422' ' ' CYS . 40.6 tp -88.9 -35.52 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.48 -59.38 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.78 -39.75 98.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.76 -41.41 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.735 0.303 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.2 mt -54.21 -41.75 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.31 -9.54 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.83 -52.81 15.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.04 -51.33 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.937 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.721 HG21 HD22 ' A' ' 377' ' ' LEU . 29.3 m . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.41 118.08 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.24 133.51 52.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -96.0 26.59 4.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.2 -38.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.0 p -119.72 -41.23 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.63 22.81 6.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.25 137.41 32.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.321 . . . . 0.0 110.86 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.62 138.34 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -122.5 128.39 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -58.23 -29.5 65.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.29 171.45 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 -36.82 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -52.29 -42.29 63.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -26.2 62.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.721 HD22 HG21 ' A' ' 362' ' ' VAL . 41.7 tp -77.63 -26.11 50.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -67.6 -53.7 25.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.809 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -61.02 -26.17 67.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.73 -54.64 8.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -53.4 -34.79 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 379' ' ' ARG . 39.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.5 mttt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.54 0.686 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.75 -41.39 0.92 Allowed 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.722 -1.783 . . . . 0.0 112.35 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -124.96 98.41 5.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.8 t -112.47 156.38 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.41 129.19 64.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.62 37.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.723 2.282 . . . . 0.0 112.34 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -94.82 -65.0 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.56 -69.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.64 -12.41 5.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.39 168.38 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -126.9 134.81 50.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.1 144.46 49.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.52 23.5 10.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.53 155.82 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -89.29 -20.9 23.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.69 -24.71 61.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -88.66 -59.75 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.7 -33.57 34.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.7 t -64.79 -46.51 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.838 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -77.49 -19.81 55.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -81.2 -51.06 8.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 405' ' ' MET . 98.1 t -61.16 -54.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.156 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -58.72 -35.8 73.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -30.07 24.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.565 0.698 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -118.5 138.17 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.525 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.79 146.56 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.131 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.692 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.94 159.04 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.75 -6.52 48.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.27 -75.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -76.9 -17.27 59.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.0 61.98 4.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -89.19 -76.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.525 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.78 133.29 3.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -136.47 137.06 39.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -55.87 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.16 160.57 26.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.62 0.724 . . . . 0.0 110.838 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.22 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.335 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -34.73 58.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -62.14 -30.4 71.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 422' ' ' CYS . 69.0 tp -80.28 -33.59 37.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.689 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -61.16 -41.81 97.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -68.68 -35.61 80.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -62.96 -46.3 88.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.0 mt -51.44 -35.17 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.63 -21.17 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.8 -66.94 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.19 -59.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.841 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -85.84 123.91 31.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -57.45 135.89 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -96.62 30.62 2.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.81 -41.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.51 -33.57 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.74 24.55 7.3 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 129.59 43.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 370' ' ' ILE . 4.4 mp -87.7 148.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.68 132.67 48.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.31 -27.0 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.19 175.44 9.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.2 -27.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.77 -44.19 96.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.9 -25.85 67.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.92 -25.8 37.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -64.77 -44.58 89.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.02 62.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -76.97 -48.38 18.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -52.41 -35.42 51.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.929 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 2.6 mtmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.72 -43.76 0.58 Allowed 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.344 -0.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -120.92 102.17 8.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 6.1 p -113.88 153.39 29.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -82.36 129.45 63.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.633 0.73 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -20.82 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.248 . . . . 0.0 112.331 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.74 -69.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.03 -68.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.88 18.33 3.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 172.18 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -124.38 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -127.39 138.62 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.72 25.71 4.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 152.38 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -14.18 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -32.99 50.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.24 -57.81 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.87 -32.75 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 81.1 p -65.9 -48.88 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.32 -18.45 60.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -83.1 -51.33 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 95.7 t -63.4 -58.79 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -31.59 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -25.17 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.594 0.711 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.36 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.304 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.25 135.95 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.93 146.38 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.739 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.09 159.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -92.68 -6.44 49.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 -75.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.4 p -76.88 -17.27 59.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 62.13 4.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.11 -76.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.341 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.46 135.57 3.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.15 135.71 34.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.345 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -57.17 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 160.58 27.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -47.88 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.87 -32.73 54.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -61.51 -30.3 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 422' ' ' CYS . 53.7 tp -80.34 -36.24 34.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.73 -38.77 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.39 -34.76 63.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.463 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.4 t60 -65.99 -49.07 69.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.7 mt -51.62 -32.37 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -91.68 -24.9 19.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -77.19 -66.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 438' ' ' HIS . 59.8 t -75.3 -63.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.84 127.36 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.81 134.32 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -98.45 31.71 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.12 -45.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.2 p -114.02 -34.07 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.53 27.74 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.478 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -96.54 134.2 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 31.0 mm -87.47 147.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 377' ' ' LEU . 39.1 m-85 -131.6 131.01 42.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -32.47 70.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 170.66 15.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.82 -28.22 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -55.02 -45.88 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -46.39 75.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 371' ' ' PHE . 21.2 tp -52.13 -30.33 25.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -53.7 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -62.12 -31.76 72.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -70.43 -51.4 29.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -52.21 -31.07 30.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.96 179.905 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.508 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.9 mttt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.74 -47.53 0.31 Allowed 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.343 -0.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -117.87 98.31 6.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' SER . . . . . 0.5 ' HG ' ' N ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -111.86 157.49 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.1 t -82.35 129.15 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -15.3 36.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.0 -65.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.74 -69.52 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.52 -12.81 5.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 168.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -124.92 132.86 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.9 134.92 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -95.66 25.31 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.12 151.68 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -89.26 -17.49 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -23.12 56.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -91.35 -59.33 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.572 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -51.73 -33.9 36.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.2 t -65.08 -35.39 80.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -88.46 -20.1 25.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' HIS . . . . . 0.401 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 79.5 t60 -82.52 -45.64 14.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 405' ' ' MET . 94.9 t -64.14 -53.2 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -34.54 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 4.1 t -51.98 -30.13 23.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' HIS . . . . . 0.401 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 20.8 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.55 0.69 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.09 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.346 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -119.43 137.86 53.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.35 146.57 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.73 158.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.24 -6.31 50.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -75.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.6 p -75.8 -17.37 59.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.38 60.95 5.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -88.84 -76.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.63 135.31 3.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -136.73 137.94 40.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 40.6 p -52.24 -47.93 65.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -110.41 160.52 28.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.6 64.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.82 -25.85 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 45.6 tp -87.71 -27.69 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.4 t30 -63.88 -38.55 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.24 45.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.515 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -60.89 -41.4 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.5 mt -53.88 -41.94 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.093 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.91 -9.03 47.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.98 -49.22 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.88 -51.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.702 HG21 HD22 ' A' ' 377' ' ' LEU . 21.7 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.31 119.67 23.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.3 t -54.9 133.81 48.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.34 29.6 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.69 -40.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 23.8 p -117.28 -30.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.59 6.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -99.56 141.31 32.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.4 mm -93.66 143.7 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.5 m-85 -128.93 128.34 43.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -29.53 70.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.53 155.05 49.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.76 -29.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -55.4 -32.22 62.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -82.98 -37.42 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.702 HD22 HG21 ' A' ' 362' ' ' VAL . 21.2 tp -63.07 -31.73 72.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.52 -39.95 92.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 382' ' ' LEU . 43.4 mtt180 -73.95 -26.88 60.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -76.82 -48.07 19.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.51 ' HZ3' HD21 ' A' ' 377' ' ' LEU . 11.5 mttp -53.06 -32.5 47.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 379' ' ' ARG . 28.9 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.521 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.582 0.706 . . . . 0.0 110.899 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.77 -47.66 0.3 Allowed 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.314 -0.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -117.24 98.89 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 57.2 p -112.85 155.8 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.37 129.26 64.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.61 36.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.244 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.99 -64.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.54 -69.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.27 -11.67 5.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 169.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -127.91 133.7 49.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.8 145.61 48.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 23.83 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 154.97 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -89.22 -19.52 25.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -24.89 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.66 -59.79 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.585 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.63 -33.13 31.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 t -64.79 -47.19 79.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.57 -20.37 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -80.61 -51.88 8.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 405' ' ' MET . 99.0 t -60.71 -55.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -56.89 -36.86 70.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.12 -30.07 24.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.533 0.682 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.88 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.743 2.295 . . . . 0.0 112.35 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -97.34 130.25 44.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.483 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.89 147.29 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.683 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -92.74 -6.35 49.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.7 m -110.34 -75.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.37 -16.31 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.99 50.67 26.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -76.49 -76.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.331 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.483 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 128.13 127.14 2.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -54.68 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 160.67 25.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.28 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.31 -36.44 61.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -32.75 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -77.23 -35.26 55.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.86 -28.17 69.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -84.34 -31.56 24.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -64.56 -47.57 78.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 48.0 mt -51.69 -34.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -21.52 20.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.44 -66.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.57 -61.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.923 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.496 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.1 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.841 0.353 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.93 140.63 30.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 366' ' ' ILE . 18.8 t -74.43 140.85 44.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.96 28.49 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ILE . . . . . 0.435 HD12 ' SG ' ' A' ' 364' ' ' CYS . 2.6 mp -134.93 -46.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.2 p -112.55 -31.38 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.78 26.09 10.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.46 135.07 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -86.01 145.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.49 ' CD1' HD13 ' A' ' 377' ' ' LEU . 24.7 m-85 -126.34 147.22 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -65.46 -42.95 91.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -123.28 169.98 10.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.08 -29.8 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -63.51 -45.68 89.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -26.13 68.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.496 HD22 ' CG1' ' A' ' 362' ' ' VAL . 15.3 tp -78.99 -27.81 43.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.942 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -49.71 73.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.422 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -65.44 -24.96 67.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -74.33 -54.58 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.479 ' HE3' HD21 ' A' ' 377' ' ' LEU . 14.3 mttt -51.9 -30.18 23.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.577 0.703 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.6 Cg_endo -69.77 -48.39 0.27 Allowed 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.658 -1.809 . . . . 0.0 112.345 -0.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -115.11 103.72 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 47.7 p -115.24 155.46 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.858 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 11.9 t -82.34 129.18 64.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.62 29.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.36 -57.29 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.4 m -76.83 -69.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.39 -12.21 6.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 171.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.89 133.64 47.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.49 141.58 51.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 23.96 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 152.73 32.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 -13.74 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.88 -22.77 49.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -59.03 2.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.591 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.6 -33.47 33.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 t -65.02 -48.53 73.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -75.42 -19.79 59.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -81.36 -49.69 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 405' ' ' MET . 98.9 t -64.77 -60.08 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -52.02 -35.24 46.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 -28.9 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.986 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.57 0.7 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -48.41 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.24 . . . . 0.0 112.349 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.64 138.41 52.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.77 146.5 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.132 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.69 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.78 158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -92.3 -6.5 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -110.07 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.2 p -75.84 -17.37 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.61 61.09 5.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -88.62 -76.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.54 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.75 135.58 3.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.91 139.75 39.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -49.93 68.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.31 160.56 26.59 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.31 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -53.55 -37.88 63.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.17 -26.25 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 422' ' ' CYS . 55.8 tp -88.36 -26.29 22.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.8 t30 -61.63 -49.8 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -67.44 -39.72 91.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -51.87 -41.14 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.9 mt -53.84 -42.2 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -9.11 50.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 -43.47 54.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.03 -50.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.569 ' CG1' HD22 ' A' ' 377' ' ' LEU . 14.2 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.23 134.22 54.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.065 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.82 133.56 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.03 28.11 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.24 -39.83 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 25.8 p -120.1 -33.3 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.65 35.18 4.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -104.55 138.14 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.31 148.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 377' ' ' LEU . 28.3 m-85 -131.62 129.82 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -29.21 46.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -141.67 -179.85 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.33 -28.15 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -55.72 -58.6 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -56.9 -29.4 62.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.831 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.569 HD22 ' CG1' ' A' ' 362' ' ' VAL . 40.7 tp -75.76 -27.55 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.63 -49.61 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -70.49 -25.91 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -71.71 -44.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -58.3 -25.65 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.8 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 1.4 mttp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.594 0.711 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.4 Cg_endo -69.81 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.353 -0.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.96 103.29 10.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 92.5 p -109.0 156.37 19.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.6 t -82.35 128.83 65.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -10.84 29.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.734 2.289 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.38 -67.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 57.7 m -59.57 -68.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.82 17.67 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.25 172.82 8.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.366 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 139.51 50.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -127.76 131.4 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 23.64 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.58 138.98 18.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -81.53 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.73 -23.38 29.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.55 -56.75 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.68 -31.44 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -63.44 -54.79 31.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -73.59 -19.32 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -79.19 -47.74 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 405' ' ' MET . 96.0 t -67.19 -57.41 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -52.03 -36.24 49.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.2 t -53.15 -28.8 27.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.546 0.688 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -46.84 1.08 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.88 136.09 50.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.502 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -128.45 147.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.79 158.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -92.3 -6.43 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.35 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -75.82 -17.08 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.78 56.27 10.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -83.23 -76.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.502 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.38 128.58 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.449 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.97 142.02 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 p -51.99 -50.42 61.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.98 160.61 26.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.63 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.78 -38.22 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.45 -27.83 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 422' ' ' CYS . 56.9 tp -82.23 -33.22 29.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.608 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -60.12 -40.16 88.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.88 -36.11 61.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.03 -44.66 94.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 436' ' ' ASN . 12.2 mt -51.53 -38.02 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -21.38 23.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -64.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 52.3 t -84.54 -59.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.4 m 59.99 33.18 21.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 8.9 p -144.51 74.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -108.8 65.12 0.25 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.61 174.98 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.862 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.2 m -91.61 117.15 29.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.47 -175.67 38.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.49 HG21 HD22 ' A' ' 377' ' ' LEU . 35.4 m -97.51 166.01 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.353 . . . . 0.0 111.122 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -134.73 118.61 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.2 t -53.86 135.72 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.39 29.88 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.72 -43.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 9.0 p -118.32 -35.55 3.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.84 27.37 6.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -89.11 138.68 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.75 143.8 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 377' ' ' LEU . 51.2 m-85 -129.03 132.54 47.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.8 ptt-85 -58.81 -28.49 66.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -136.99 -178.25 5.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.9 -33.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -57.48 -51.53 69.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -57.48 -26.67 61.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 362' ' ' VAL . 27.3 tp -84.37 -26.38 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -38.88 90.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -76.6 -26.17 54.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -71.55 -50.25 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -53.13 -29.58 31.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 379' ' ' ARG . 24.0 mt -76.39 -32.83 58.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -29.59 62.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.97 149.27 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.18 160.15 14.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -111.68 79.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 54.22 85.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.941 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -178.33 159.57 1.15 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.59 0.709 . . . . 0.0 110.948 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.77 -43.82 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 -0.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -119.1 97.78 5.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.951 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.5 t -112.85 156.51 22.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.1 t -82.38 129.29 63.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -19.29 36.29 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.27 -66.28 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.69 -69.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.29 -11.92 5.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.42 169.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.04 132.27 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.23 146.93 48.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.43 25.88 10.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 151.39 31.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -89.21 -15.52 33.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -77.48 -24.2 50.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mmt-85 -90.55 -59.72 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.65 -31.91 27.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.7 t -64.26 -43.22 95.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.88 -20.92 41.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.16 -49.42 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 405' ' ' MET . 98.2 t -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -52.05 -36.57 50.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -30.12 24.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -85.95 -43.7 12.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.9 t0 60.89 77.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -96.46 93.92 1.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.5 160.34 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.82 -34.28 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 75.07 -110.71 3.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -61.27 160.51 22.81 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -43.12 2.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.719 2.279 . . . . 0.0 112.33 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.97 133.94 55.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -127.27 146.96 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.684 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.22 159.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.34 48.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -75.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.6 p -77.12 -17.09 58.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.11 59.16 7.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -85.94 -75.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 126.98 2.78 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.52 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.13 138.93 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.4 t -52.03 -55.24 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.15 160.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -48.21 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.333 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.84 -32.36 44.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -63.91 -35.52 80.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.684 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.6 tp -73.81 -34.27 64.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.55 -35.98 81.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.36 58.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -70.19 -50.19 42.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.764 0.316 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 50.3 mt -51.72 -33.34 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.56 -24.62 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -75.76 -66.85 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.73 -62.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -82.7 -169.89 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.0 t 63.37 92.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -172.8 68.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 170.81 15.68 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -32.9 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.3 8.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.503 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 86.3 p -154.71 161.48 41.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.87 168.94 15.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.835 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -145.71 -165.28 11.27 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.1 p -173.5 179.98 1.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 3.8 m -112.96 60.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -179.93 175.65 46.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.93 159.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.173 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.66 128.13 40.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.71 133.47 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -97.48 29.75 3.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.537 HD13 ' CD2' ' A' ' 384' ' ' HIS . 2.6 mp -134.16 -43.57 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 24.2 p -116.26 -27.32 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 92.13 37.09 6.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -101.28 134.72 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.32 143.39 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 41.8 m-85 -125.08 159.44 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -84.22 -27.22 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -137.49 -176.83 4.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 18.7 m -90.3 -30.42 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.83 -44.7 88.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.66 -25.96 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 371' ' ' PHE . 52.2 tp -82.44 -29.74 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.26 -45.23 77.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -26.05 68.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -81.71 -43.15 18.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -51.95 -37.92 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 52.5 mt -58.68 -33.22 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.8 m -63.46 -27.58 69.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.537 ' CD2' HD13 ' A' ' 366' ' ' ILE . 40.2 m-70 -78.97 66.59 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.08 149.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 129.29 56.57 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -170.5 50.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.947 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -177.14 159.58 1.44 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.905 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.71 -48.03 0.29 Allowed 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 -1.799 . . . . 0.0 112.393 -0.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -114.25 96.59 5.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 p -113.38 155.57 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 19.2 t -82.48 129.36 63.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.659 0.743 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -28.46 25.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.82 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.52 -68.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.62 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 168.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -126.47 132.49 51.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.26 140.07 53.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.07 23.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.44 151.32 30.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -89.23 -9.08 52.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.17 -24.48 37.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.29 -56.85 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.564 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -53.21 -34.82 58.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 17.2 t -65.74 -30.09 70.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -92.77 -20.79 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -84.07 -46.54 11.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 405' ' ' MET . 93.9 t -62.69 -52.81 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -64.15 -30.12 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -26.58 39.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -88.45 -46.06 9.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.94 101.04 10.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 76.6 121.28 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.9 p -177.04 109.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.62 150.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.11 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -131.41 -97.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 160.6 60.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -46.69 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -110.79 136.41 49.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.1 147.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.159 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.86 159.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.57 -6.4 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 16.8 t -109.98 -75.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.26 -16.88 59.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.75 57.47 8.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -84.21 -76.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.67 128.8 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -128.63 140.2 51.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.3 t -52.01 -57.86 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.45 160.51 26.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.353 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -31.1 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 422' ' ' CYS . 59.7 tp -72.52 -37.89 68.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.81 -31.7 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -79.53 -33.47 34.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -64.02 -48.13 77.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.3 mt -51.61 -32.94 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -91.58 -24.03 19.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -66.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.8 -60.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -79.11 -170.42 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.9 m 51.94 70.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -151.93 172.46 31.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 95.09 0.54 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.723 2.282 . . . . 0.0 112.32 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.53 106.28 15.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.13 139.43 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.474 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 52.7 p -156.34 136.62 12.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 14.9 p -176.7 106.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 134.63 122.43 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.29 125.81 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p -160.85 127.89 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -139.84 146.45 17.96 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.513 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.0 p -96.25 141.25 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -112.39 129.09 56.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 6.5 t -59.97 138.77 57.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.8 28.88 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.0 mt -132.54 -41.37 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.1 p -116.94 -33.09 4.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.42 29.49 7.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.66 138.57 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.737 0.304 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 44.4 mm -89.34 144.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -128.29 137.84 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -67.1 -31.29 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.17 151.65 49.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.7 t -72.3 -29.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -58.3 -37.77 75.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -78.36 -27.06 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.513 HD22 ' CG1' ' A' ' 362' ' ' VAL . 38.4 tp -71.54 -28.17 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.26 -55.97 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -55.15 -33.96 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -68.08 -50.56 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -53.67 -32.12 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 2.9 mt -70.39 -32.93 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 3.3 t -70.59 -28.36 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.38 -59.04 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.3 m -78.05 143.42 37.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -145.81 165.8 27.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.533 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -103.61 82.24 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.951 0.405 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER -172.33 159.61 4.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.592 0.711 . . . . 0.0 110.896 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.74 -40.05 1.19 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.313 -0.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -123.64 96.7 5.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.7 t -113.14 156.77 22.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.8 t -82.36 129.36 63.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -19.88 35.47 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.717 2.278 . . . . 0.0 112.366 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 69.7 t -91.63 -64.49 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.8 m -69.08 -69.05 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.67 -10.98 6.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 164.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.71 55.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.33 139.22 53.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.74 28.0 5.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.16 144.72 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -89.27 -9.14 51.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.62 -24.17 33.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -92.65 -58.72 2.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.623 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.3 ppp? -51.91 -35.06 44.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 3.4 t -61.5 -33.66 74.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -91.27 -20.98 21.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -80.74 -39.37 27.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 405' ' ' MET . 96.9 t -68.04 -51.1 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -58.12 -36.04 72.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 1.5 t -52.09 -30.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -88.99 -48.33 7.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.28 175.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 108.62 46.45 0.97 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.71 177.53 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 64.8 t -127.13 101.1 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -75.85 -90.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -77.32 160.59 75.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -47.1 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -109.13 135.63 49.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.05 147.03 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.668 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.73 159.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -92.85 -6.41 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.66 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -76.83 -16.67 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 57.82 8.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.506 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -84.38 -76.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.57 128.89 2.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.91 139.46 52.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -53.59 39.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.832 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -105.23 160.68 25.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -47.74 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.703 2.269 . . . . 0.0 112.387 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.9 -33.1 55.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -63.82 -31.74 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 422' ' ' CYS . 58.2 tp -76.76 -36.86 56.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -60.23 -36.43 77.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.15 57.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.459 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -65.98 -48.08 72.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.9 mt -51.92 -35.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -91.61 -16.98 26.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -83.35 -66.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 438' ' ' HIS . 97.6 t -74.71 -63.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -78.59 59.26 2.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.34 133.92 48.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -168.61 -73.98 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -23.25 30.94 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 0.0 112.296 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 30.7 t -102.72 149.38 24.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 m -131.14 -172.14 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 CA-C-O 119.161 -0.8 . . . . 0.0 112.488 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 50.6 p -138.42 146.36 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.28 155.67 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 135.82 110.89 1.09 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.37 117.38 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.827 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 53.8 p -74.44 164.96 25.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 175.34 165.28 31.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.556 HG21 HD22 ' A' ' 377' ' ' LEU . 26.9 m -103.72 170.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.12 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -132.85 119.92 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.4 ' SG ' HD12 ' A' ' 366' ' ' ILE . 3.7 t -55.37 133.1 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.23 29.06 2.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.4 HD12 ' SG ' ' A' ' 364' ' ' CYS . 2.3 mp -131.4 -40.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.9 p -118.19 -39.96 3.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.44 26.0 5.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 134.77 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.6 mm -89.3 137.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.4 ' CD1' HD13 ' A' ' 377' ' ' LEU . 58.7 m-85 -121.72 128.07 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.498 ' H ' ' NE ' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -58.72 -27.06 64.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.01 172.54 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 -34.82 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.18 -30.88 62.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -80.98 -26.05 36.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.916 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 362' ' ' VAL . 40.6 tp -76.71 -25.95 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -73.68 -53.09 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -54.07 -29.94 46.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.7 OUTLIER -62.21 -37.23 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 20.2 m -74.78 -32.16 61.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -52.44 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 96.5 p -132.73 138.58 47.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -133.85 179.79 17.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -133.38 79.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 110.895 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.3 ptpt -174.1 159.54 2.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.553 0.692 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.76 -45.6 0.41 Allowed 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 -1.782 . . . . 0.0 112.372 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.13 100.12 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 14.9 p -113.32 155.68 24.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 21.0 t -82.4 129.41 63.31 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -31.54 20.02 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.337 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.72 -66.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 22.2 m -67.05 -67.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.29 -11.93 6.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 168.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 132.35 50.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 25.38 5.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.08 42.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -89.24 -22.3 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -54.83 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -55.72 -58.93 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -53.62 -33.83 56.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -66.44 -29.26 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -93.85 -20.77 19.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.61 -46.64 11.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 405' ' ' MET . 93.5 t -62.85 -53.43 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -63.33 -30.35 71.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -26.69 40.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -88.19 -49.21 7.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 179.89 1.0 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.56 7.52 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.5 t -165.85 151.46 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.879 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.62 145.85 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.77 -108.42 2.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -55.81 157.48 7.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.47 136.71 53.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.538 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.92 146.67 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.643 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.79 158.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.49 -6.33 50.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.98 -75.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 29.2 p -76.27 -17.11 59.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 62.25 4.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -89.31 -76.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.858 0.361 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.538 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.8 134.14 3.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -136.95 135.83 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -54.69 26.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.82 160.43 26.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.577 0.703 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.65 2.233 . . . . 0.0 112.366 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.54 -35.8 61.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -60.1 -28.81 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 422' ' ' CYS . 54.4 tp -84.48 -30.44 25.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.1 t30 -63.77 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -82.75 -33.75 23.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -60.88 -46.9 88.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 436' ' ' ASN . 5.8 mt -51.55 -33.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -23.41 19.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.69 -61.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -81.64 -173.23 4.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.7 m 58.19 178.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 127.34 178.08 15.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 102.58 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.722 2.281 . . . . 0.0 112.301 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.2 p -164.2 113.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.894 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.8 m -94.91 162.88 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.159 -0.8 . . . . 0.0 112.44 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.99 -39.18 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 6.7 t 55.79 88.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.31 -144.7 15.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t 57.08 -179.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.83 -173.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.05 -139.05 2.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 374' ' ' VAL . 28.2 m -92.22 149.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.13 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.62 118.99 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.09 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 35.1 t -52.71 133.04 36.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 30.58 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.453 HG21 ' CG ' ' A' ' 384' ' ' HIS . 2.8 mp -131.14 -39.83 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 19.9 p -121.33 -35.97 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 106.06 24.85 6.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -93.64 139.06 31.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.19 143.77 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.59 ' CD1' HD13 ' A' ' 377' ' ' LEU . 40.9 m-85 -130.73 129.28 42.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -33.06 71.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -129.99 150.9 51.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 362' ' ' VAL . 61.9 t -79.2 -37.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -53.15 -31.16 41.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -36.69 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 371' ' ' PHE . 42.1 tp -57.67 -36.32 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.06 -55.85 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.619 ' HA ' HD12 ' A' ' 382' ' ' LEU . 81.6 mtt180 -58.76 -34.3 71.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -67.16 -59.49 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -54.48 -28.82 47.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 379' ' ' ARG . 14.3 mt -69.32 -29.79 67.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.36 -26.17 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.453 ' CG ' HG21 ' A' ' 366' ' ' ILE . 1.8 m-70 -51.93 -74.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 6.2 p -123.26 123.92 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -179.91 -52.24 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -90.42 96.56 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -178.29 159.55 1.16 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.77 -42.46 0.75 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.394 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -124.35 100.33 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.54 156.91 22.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.43 129.36 63.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -19.57 35.79 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.08 -66.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 28.2 m -65.05 -69.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.64 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.14 172.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -129.39 135.25 48.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.59 146.99 47.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 22.47 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 158.71 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -89.26 -22.11 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.48 -32.67 68.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.04 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.551 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.8 -32.59 31.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.824 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 77.3 p -66.79 -47.62 71.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -75.64 -18.89 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -83.78 -54.02 5.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 405' ' ' MET . 95.5 t -60.52 -60.03 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -51.88 -38.33 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -30.01 24.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -83.96 -36.58 23.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.41 86.34 3.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 164.12 98.71 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.51 157.59 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 110.833 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 28.3 t -85.31 -66.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 97.69 -113.85 4.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -69.26 157.38 89.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.44 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -116.81 137.51 52.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.54 146.53 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.646 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.57 158.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -92.52 -6.39 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.95 -75.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.33 -17.05 59.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.66 61.9 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.448 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -89.06 -76.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 137.17 136.45 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.488 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -140.17 140.12 35.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.72 -56.92 14.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.97 160.57 26.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -48.07 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.66 -37.08 62.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -25.9 64.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 422' ' ' CYS . 62.6 tp -86.87 -37.1 18.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -55.13 -38.63 68.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.73 -42.01 32.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.6 t60 -51.97 -48.96 64.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.85 -29.35 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.59 -20.91 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -84.36 -66.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.6 t -72.92 -55.45 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -91.45 45.96 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.13 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -174.82 71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 172.27 12.91 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.722 2.281 . . . . 0.0 112.348 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 30.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 p -130.8 157.58 42.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.528 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.35 169.25 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.15 151.88 50.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 164.34 178.6 37.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.17 174.06 6.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.5 m -103.25 -176.82 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -177.25 91.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.509 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.1 m -92.48 159.49 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.26 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.2 t -56.12 133.58 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.27 27.48 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.46 -39.08 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.66 -40.23 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.31 25.7 5.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.26 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.334 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.6 mm -99.64 143.99 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 377' ' ' LEU . 52.9 m-85 -127.14 141.56 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -26.28 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -136.33 173.56 11.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.05 -31.43 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.26 -27.24 68.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 -40.63 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.51 HD22 ' CG2' ' A' ' 362' ' ' VAL . 38.9 tp -63.3 -27.94 69.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -64.83 -54.58 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.425 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -56.59 -26.88 56.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -81.28 -42.05 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -54.38 -35.69 63.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.9 mt -67.9 -25.99 65.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -26.44 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -75.43 81.42 2.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.37 168.08 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -52.31 146.16 16.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.453 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 -169.64 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 110.86 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -134.07 159.34 72.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.571 0.701 . . . . 0.0 110.903 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.64 -48.76 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.371 -0.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -123.64 99.81 6.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.27 156.68 22.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 22.5 t -84.75 129.43 56.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.575 0.702 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.9 19.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.703 2.269 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.51 -67.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.53 -67.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 121.98 12.9 5.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 165.45 23.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -116.7 135.26 53.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.21 133.97 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.33 24.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.45 143.5 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -21.27 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.91 -19.43 61.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -95.33 -59.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.86 -34.25 40.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.1 t -65.01 -34.43 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.37 -20.42 24.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -82.8 -45.38 14.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 94.5 t -65.47 -58.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -53.91 -37.26 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.97 24.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -83.14 -31.98 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -130.56 101.05 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -88.77 -125.08 2.43 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.8 m -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.879 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 9.6 m -135.89 146.74 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -78.33 -94.15 0.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 160.66 9.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.613 0.72 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -47.51 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.724 2.282 . . . . 0.0 112.311 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -109.6 135.86 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.11 146.59 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.593 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.06 159.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -92.54 -6.49 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.85 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.842 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.31 -17.03 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.92 55.65 11.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -82.24 -76.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 131.2 128.89 3.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.499 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -128.55 142.05 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 8.1 t -52.04 -57.5 9.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -100.81 160.6 26.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -47.87 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.316 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.55 -38.18 66.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -31.03 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 422' ' ' CYS . 60.2 tp -80.86 -36.01 31.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.65 -32.45 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -80.86 -39.83 12.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.525 ' CE1' HG21 ' A' ' 442' ' ' VAL . 22.7 t60 -53.05 -48.33 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.833 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.61 -28.16 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -91.56 -15.14 29.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -93.71 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.525 HG21 ' CE1' ' A' ' 438' ' ' HIS . 97.8 t -69.71 -65.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -84.32 54.7 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.7 t -91.21 -172.97 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.6 173.17 22.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 118.45 5.69 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.367 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.0 t -150.97 105.73 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.91 172.83 11.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.901 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.516 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 65.1 m -148.2 83.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -171.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -87.68 -157.46 31.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.515 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.93 127.46 47.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.835 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.4 t -165.81 137.04 3.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 170.11 -169.38 42.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 377' ' ' LEU . 7.2 p -127.08 140.68 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 370' ' ' ILE . . . -100.47 118.71 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.5 t -52.39 134.0 34.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.9 27.06 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.457 HG21 ' CG ' ' A' ' 384' ' ' HIS . 2.7 mp -126.95 -38.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 8.1 p -120.18 -35.48 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 31.47 5.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.59 139.62 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 363' ' ' ALA . 36.5 mm -87.87 141.97 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 38.8 m-85 -125.66 132.78 52.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -34.76 69.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 154.43 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.67 -33.15 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -53.26 -32.68 49.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -38.36 27.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.517 HD22 ' CG1' ' A' ' 362' ' ' VAL . 50.6 tp -53.25 -37.99 62.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -52.72 -49.43 65.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 382' ' ' LEU . 70.4 mtt180 -65.63 -26.56 67.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -75.54 -58.89 3.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -55.23 -28.64 54.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.4 mt -68.98 -27.43 65.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 21.8 m -83.51 -26.75 29.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.457 ' CG ' HG21 ' A' ' 366' ' ' ILE . 2.4 m-70 -52.47 -33.06 42.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -37.52 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.98 -125.81 7.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 57.62 74.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -176.53 159.53 1.66 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.2 Cg_endo -69.83 -39.64 1.29 Allowed 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.343 -0.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -124.02 101.61 7.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 68.9 p -112.07 152.96 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.1 t -82.37 129.08 64.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.0 37.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.98 -54.4 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.32 -69.09 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.42 -9.98 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 166.9 0.69 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 130.61 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -118.53 158.78 24.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 22.81 12.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.79 133.28 15.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -79.17 -22.79 44.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -74.11 -22.16 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -61.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.619 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.4 ppp? -51.75 -30.08 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 t -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -92.62 -21.0 20.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -81.02 -26.57 36.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 405' ' ' MET . 98.8 t -83.91 -61.15 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -51.93 -35.64 46.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.7 t -52.07 -30.05 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -79.7 -42.35 24.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.34 116.09 9.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -158.18 36.24 0.52 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.536 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.8 m -155.56 179.51 9.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.03 141.71 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -133.44 -76.1 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -58.98 160.67 10.56 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.555 0.693 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -45.86 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.673 2.249 . . . . 0.0 112.371 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.07 137.23 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.99 147.07 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.143 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.1 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -92.92 -6.41 48.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.37 -75.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.08 -16.85 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.97 58.37 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -85.07 -76.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.84 129.32 2.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.02 140.4 51.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -57.16 10.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.44 160.6 25.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -47.5 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -29.81 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -67.04 -37.5 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.657 HD11 ' HA ' ' A' ' 422' ' ' CYS . 65.7 tp -71.52 -36.59 71.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -57.83 -36.46 72.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.56 -36.5 48.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.669 ' CE1' HG21 ' A' ' 442' ' ' VAL . 22.9 t60 -61.33 -37.84 84.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.5 -22.74 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -19.85 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.03 -66.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.669 HG21 ' CE1' ' A' ' 438' ' ' HIS . 96.4 t -59.2 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.058 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -82.15 67.07 8.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.79 121.33 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -174.16 -166.75 32.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 134.56 28.3 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.354 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.94 -72.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -83.39 176.56 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.512 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 3.4 m 62.58 46.88 5.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 13.6 p -153.81 142.72 21.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 167.71 104.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 29.4 t -78.93 136.63 37.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.3 t -162.59 112.53 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.95 71.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.673 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.7 m -90.13 131.49 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 111.152 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -90.76 138.97 31.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.12 140.17 52.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.76 26.18 4.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.69 -51.67 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.9 p -108.54 -25.08 11.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.84 43.03 5.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -111.24 131.8 54.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -85.93 146.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.6 m-85 -128.21 127.46 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -53.34 -32.44 49.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.15 160.15 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.15 -39.44 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -54.46 -33.31 59.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -75.98 -26.0 56.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.673 HD22 ' CG2' ' A' ' 362' ' ' VAL . 45.3 tp -77.2 -27.5 53.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -67.54 -50.78 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -64.01 -24.85 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.6 -53.66 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -62.73 -22.17 66.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.6 OUTLIER -51.43 -64.92 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.67 -41.07 8.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 51.44 38.75 22.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.0 p -95.31 -58.86 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.03 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -139.85 74.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER -173.88 159.6 2.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.571 0.701 . . . . 0.0 110.884 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.65 -46.48 0.36 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.367 -0.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -122.81 98.06 5.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 29.7 p -113.59 155.57 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.42 129.46 63.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -30.14 22.87 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.371 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.86 -65.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.7 m -69.04 -67.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.44 -11.08 6.43 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.11 169.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -125.29 133.85 52.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -125.61 135.76 52.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 23.11 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.48 151.58 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -89.28 -11.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.6 -23.83 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.863 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.31 -56.14 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.7 ppp? -53.94 -35.56 61.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.7 t -65.94 -26.93 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.4 -21.25 18.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -84.74 -45.86 11.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 405' ' ' MET . 88.2 t -62.86 -51.96 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -65.39 -31.79 73.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -30.22 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -80.21 -36.22 35.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.73 119.66 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -142.18 50.09 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 94.1 p -165.08 118.86 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.3 -58.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 94.68 -88.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 155.15 41.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.18 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.73 2.286 . . . . 0.0 112.307 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.07 129.09 51.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.27 147.44 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.557 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.81 158.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -6.42 49.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.55 -16.88 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.68 59.36 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -86.53 -76.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.78 133.1 3.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -135.05 143.18 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.2 m -52.03 -61.12 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.3 160.58 27.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.734 2.289 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.96 -31.45 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -66.44 -29.88 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.7 tp -82.01 -32.15 30.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.81 -40.43 88.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.58 -40.98 58.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.432 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.3 t60 -52.03 -47.25 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.811 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 21.2 mt -51.74 -32.29 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -23.33 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -66.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 438' ' ' HIS . 49.0 t -77.21 -62.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -82.7 -171.88 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.5 t 61.86 81.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -179.42 -179.62 48.76 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -28.33 25.49 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.708 2.272 . . . . 0.0 112.293 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 28.8 t -68.69 101.83 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.3 m -158.53 104.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.847 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.485 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.27 113.33 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.795 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.2 172.55 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -135.86 152.48 21.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.39 156.71 29.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.895 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 75.9 p -129.6 156.38 44.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.34 171.0 12.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.624 HG11 HD22 ' A' ' 377' ' ' LEU . 21.9 t -91.02 128.5 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -98.16 116.35 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.6 134.2 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 27.35 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.36 -39.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.31 -40.56 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.77 25.83 5.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.517 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.32 140.33 29.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.82 143.91 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.48 139.52 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -69.81 -26.22 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.75 167.21 22.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 362' ' ' VAL . 22.3 t -84.06 -38.19 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.56 -28.65 47.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -43.88 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.624 HD22 HG11 ' A' ' 362' ' ' VAL . 23.0 tp -55.47 -31.63 62.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.36 -57.06 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -54.5 -30.02 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -74.82 -49.0 22.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.49 -35.49 65.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 8.9 mt -72.65 -25.99 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 5.9 t -86.21 -26.12 25.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -34.06 40.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.72 165.12 31.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 112.07 22.31 5.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.506 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -153.11 92.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -179.27 159.53 0.95 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.568 0.699 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.72 -43.88 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.368 -0.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -121.02 99.05 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.36 156.88 22.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.0 t -82.35 129.38 63.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.06 35.42 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.628 2.219 . . . . 0.0 112.313 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 65.4 t -91.34 -64.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.9 m -69.46 -69.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.98 -10.22 6.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 165.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.0 136.35 53.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -128.54 133.85 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.67 25.75 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.54 142.54 23.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -85.02 -20.72 30.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.21 -17.3 61.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -97.92 -59.72 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.6 ppp? -51.8 -33.77 37.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 5.6 t -63.81 -34.83 78.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.72 -20.6 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -81.38 -43.83 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 405' ' ' MET . 98.3 t -65.25 -52.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.136 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -61.05 -34.18 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.11 -30.0 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -82.64 -41.36 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.66 127.47 32.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -152.43 -40.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 47.3 t -146.61 -70.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 98.36 -91.02 1.08 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -79.3 153.72 76.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.624 0.725 . . . . 0.0 110.83 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -47.97 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.659 2.239 . . . . 0.0 112.313 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.54 131.37 43.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.4 147.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.75 159.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -92.92 -6.41 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.8 m -109.78 -75.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.7 p -76.77 -16.62 59.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 53.94 16.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.48 -75.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 129.33 126.37 2.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.11 144.35 50.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -56.95 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -101.79 160.6 26.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.654 2.236 . . . . 0.0 112.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.17 -38.24 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -79.77 -35.05 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -59.48 -45.19 92.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.25 -34.71 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.629 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.9 t60 -62.9 -34.0 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.35 -28.36 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.58 -17.47 25.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -95.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.629 HG21 ' CE1' ' A' ' 438' ' ' HIS . 74.2 t -67.96 -66.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -83.64 55.35 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.97 -37.56 11.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -163.4 -165.87 21.27 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.389 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 8.3 t -162.07 74.87 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -174.29 153.57 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.189 -0.784 . . . . 0.0 112.493 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 12.1 p -122.18 149.33 43.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.922 0.391 . . . . 0.0 110.824 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.79 166.89 16.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.812 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -160.43 128.79 2.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.16 169.15 21.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.855 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 4.7 p -168.15 134.64 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 178.57 139.28 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.22 147.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.03 121.4 41.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.69 131.77 35.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.92 26.73 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.469 HG21 ' CG ' ' A' ' 384' ' ' HIS . 4.1 mt -127.17 -40.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.59 -38.91 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.86 26.82 5.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 137.96 32.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 141.64 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -126.02 143.38 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -68.25 -33.43 74.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.18 149.15 52.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 79.9 t -78.25 -31.57 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -38.39 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 48.7 tp -53.26 -36.56 61.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -52.67 -46.39 67.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 382' ' ' LEU . 1.2 mtt-85 -65.6 -27.36 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -76.18 -58.19 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -57.09 -27.19 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 379' ' ' ARG . 10.1 mt -64.63 -29.16 70.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.48 -26.2 23.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.469 ' CG ' HG21 ' A' ' 366' ' ' ILE . 1.1 m-70 -52.01 118.77 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.6 t -179.23 93.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -134.01 105.97 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -179.22 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.7 mttt -153.41 161.07 30.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.74 -48.88 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.351 -0.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.67 101.5 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.0 t -108.6 150.58 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.82 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.31 128.5 67.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.35 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.6 t -105.51 -64.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.1 -69.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 131.64 -14.14 5.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.43 166.84 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -124.0 140.29 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.01 148.5 46.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.13 25.41 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 142.29 21.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -7.69 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.68 -25.14 28.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -90.75 -56.39 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.74 -30.98 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 t -65.31 -36.2 83.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.03 -12.33 36.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -91.62 -36.8 13.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 405' ' ' MET . 90.4 t -76.94 -51.5 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -64.77 -27.71 69.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -25.58 46.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.33 -26.41 55.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.24 -29.8 24.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -158.77 93.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.6 -38.82 2.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.374 . . . . 0.0 110.858 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.13 148.66 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -54.13 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 160.6 37.91 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -47.18 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.1 136.27 48.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.5 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.122 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.538 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.7 t -52.37 159.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -93.71 -6.46 46.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 m -109.53 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.38 -14.78 59.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.83 52.47 20.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -74.96 -76.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.5 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.68 116.03 2.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.481 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -114.95 143.48 45.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -54.94 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.51 160.1 27.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -41.58 4.13 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.258 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.55 -17.03 59.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -86.6 -9.53 55.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 422' ' ' CYS . 19.3 tp -93.3 -40.66 10.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.493 ' HA ' HD12 ' A' ' 439' ' ' ILE . 1.2 p-10 -65.02 -35.41 81.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.32 72.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 442' ' ' VAL . 18.8 t60 -75.67 -43.88 45.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 436' ' ' ASN . 45.3 mt -51.5 -31.19 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -91.81 -33.13 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -67.0 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.8 t -76.01 -62.61 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.35 -176.46 6.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.79 156.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.76 173.28 13.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 79.45 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.7 p -80.94 175.09 10.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.36 103.69 16.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.508 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.24 -170.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 2.1 t 62.36 166.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.71 101.29 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -132.35 36.13 3.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.877 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.98 84.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -148.27 155.18 26.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.696 HG11 HD22 ' A' ' 377' ' ' LEU . 22.0 t -101.34 138.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.94 112.59 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.2 t -53.95 133.61 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.62 29.23 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -132.19 -44.2 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.7 p -114.87 -32.46 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.34 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -96.82 142.32 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.12 131.81 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 377' ' ' LEU . 49.9 m-85 -117.25 131.87 56.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -61.0 -26.65 67.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.04 171.83 13.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.68 HG22 HG21 ' A' ' 362' ' ' VAL . 72.8 t -86.66 -36.48 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.76 -27.12 58.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -26.24 30.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.696 HD22 HG11 ' A' ' 362' ' ' VAL . 16.7 tp -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.99 -50.8 67.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.4 OUTLIER -63.75 -26.58 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -70.87 -55.23 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -53.62 -32.42 51.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 379' ' ' ARG . 29.1 mt -64.69 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 36.1 m -86.43 -26.63 24.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -67.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.48 113.17 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -151.35 -77.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -120.02 81.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.918 0.389 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -166.34 159.55 12.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.77 -45.97 0.39 Allowed 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.33 -0.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.37 98.34 6.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 157.28 21.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.3 t -82.43 129.33 63.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -22.58 31.81 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.719 2.279 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.02 -68.17 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 32.6 m -63.04 -69.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.74 -12.35 5.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.81 169.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 131.92 50.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -120.83 142.68 49.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -98.16 25.37 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.41 158.24 42.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -23.31 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -69.03 -53.91 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -60.61 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.92 -34.04 39.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.2 t -65.12 -34.56 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -88.84 -20.74 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -82.27 -47.57 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 96.2 t -62.12 -53.52 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -62.53 -31.98 72.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -27.8 35.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -88.61 -35.78 16.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -54.25 130.35 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -173.64 39.43 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.462 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.9 t -168.56 -172.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.27 60.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -51.75 -28.47 23.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.91 160.5 27.13 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.54 0.686 . . . . 0.0 110.912 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -44.31 2.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.32 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 137.23 51.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.497 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -131.14 145.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.718 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.23 159.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.38 -6.39 50.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -111.08 -75.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -75.28 -16.55 60.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.02 45.84 32.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -71.27 -75.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.497 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 127.51 121.16 2.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -122.57 141.81 51.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.54 -57.02 11.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.844 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -97.94 160.74 27.72 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.674 0.749 . . . . 0.0 110.831 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.34 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -37.26 61.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -28.42 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 422' ' ' CYS . 42.1 tp -86.94 -36.35 18.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.601 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.32 -59.24 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.66 98.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.514 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.73 -41.22 61.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.4 mt -54.11 -41.94 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -9.73 49.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -71.8 -50.5 29.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.84 -50.65 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -79.23 58.66 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.3 t -104.34 -28.1 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.13 -170.38 54.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 150.74 68.77 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.8 t -101.38 -36.84 8.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.5 p -118.66 -47.48 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.126 -0.819 . . . . 0.0 112.533 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.8 104.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.833 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.06 86.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -136.95 -124.28 2.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.429 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.5 p 54.94 -171.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.22 172.45 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -137.24 137.42 8.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.95 148.79 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -118.34 127.41 53.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.05 135.65 57.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 28.51 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.3 -46.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.0 p -112.45 -33.07 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.51 32.4 6.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -98.16 134.79 40.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.3 mm -87.44 145.97 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.484 ' CD1' HD13 ' A' ' 377' ' ' LEU . 50.2 m-85 -129.79 131.52 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -61.32 -29.52 69.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.23 163.31 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 41.1 t -79.16 -31.19 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.5 -29.05 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -82.93 -25.87 31.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.6 tp -78.08 -25.85 47.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.99 -54.08 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.744 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.5 OUTLIER -59.11 -25.85 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -72.91 -54.12 9.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -52.37 -39.67 61.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 379' ' ' ARG . 12.2 mt -60.88 -30.78 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.22 -26.74 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -28.9 43.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 9.8 t -109.26 123.99 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -66.53 -161.36 1.08 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -177.7 177.16 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.902 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER 64.18 155.43 0.12 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.521 0.677 . . . . 0.0 110.896 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.7 -42.42 0.75 Allowed 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.349 -0.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -123.59 97.99 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.96 157.25 20.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -82.33 129.13 64.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.61 37.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.237 . . . . 0.0 112.355 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.9 -66.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 29.1 m -64.75 -69.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.65 -12.95 5.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.04 171.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.333 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -128.97 135.43 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.92 148.22 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -104.99 23.53 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 155.27 37.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -19.39 25.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -74.22 -24.68 59.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -88.86 -59.92 2.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.6 -32.91 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -64.67 -48.31 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.49 -19.91 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -80.35 -48.98 12.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 405' ' ' MET . 97.5 t -64.91 -59.08 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -52.51 -37.16 56.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.5 t -52.97 -29.09 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -83.1 -30.55 27.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.812 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -52.02 103.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 132.19 -151.5 19.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.1 t -108.46 -40.89 4.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 22.6 t 62.92 70.31 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -98.7 -37.4 4.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 160.59 26.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.61 0.719 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -46.11 1.33 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.54 132.85 53.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.66 146.89 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.169 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.68 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.86 159.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.96 -6.38 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.5 m -109.52 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.18 -16.73 58.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 57.65 8.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -83.92 -76.1 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.13 128.14 2.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -128.25 139.82 52.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.6 t -52.01 -54.65 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 160.6 25.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.17 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -53.4 -34.89 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -61.41 -31.79 71.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 422' ' ' CYS . 63.5 tp -77.85 -31.47 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.04 -37.29 86.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.42 -34.16 54.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.655 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -63.94 -36.92 85.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.74 0.305 . . . . 0.0 110.804 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 79.0 mt -72.8 -25.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -20.53 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -96.86 -64.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.655 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -66.13 -68.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -86.49 54.66 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -32.23 21.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 164.72 74.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 160.09 50.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -56.52 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.21 144.84 32.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.161 -0.8 . . . . 0.0 112.52 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 80.1 p -143.44 141.33 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 31.6 m -156.9 144.04 18.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -94.69 -156.69 32.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.5 m -132.93 101.56 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 110.891 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.18 163.71 12.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 138.95 172.12 12.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.431 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.33 141.35 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -109.08 132.63 53.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.3 t -69.85 133.87 47.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.89 26.26 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 384' ' ' HIS . 2.7 mp -128.12 -38.59 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.76 -36.47 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.35 -17.82 23.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -51.99 132.2 32.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.332 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.65 147.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 377' ' ' LEU . 53.2 m-85 -131.76 125.06 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -62.83 -34.49 77.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.17 155.7 33.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.12 -27.15 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.96 -43.97 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -34.36 77.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.7 tp -66.14 -30.69 71.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.5 -57.14 14.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.609 ' HA ' HD12 ' A' ' 382' ' ' LEU . 9.6 mtt180 -57.23 -30.59 64.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -69.33 -56.29 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -51.94 -32.83 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 379' ' ' ARG . 7.3 mt -57.33 -32.47 66.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 45.4 m -72.42 -39.42 67.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.422 ' CD2' HD13 ' A' ' 366' ' ' ILE . 13.0 m-70 -52.89 -62.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 29.8 m -90.18 168.45 11.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 130.79 -19.38 4.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.5 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.12 82.28 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -169.47 159.55 7.3 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.81 -42.79 0.7 Allowed 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.626 -1.823 . . . . 0.0 112.317 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.05 99.55 6.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 154.79 28.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 26.7 t -82.42 129.67 62.22 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.83 24.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.296 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 96.7 t -84.75 -72.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 48.6 m -56.46 -67.78 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.03 4.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.55 170.67 13.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -121.84 133.64 54.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -128.78 139.54 52.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 26.6 6.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.27 151.33 30.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -89.25 -16.52 31.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.5 -24.08 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -90.43 -59.67 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.589 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.56 -32.72 29.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.5 t -64.27 -46.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -78.56 -20.43 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -79.93 -49.68 11.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 405' ' ' MET . 95.3 t -63.01 -58.73 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -51.98 -37.66 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -28.21 32.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -89.57 -50.95 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 t0 72.2 -69.45 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 107.43 27.1 5.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 8.6 t -89.53 69.98 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.881 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.72 -25.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 151.28 -120.1 1.06 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 160.58 80.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.558 0.694 . . . . 0.0 110.932 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -47.37 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.64 135.65 49.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.06 146.93 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.05 159.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.24 -6.4 47.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -75.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.1 p -77.65 -17.0 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.38 58.63 7.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -85.34 -75.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 128.72 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -128.6 139.27 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 m -51.93 -55.55 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 160.6 25.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 -47.09 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -54.39 -33.26 58.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -36.16 81.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.627 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.9 tp -72.17 -29.9 64.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.95 -44.81 95.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.82 -35.65 91.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.641 ' CE1' HG21 ' A' ' 442' ' ' VAL . 32.3 t60 -63.11 -34.63 78.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.02 -25.94 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.47 -17.76 25.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -100.37 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -68.31 -67.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -89.38 50.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.2 t -76.29 134.92 39.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -104.56 175.85 22.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 167.39 24.54 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.665 2.243 . . . . 0.0 112.377 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -118.53 -44.03 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.6 m 53.66 73.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.134 -0.815 . . . . 0.0 112.503 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.5 t -174.57 152.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 110.815 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.94 139.19 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 106.77 150.75 17.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.05 169.84 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 t -171.79 149.65 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 178.84 150.53 8.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 377' ' ' LEU . 7.5 p -115.33 136.33 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.115 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -106.4 128.9 54.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 8.5 t -62.1 134.91 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 26.19 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.28 -39.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -121.71 -38.8 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.88 30.18 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.38 137.05 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.97 147.98 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -133.09 135.95 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.26 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.05 158.12 45.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.91 -25.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.08 -34.07 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -77.94 -34.56 51.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 362' ' ' VAL . 24.1 tp -60.87 -35.26 76.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -55.7 -42.41 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -66.82 -46.65 74.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -61.22 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -51.92 -31.0 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 1.9 mt -89.77 -25.97 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.4 m -62.46 -25.85 68.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.84 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -57.39 179.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.23 92.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 129.96 -147.15 17.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -169.23 1.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.879 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -137.57 159.47 69.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.699 . . . . 0.0 110.872 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.1 Cg_endo -69.75 -48.9 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.358 -0.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -123.68 100.0 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.91 157.58 21.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -84.08 129.27 59.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -24.39 29.83 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.673 2.248 . . . . 0.0 112.358 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.17 -65.02 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.2 m -69.37 -69.1 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.24 -11.34 5.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 167.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.11 121.01 33.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -110.67 136.86 49.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 24.26 5.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 153.18 33.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -89.19 -18.94 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.07 -25.45 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt-85 -88.46 -59.39 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.66 -33.74 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.8 t -64.88 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -88.56 -20.55 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -82.11 -46.8 13.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 405' ' ' MET . 90.5 t -62.88 -52.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -25.55 45.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -83.95 -25.17 30.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.79 148.59 5.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -59.3 -171.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 6.3 t -61.99 167.99 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.828 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.84 -25.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 68.16 -92.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.478 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -92.52 160.54 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.561 0.696 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -38.42 7.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.47 136.31 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.8 145.87 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.097 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.686 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.94 159.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -6.52 50.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.4 m -111.35 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -74.9 -16.43 60.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.93 43.28 30.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -68.26 -76.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.26 120.82 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -121.63 143.35 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -53.77 45.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.46 160.67 25.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -48.37 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.725 2.284 . . . . 0.0 112.31 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -53.15 -37.47 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.88 -26.47 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 422' ' ' CYS . 40.6 tp -88.9 -35.52 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.48 -59.38 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.78 -39.75 98.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.76 -41.41 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.735 0.303 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.2 mt -54.21 -41.75 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.31 -9.54 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.83 -52.81 15.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.04 -51.33 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -78.1 59.39 2.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 33.5 t -97.43 122.23 40.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 168.92 174.74 37.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.492 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -39.88 5.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 6.5 t -169.91 120.29 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.2 m -148.27 31.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 6.7 p -87.91 131.8 34.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 162.96 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.871 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -174.37 39.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.531 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.29 117.84 31.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.22 146.93 15.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -144.54 163.9 27.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.721 HG21 HD22 ' A' ' 377' ' ' LEU . 29.3 m -98.63 161.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.41 118.08 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.24 133.51 52.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -96.0 26.59 4.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.2 -38.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.0 p -119.72 -41.23 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.63 22.81 6.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.25 137.41 32.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.321 . . . . 0.0 110.86 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.62 138.34 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -122.5 128.39 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -58.23 -29.5 65.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.29 171.45 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 -36.82 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -52.29 -42.29 63.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -26.2 62.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.721 HD22 HG21 ' A' ' 362' ' ' VAL . 41.7 tp -77.63 -26.11 50.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -67.6 -53.7 25.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.809 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -61.02 -26.17 67.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.73 -54.64 8.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -53.4 -34.79 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 379' ' ' ARG . 39.7 mt -57.93 -28.34 64.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.8 m -77.43 -37.76 50.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -52.57 -51.22 60.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.3 m -111.37 123.39 50.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -79.06 -141.71 2.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -179.24 172.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.958 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.5 mttt 64.19 155.48 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.54 0.686 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.75 -41.39 0.92 Allowed 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.722 -1.783 . . . . 0.0 112.35 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -124.96 98.41 5.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.8 t -112.47 156.38 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.41 129.19 64.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.62 37.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.723 2.282 . . . . 0.0 112.34 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -94.82 -65.0 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.56 -69.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.64 -12.41 5.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.39 168.38 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -126.9 134.81 50.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.1 144.46 49.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.52 23.5 10.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.53 155.82 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -89.29 -20.9 23.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.69 -24.71 61.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -88.66 -59.75 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.7 -33.57 34.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.7 t -64.79 -46.51 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.838 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -77.49 -19.81 55.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -81.2 -51.06 8.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 405' ' ' MET . 98.1 t -61.16 -54.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.156 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -58.72 -35.8 73.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -30.07 24.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -86.4 -47.99 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.13 -58.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 68.8 -160.49 52.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.7 112.74 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 110.9 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.34 116.07 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.101 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -108.42 -69.26 0.66 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -90.29 157.51 44.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -118.5 138.17 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.525 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.79 146.56 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.131 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.692 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.94 159.04 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.75 -6.52 48.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.27 -75.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -76.9 -17.27 59.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.0 61.98 4.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -89.19 -76.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.525 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.78 133.29 3.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -136.47 137.06 39.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -55.87 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.16 160.57 26.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.62 0.724 . . . . 0.0 110.838 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.22 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.335 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -34.73 58.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -62.14 -30.4 71.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 422' ' ' CYS . 69.0 tp -80.28 -33.59 37.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.689 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -61.16 -41.81 97.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -68.68 -35.61 80.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -62.96 -46.3 88.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.0 mt -51.44 -35.17 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.63 -21.17 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.8 -66.94 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.19 -59.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -78.59 -172.26 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 39.1 m 53.73 76.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -70.82 -167.2 7.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.515 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 125.72 12.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.34 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -67.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.91 -175.56 3.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.454 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.33 134.0 9.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.888 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 8.1 t -135.58 162.08 33.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -164.99 162.79 35.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.8 p -164.71 179.2 6.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.6 p -169.71 157.78 7.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.11 133.09 3.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 30.8 m -90.87 126.32 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -85.84 123.91 31.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -57.45 135.89 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -96.62 30.62 2.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 384' ' ' HIS . 2.9 mp -133.81 -41.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.51 -33.57 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.74 24.55 7.3 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 129.59 43.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 370' ' ' ILE . 4.4 mp -87.7 148.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.68 132.67 48.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.31 -27.0 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.19 175.44 9.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.2 -27.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.77 -44.19 96.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.9 -25.85 67.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.92 -25.8 37.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -64.77 -44.58 89.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.02 62.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -76.97 -48.38 18.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -52.41 -35.42 51.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.86 -31.05 62.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 22.3 t -64.44 -34.13 77.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.4 ' CD2' HD13 ' A' ' 366' ' ' ILE . 13.2 m-70 -52.52 123.09 10.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.8 p -175.01 155.9 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 140.77 -156.98 25.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.508 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.54 178.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.413 . . . . 0.0 110.856 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 2.6 mtmm 64.12 155.5 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.72 -43.76 0.58 Allowed 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.344 -0.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -120.92 102.17 8.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 6.1 p -113.88 153.39 29.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -82.36 129.45 63.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.633 0.73 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -20.82 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.248 . . . . 0.0 112.331 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.74 -69.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.03 -68.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.88 18.33 3.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 172.18 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -124.38 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -127.39 138.62 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.72 25.71 4.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 152.38 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -14.18 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -32.99 50.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.24 -57.81 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.87 -32.75 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 81.1 p -65.9 -48.88 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.32 -18.45 60.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -83.1 -51.33 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 95.7 t -63.4 -58.79 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -31.59 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -25.17 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -89.33 9.2 26.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.82 -59.3 4.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.28 -127.21 34.7 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.95 -53.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.878 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 60.4 t 51.99 86.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -86.93 -148.37 12.83 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -53.05 157.42 2.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.711 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.36 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.304 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.25 135.95 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.93 146.38 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.739 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.09 159.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -92.68 -6.44 49.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 -75.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.4 p -76.88 -17.27 59.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 62.13 4.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.11 -76.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.341 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.46 135.57 3.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.15 135.71 34.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.345 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -57.17 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 160.58 27.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -47.88 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.87 -32.73 54.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -61.51 -30.3 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 422' ' ' CYS . 53.7 tp -80.34 -36.24 34.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.73 -38.77 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.39 -34.76 63.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.463 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.4 t60 -65.99 -49.07 69.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.7 mt -51.62 -32.37 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -91.68 -24.9 19.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -77.19 -66.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 438' ' ' HIS . 59.8 t -75.3 -63.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -83.23 -169.88 2.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 t 62.67 179.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.23 -179.39 25.98 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 128.69 16.42 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.704 2.27 . . . . 0.0 112.373 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.94 -65.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 60.2 p -70.93 113.46 8.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.465 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.53 155.74 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 0.0 110.84 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 12.9 t -159.22 157.74 31.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -161.96 110.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 75.3 m -161.35 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.861 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 75.7 m -142.99 94.49 2.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -158.99 132.26 3.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.483 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.85 144.09 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.84 127.36 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.81 134.32 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -98.45 31.71 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.12 -45.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.2 p -114.02 -34.07 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.53 27.74 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.478 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -96.54 134.2 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 31.0 mm -87.47 147.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 377' ' ' LEU . 39.1 m-85 -131.6 131.01 42.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -32.47 70.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 170.66 15.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.82 -28.22 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -55.02 -45.88 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -46.39 75.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 371' ' ' PHE . 21.2 tp -52.13 -30.33 25.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -53.7 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -62.12 -31.76 72.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -70.43 -51.4 29.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -52.21 -31.07 30.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 4.5 mt -72.3 -38.38 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.96 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 48.2 t -66.04 -29.45 69.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.22 -48.92 77.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.5 p 54.96 -171.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 174.56 115.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.52 167.24 1.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.508 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.9 mttt 64.19 155.43 0.12 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.74 -47.53 0.31 Allowed 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.343 -0.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -117.87 98.31 6.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.86 157.49 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.1 t -82.35 129.15 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -15.3 36.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.0 -65.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.74 -69.52 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.52 -12.81 5.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 168.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -124.92 132.86 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.9 134.92 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -95.66 25.31 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.12 151.68 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -89.26 -17.49 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -23.12 56.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -91.35 -59.33 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.572 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -51.73 -33.9 36.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.2 t -65.08 -35.39 80.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -88.46 -20.1 25.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -82.52 -45.64 14.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 405' ' ' MET . 94.9 t -64.14 -53.2 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -34.54 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 4.1 t -51.98 -30.13 23.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -86.42 -45.15 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.2 t70 63.19 164.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 175.49 -169.79 42.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.491 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 6.3 t 58.8 -171.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.53 89.72 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -94.27 -18.72 35.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.469 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -79.52 157.35 74.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.55 0.69 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.09 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.346 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -119.43 137.86 53.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.35 146.57 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.73 158.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.24 -6.31 50.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -75.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.6 p -75.8 -17.37 59.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.38 60.95 5.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -88.84 -76.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.63 135.31 3.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -136.73 137.94 40.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 40.6 p -52.24 -47.93 65.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -110.41 160.52 28.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.6 64.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.82 -25.85 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 45.6 tp -87.71 -27.69 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.4 t30 -63.88 -38.55 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.24 45.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.515 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -60.89 -41.4 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.5 mt -53.88 -41.94 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.093 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.91 -9.03 47.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.98 -49.22 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.88 -51.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -82.28 56.17 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 t -115.87 132.95 56.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.09 -72.97 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -34.8 13.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.7 p -164.53 164.38 21.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.7 t -148.98 121.11 8.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.154 -0.803 . . . . 0.0 112.484 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 41.8 t -161.76 152.13 17.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 130.67 36.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.842 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 176.62 57.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.1 t -170.94 -173.55 1.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.369 . . . . 0.0 110.872 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.48 165.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 141.06 80.76 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.702 HG21 HD22 ' A' ' 377' ' ' LEU . 21.7 m -92.65 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.31 119.67 23.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.3 t -54.9 133.81 48.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.34 29.6 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.69 -40.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 23.8 p -117.28 -30.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.59 6.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -99.56 141.31 32.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.4 mm -93.66 143.7 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.5 m-85 -128.93 128.34 43.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -29.53 70.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.53 155.05 49.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.76 -29.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -55.4 -32.22 62.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -82.98 -37.42 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.702 HD22 HG21 ' A' ' 362' ' ' VAL . 21.2 tp -63.07 -31.73 72.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.52 -39.95 92.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 382' ' ' LEU . 43.4 mtt180 -73.95 -26.88 60.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -76.82 -48.07 19.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.51 ' HZ3' HD21 ' A' ' 377' ' ' LEU . 11.5 mttp -53.06 -32.5 47.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 379' ' ' ARG . 28.9 mt -60.3 -33.59 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.14 -26.75 65.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.807 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -76.54 86.09 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.71 95.17 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 173.66 -168.71 41.67 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.539 ' H ' ' NE ' ' A' ' 398' ' ' ARG . 1.1 tt0 63.26 170.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.521 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER 64.07 155.49 0.12 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.582 0.706 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.77 -47.66 0.3 Allowed 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.314 -0.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -117.24 98.89 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 57.2 p -112.85 155.8 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.37 129.26 64.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.61 36.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.244 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.99 -64.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.54 -69.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.27 -11.67 5.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 169.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ARG . . . . . 0.539 ' NE ' ' H ' ' A' ' 387' ' ' GLU . 1.4 mpt_? -127.91 133.7 49.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.8 145.61 48.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 23.83 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 154.97 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -89.22 -19.52 25.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -24.89 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.66 -59.79 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.585 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.63 -33.13 31.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 t -64.79 -47.19 79.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.57 -20.37 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -80.61 -51.88 8.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 405' ' ' MET . 99.0 t -60.71 -55.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -56.89 -36.86 70.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.12 -30.07 24.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -84.9 -38.67 19.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.33 172.72 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -131.75 -38.43 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.3 m -94.52 122.15 36.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.14 -26.57 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 109.25 -86.83 0.46 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -82.49 153.67 68.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.533 0.682 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.88 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.743 2.295 . . . . 0.0 112.35 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -97.34 130.25 44.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.483 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.89 147.29 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.683 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -92.74 -6.35 49.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.7 m -110.34 -75.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.37 -16.31 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.99 50.67 26.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -76.49 -76.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.331 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.483 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 128.13 127.14 2.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -54.68 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 160.67 25.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.28 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.31 -36.44 61.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -32.75 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -77.23 -35.26 55.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.86 -28.17 69.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -84.34 -31.56 24.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -64.56 -47.57 78.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 48.0 mt -51.69 -34.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -21.52 20.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.44 -66.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.57 -61.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -77.59 -170.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p 63.14 22.68 13.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.76 171.07 32.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 85.27 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.92 27.04 3.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 79.3 p -139.99 -51.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.481 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 2.1 m -146.98 -43.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.45 157.1 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -141.94 36.95 1.63 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 64.6 p -152.25 101.84 2.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 0.0 110.854 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.67 124.1 1.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.829 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.15 151.77 23.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.496 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.1 p -98.47 131.17 46.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.93 140.63 30.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 366' ' ' ILE . 18.8 t -74.43 140.85 44.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.96 28.49 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ILE . . . . . 0.474 HG21 ' CG ' ' A' ' 384' ' ' HIS . 2.6 mp -134.93 -46.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.2 p -112.55 -31.38 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.78 26.09 10.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.46 135.07 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -86.01 145.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.49 ' CD1' HD13 ' A' ' 377' ' ' LEU . 24.7 m-85 -126.34 147.22 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -65.46 -42.95 91.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -123.28 169.98 10.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.08 -29.8 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -63.51 -45.68 89.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -26.13 68.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.496 HD22 ' CG1' ' A' ' 362' ' ' VAL . 15.3 tp -78.99 -27.81 43.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.942 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -49.71 73.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.422 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -65.44 -24.96 67.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -74.33 -54.58 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.479 ' HE3' HD21 ' A' ' 377' ' ' LEU . 14.3 mttt -51.9 -30.18 23.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.8 mt -72.01 -36.7 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.45 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.474 ' CG ' HG21 ' A' ' 366' ' ' ILE . 11.2 m-70 -51.98 137.94 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.86 100.98 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 153.77 90.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -179.37 167.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.912 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER 64.08 155.69 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 0.0 110.883 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.6 Cg_endo -69.77 -48.39 0.27 Allowed 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.658 -1.809 . . . . 0.0 112.345 -0.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -115.11 103.72 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 47.7 p -115.24 155.46 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.858 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 11.9 t -82.34 129.18 64.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.62 29.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.36 -57.29 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.4 m -76.83 -69.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.39 -12.21 6.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 171.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.89 133.64 47.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.49 141.58 51.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 23.96 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 152.73 32.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 -13.74 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.88 -22.77 49.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -59.03 2.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.591 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.6 -33.47 33.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 t -65.02 -48.53 73.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -75.42 -19.79 59.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -81.36 -49.69 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 405' ' ' MET . 98.9 t -64.77 -60.08 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -52.02 -35.24 46.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 -28.9 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -82.61 -48.8 10.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.08 -172.94 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 113.24 -41.84 2.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 5.5 t -66.55 152.98 44.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 40.2 t -91.12 90.66 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -113.9 -82.16 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -63.35 157.49 63.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.57 0.7 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -48.41 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.24 . . . . 0.0 112.349 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.64 138.41 52.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.77 146.5 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.132 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.69 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.78 158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -92.3 -6.5 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -110.07 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.2 p -75.84 -17.37 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.61 61.09 5.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -88.62 -76.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.54 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.75 135.58 3.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.91 139.75 39.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -49.93 68.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.31 160.56 26.59 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.31 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -53.55 -37.88 63.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.17 -26.25 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 422' ' ' CYS . 55.8 tp -88.36 -26.29 22.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.8 t30 -61.63 -49.8 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -67.44 -39.72 91.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -51.87 -41.14 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.9 mt -53.84 -42.2 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -9.11 50.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 -43.47 54.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.03 -50.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -79.31 58.57 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.76 172.67 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -112.07 172.09 14.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.49 69.01 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.38 -60.33 3.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.0 t -135.84 131.97 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.497 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.52 177.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 0.0 110.866 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 7.9 m -153.98 170.43 21.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -157.14 82.19 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 73.2 m -108.66 -43.79 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.5 m 63.17 -179.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 153.17 -166.15 31.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.569 ' CG1' HD22 ' A' ' 377' ' ' LEU . 14.2 p -90.28 148.54 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.23 134.22 54.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.065 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.82 133.56 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.03 28.11 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.24 -39.83 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 25.8 p -120.1 -33.3 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.65 35.18 4.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -104.55 138.14 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.31 148.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 377' ' ' LEU . 28.3 m-85 -131.62 129.82 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -29.21 46.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -141.67 -179.85 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.33 -28.15 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -55.72 -58.6 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -56.9 -29.4 62.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.831 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.569 HD22 ' CG1' ' A' ' 362' ' ' VAL . 40.7 tp -75.76 -27.55 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.63 -49.61 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -70.49 -25.91 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -71.71 -44.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -58.3 -25.65 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.8 mt -83.57 -46.37 12.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -16.4 62.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.54 124.17 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.4 p -145.92 -42.44 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.35 79.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.55 165.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 110.905 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 1.4 mttp 64.18 155.58 0.12 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.594 0.711 . . . . 0.0 110.896 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.4 Cg_endo -69.81 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.353 -0.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.96 103.29 10.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 92.5 p -109.0 156.37 19.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.6 t -82.35 128.83 65.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -10.84 29.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.734 2.289 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.38 -67.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 57.7 m -59.57 -68.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.82 17.67 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.25 172.82 8.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.366 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 139.51 50.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -127.76 131.4 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 23.64 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.58 138.98 18.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -81.53 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.73 -23.38 29.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.55 -56.75 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.68 -31.44 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -63.44 -54.79 31.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -73.59 -19.32 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -79.19 -47.74 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 405' ' ' MET . 96.0 t -67.19 -57.41 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -52.03 -36.24 49.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.2 t -53.15 -28.8 27.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -84.64 -42.11 15.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -102.85 50.11 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 153.26 111.29 0.45 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 16.8 t 58.08 82.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.875 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.07 -69.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.72 -116.45 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.27 160.68 8.83 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.546 0.688 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -46.84 1.08 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.88 136.09 50.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.502 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -128.45 147.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.79 158.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -92.3 -6.43 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.35 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -75.82 -17.08 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.78 56.27 10.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -83.23 -76.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.502 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.38 128.58 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.449 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.97 142.02 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 p -51.99 -50.42 61.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.98 160.61 26.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.63 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.78 -38.22 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.45 -27.83 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 422' ' ' CYS . 56.9 tp -82.23 -33.22 29.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.608 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -60.12 -40.16 88.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.88 -36.11 61.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.03 -44.66 94.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 436' ' ' ASN . 12.2 mt -51.53 -38.02 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -21.38 23.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -64.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 52.3 t -84.54 -59.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -80.56 -175.19 5.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.21 160.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -175.19 -176.04 43.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 82.76 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.665 2.243 . . . . 0.0 112.344 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.82 121.84 15.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 -61.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.483 -179.983 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.49 HG21 HD22 ' A' ' 377' ' ' LEU . 35.4 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.84 0.353 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -134.73 118.61 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.2 t -53.86 135.72 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.39 29.88 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.72 -43.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 9.0 p -118.32 -35.55 3.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.84 27.37 6.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -89.11 138.68 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.75 143.8 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 377' ' ' LEU . 51.2 m-85 -129.03 132.54 47.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.8 ptt-85 -58.81 -28.49 66.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -136.99 -178.25 5.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.9 -33.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -57.48 -51.53 69.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -57.48 -26.67 61.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 362' ' ' VAL . 27.3 tp -84.37 -26.38 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -38.88 90.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -76.6 -26.17 54.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -71.55 -50.25 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -53.13 -29.58 31.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 379' ' ' ARG . 24.0 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.59 0.709 . . . . 0.0 110.948 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.77 -43.82 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 -0.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -119.1 97.78 5.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.951 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.5 t -112.85 156.51 22.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.1 t -82.38 129.29 63.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -19.29 36.29 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.27 -66.28 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.69 -69.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.29 -11.92 5.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.42 169.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.04 132.27 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.23 146.93 48.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.43 25.88 10.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 151.39 31.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -89.21 -15.52 33.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -77.48 -24.2 50.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mmt-85 -90.55 -59.72 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.65 -31.91 27.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.7 t -64.26 -43.22 95.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.88 -20.92 41.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . 0.401 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 81.1 t60 -80.16 -49.42 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 405' ' ' MET . 98.2 t -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -52.05 -36.57 50.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -30.12 24.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . 0.401 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 26.9 m-70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 9.2 mptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -43.12 2.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.719 2.279 . . . . 0.0 112.33 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.97 133.94 55.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -127.27 146.96 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.684 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.22 159.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.34 48.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -75.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.6 p -77.12 -17.09 58.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.11 59.16 7.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -85.94 -75.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 126.98 2.78 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.52 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.13 138.93 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.4 t -52.03 -55.24 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.15 160.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -48.21 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.333 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.84 -32.36 44.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -63.91 -35.52 80.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.684 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.6 tp -73.81 -34.27 64.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.55 -35.98 81.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.36 58.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -70.19 -50.19 42.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.764 0.316 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 50.3 mt -51.72 -33.34 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.56 -24.62 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -75.76 -66.85 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.73 -62.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.799 0.333 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.66 128.13 40.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.71 133.47 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -97.48 29.75 3.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.16 -43.57 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 24.2 p -116.26 -27.32 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 92.13 37.09 6.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -101.28 134.72 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.32 143.39 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 41.8 m-85 -125.08 159.44 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -84.22 -27.22 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -137.49 -176.83 4.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 18.7 m -90.3 -30.42 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.83 -44.7 88.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.66 -25.96 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 371' ' ' PHE . 52.2 tp -82.44 -29.74 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.26 -45.23 77.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -26.05 68.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -81.71 -43.15 18.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -51.95 -37.92 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.559 0.695 . . . . 0.0 110.905 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.71 -48.03 0.29 Allowed 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 -1.799 . . . . 0.0 112.393 -0.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -114.25 96.59 5.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 p -113.38 155.57 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 19.2 t -82.48 129.36 63.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.659 0.743 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -28.46 25.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.82 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.52 -68.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.62 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 168.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -126.47 132.49 51.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.26 140.07 53.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.07 23.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.44 151.32 30.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -89.23 -9.08 52.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.17 -24.48 37.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.29 -56.85 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.564 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -53.21 -34.82 58.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 17.2 t -65.74 -30.09 70.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -92.77 -20.79 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -84.07 -46.54 11.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 405' ' ' MET . 93.9 t -62.69 -52.81 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -64.15 -30.12 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -26.58 39.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -46.69 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -110.79 136.41 49.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.1 147.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.159 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.86 159.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.57 -6.4 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 16.8 t -109.98 -75.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.26 -16.88 59.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.75 57.47 8.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -84.21 -76.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.67 128.8 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -128.63 140.2 51.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.3 t -52.01 -57.86 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.45 160.51 26.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.353 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -31.1 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 422' ' ' CYS . 59.7 tp -72.52 -37.89 68.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.81 -31.7 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -79.53 -33.47 34.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -64.02 -48.13 77.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.3 mt -51.61 -32.94 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -91.58 -24.03 19.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -66.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.8 -60.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.513 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.0 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.342 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -112.39 129.09 56.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 6.5 t -59.97 138.77 57.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.8 28.88 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.0 mt -132.54 -41.37 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.1 p -116.94 -33.09 4.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.42 29.49 7.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.66 138.57 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.737 0.304 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 44.4 mm -89.34 144.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -128.29 137.84 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -67.1 -31.29 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.17 151.65 49.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.7 t -72.3 -29.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -58.3 -37.77 75.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -78.36 -27.06 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.513 HD22 ' CG1' ' A' ' 362' ' ' VAL . 38.4 tp -71.54 -28.17 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.26 -55.97 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -55.15 -33.96 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -68.08 -50.56 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -53.67 -32.12 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.592 0.711 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.74 -40.05 1.19 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.313 -0.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -123.64 96.7 5.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.7 t -113.14 156.77 22.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.8 t -82.36 129.36 63.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -19.88 35.47 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.717 2.278 . . . . 0.0 112.366 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 69.7 t -91.63 -64.49 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.8 m -69.08 -69.05 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.67 -10.98 6.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 164.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.71 55.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.33 139.22 53.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.74 28.0 5.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.16 144.72 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -89.27 -9.14 51.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.62 -24.17 33.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -92.65 -58.72 2.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.623 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.3 ppp? -51.91 -35.06 44.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 3.4 t -61.5 -33.66 74.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -91.27 -20.98 21.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -80.74 -39.37 27.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 405' ' ' MET . 96.9 t -68.04 -51.1 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -58.12 -36.04 72.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 1.5 t -52.09 -30.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 3.0 mptt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -47.1 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -109.13 135.63 49.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.05 147.03 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.668 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.73 159.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -92.85 -6.41 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.66 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -76.83 -16.67 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 57.82 8.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.506 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -84.38 -76.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.57 128.89 2.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.91 139.46 52.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -53.59 39.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.832 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -105.23 160.68 25.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -47.74 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.703 2.269 . . . . 0.0 112.387 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.9 -33.1 55.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -63.82 -31.74 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 422' ' ' CYS . 58.2 tp -76.76 -36.86 56.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -60.23 -36.43 77.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.15 57.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.459 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -65.98 -48.08 72.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.9 mt -51.92 -35.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -91.61 -16.98 26.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -83.35 -66.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 438' ' ' HIS . 97.6 t -74.71 -63.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.556 HG21 HD22 ' A' ' 377' ' ' LEU . 26.9 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.854 0.359 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -132.85 119.92 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.4 ' SG ' HD12 ' A' ' 366' ' ' ILE . 3.7 t -55.37 133.1 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.23 29.06 2.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . 0.4 HD12 ' SG ' ' A' ' 364' ' ' CYS . 2.3 mp -131.4 -40.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.9 p -118.19 -39.96 3.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.44 26.0 5.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 134.77 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.6 mm -89.3 137.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.4 ' CD1' HD13 ' A' ' 377' ' ' LEU . 58.7 m-85 -121.72 128.07 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.498 ' H ' ' NE ' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -58.72 -27.06 64.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.01 172.54 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 -34.82 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.18 -30.88 62.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -80.98 -26.05 36.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.916 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 362' ' ' VAL . 40.6 tp -76.71 -25.95 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -73.68 -53.09 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -54.07 -29.94 46.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.3 ptpt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.553 0.692 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.76 -45.6 0.41 Allowed 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 -1.782 . . . . 0.0 112.372 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.13 100.12 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 14.9 p -113.32 155.68 24.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 21.0 t -82.4 129.41 63.31 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -31.54 20.02 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.337 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.72 -66.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 22.2 m -67.05 -67.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.29 -11.93 6.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 168.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 132.35 50.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 25.38 5.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.08 42.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -89.24 -22.3 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -54.83 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -55.72 -58.93 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -53.62 -33.83 56.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -66.44 -29.26 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -93.85 -20.77 19.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . 0.45 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 77.1 t60 -84.61 -46.64 11.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 405' ' ' MET . 93.5 t -62.85 -53.43 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -63.33 -30.35 71.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -26.69 40.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . 0.45 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 31.5 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.47 136.71 53.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.538 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.92 146.67 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.643 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.79 158.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.49 -6.33 50.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.98 -75.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 29.2 p -76.27 -17.11 59.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 62.25 4.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -89.31 -76.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.858 0.361 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.538 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.8 134.14 3.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -136.95 135.83 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -54.69 26.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.82 160.43 26.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.577 0.703 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.65 2.233 . . . . 0.0 112.366 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.54 -35.8 61.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -60.1 -28.81 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 422' ' ' CYS . 54.4 tp -84.48 -30.44 25.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.1 t30 -63.77 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -82.75 -33.75 23.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -60.88 -46.9 88.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 436' ' ' ASN . 5.8 mt -51.55 -33.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -23.41 19.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.69 -61.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 374' ' ' VAL . 28.2 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.62 118.99 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.09 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 35.1 t -52.71 133.04 36.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 30.58 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.14 -39.83 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 19.9 p -121.33 -35.97 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 106.06 24.85 6.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -93.64 139.06 31.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.19 143.77 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.59 ' CD1' HD13 ' A' ' 377' ' ' LEU . 40.9 m-85 -130.73 129.28 42.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -33.06 71.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -129.99 150.9 51.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 362' ' ' VAL . 61.9 t -79.2 -37.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -53.15 -31.16 41.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -36.69 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 371' ' ' PHE . 42.1 tp -57.67 -36.32 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.06 -55.85 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.619 ' HA ' HD12 ' A' ' 382' ' ' LEU . 81.6 mtt180 -58.76 -34.3 71.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -67.16 -59.49 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -54.48 -28.82 47.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 379' ' ' ARG . 14.3 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.77 -42.46 0.75 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.394 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -124.35 100.33 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.54 156.91 22.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.43 129.36 63.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -19.57 35.79 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.08 -66.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 28.2 m -65.05 -69.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.64 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.14 172.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -129.39 135.25 48.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.59 146.99 47.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 22.47 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 158.71 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -89.26 -22.11 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.48 -32.67 68.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.04 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.551 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.8 -32.59 31.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.824 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 77.3 p -66.79 -47.62 71.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -75.64 -18.89 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -83.78 -54.02 5.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 405' ' ' MET . 95.5 t -60.52 -60.03 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -51.88 -38.33 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -30.01 24.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.582 0.706 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.44 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -116.81 137.51 52.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.54 146.53 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.646 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.57 158.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -92.52 -6.39 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.95 -75.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.33 -17.05 59.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.66 61.9 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.448 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -89.06 -76.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 137.17 136.45 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.488 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -140.17 140.12 35.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.72 -56.92 14.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.97 160.57 26.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -48.07 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.66 -37.08 62.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -59.32 -25.9 64.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 422' ' ' CYS . 62.6 tp -86.87 -37.1 18.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -55.13 -38.63 68.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.73 -42.01 32.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.6 t60 -51.97 -48.96 64.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.85 -29.35 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.59 -20.91 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -84.36 -66.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.6 t -72.92 -55.45 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.26 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.2 t -56.12 133.58 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.27 27.48 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.46 -39.08 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.66 -40.23 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.31 25.7 5.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.26 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.334 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.6 mm -99.64 143.99 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 377' ' ' LEU . 52.9 m-85 -127.14 141.56 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -26.28 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -136.33 173.56 11.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.05 -31.43 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.26 -27.24 68.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 -40.63 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.51 HD22 ' CG2' ' A' ' 362' ' ' VAL . 38.9 tp -63.3 -27.94 69.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -64.83 -54.58 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.425 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -56.59 -26.88 56.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -81.28 -42.05 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -54.38 -35.69 63.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.9 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.571 0.701 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.64 -48.76 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.371 -0.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -123.64 99.81 6.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.27 156.68 22.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 22.5 t -84.75 129.43 56.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.575 0.702 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.9 19.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.703 2.269 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.51 -67.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.53 -67.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 121.98 12.9 5.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 165.45 23.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -116.7 135.26 53.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.21 133.97 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.33 24.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.45 143.5 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -21.27 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.91 -19.43 61.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -95.33 -59.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.86 -34.25 40.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.1 t -65.01 -34.43 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.37 -20.42 24.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -82.8 -45.38 14.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 94.5 t -65.47 -58.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -53.91 -37.26 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.97 24.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.613 0.72 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -47.51 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.724 2.282 . . . . 0.0 112.311 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -109.6 135.86 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.11 146.59 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.593 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.06 159.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -92.54 -6.49 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.85 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.842 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.31 -17.03 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.92 55.65 11.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -82.24 -76.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 131.2 128.89 3.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.499 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -128.55 142.05 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 8.1 t -52.04 -57.5 9.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -100.81 160.6 26.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -47.87 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.316 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.55 -38.18 66.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.42 -31.03 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 422' ' ' CYS . 60.2 tp -80.86 -36.01 31.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.65 -32.45 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -80.86 -39.83 12.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.525 ' CE1' HG21 ' A' ' 442' ' ' VAL . 22.7 t60 -53.05 -48.33 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.833 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.61 -28.16 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -91.56 -15.14 29.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -93.71 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.525 HG21 ' CE1' ' A' ' 438' ' ' HIS . 97.8 t -69.71 -65.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 377' ' ' LEU . 7.2 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 370' ' ' ILE . . . -100.47 118.71 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.5 t -52.39 134.0 34.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.9 27.06 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.95 -38.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 8.1 p -120.18 -35.48 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 31.47 5.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.59 139.62 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 363' ' ' ALA . 36.5 mm -87.87 141.97 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 38.8 m-85 -125.66 132.78 52.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -34.76 69.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 154.43 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.67 -33.15 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -53.26 -32.68 49.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -38.36 27.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.517 HD22 ' CG1' ' A' ' 362' ' ' VAL . 50.6 tp -53.25 -37.99 62.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -52.72 -49.43 65.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 382' ' ' LEU . 70.4 mtt180 -65.63 -26.56 67.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -75.54 -58.89 3.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -55.23 -28.64 54.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.2 Cg_endo -69.83 -39.64 1.29 Allowed 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.343 -0.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -124.02 101.61 7.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 68.9 p -112.07 152.96 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.1 t -82.37 129.08 64.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.0 37.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.98 -54.4 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.32 -69.09 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.42 -9.98 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 166.9 0.69 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 130.61 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -118.53 158.78 24.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 22.81 12.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.79 133.28 15.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -79.17 -22.79 44.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -74.11 -22.16 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -61.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.619 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.4 ppp? -51.75 -30.08 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 t -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -92.62 -21.0 20.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -81.02 -26.57 36.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 405' ' ' MET . 98.8 t -83.91 -61.15 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -51.93 -35.64 46.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.7 t -52.07 -30.05 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 6.8 mptt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.555 0.693 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -45.86 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.673 2.249 . . . . 0.0 112.371 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.07 137.23 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.99 147.07 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.143 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.1 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -92.92 -6.41 48.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.37 -75.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.08 -16.85 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.97 58.37 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -85.07 -76.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.84 129.32 2.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.02 140.4 51.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -57.16 10.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.44 160.6 25.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -47.5 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -29.81 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -67.04 -37.5 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.657 HD11 ' HA ' ' A' ' 422' ' ' CYS . 65.7 tp -71.52 -36.59 71.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -57.83 -36.46 72.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.56 -36.5 48.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.669 ' CE1' HG21 ' A' ' 442' ' ' VAL . 22.9 t60 -61.33 -37.84 84.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.5 -22.74 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -19.85 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.03 -66.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.669 HG21 ' CE1' ' A' ' 438' ' ' HIS . 96.4 t -59.2 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.058 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.673 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.7 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -90.76 138.97 31.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.12 140.17 52.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.76 26.18 4.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.69 -51.67 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.9 p -108.54 -25.08 11.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.84 43.03 5.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -111.24 131.8 54.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -85.93 146.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.6 m-85 -128.21 127.46 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -53.34 -32.44 49.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.15 160.15 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.15 -39.44 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -54.46 -33.31 59.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -75.98 -26.0 56.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.673 HD22 ' CG2' ' A' ' 362' ' ' VAL . 45.3 tp -77.2 -27.5 53.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -67.54 -50.78 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -64.01 -24.85 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.6 -53.66 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -62.73 -22.17 66.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.571 0.701 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.65 -46.48 0.36 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.367 -0.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -122.81 98.06 5.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 29.7 p -113.59 155.57 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.42 129.46 63.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -30.14 22.87 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.371 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.86 -65.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.7 m -69.04 -67.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.44 -11.08 6.43 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.11 169.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -125.29 133.85 52.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -125.61 135.76 52.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 23.11 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.48 151.58 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -89.28 -11.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.6 -23.83 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.863 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.31 -56.14 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.7 ppp? -53.94 -35.56 61.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.7 t -65.94 -26.93 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.4 -21.25 18.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -84.74 -45.86 11.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 405' ' ' MET . 88.2 t -62.86 -51.96 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -65.39 -31.79 73.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -30.22 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.18 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.73 2.286 . . . . 0.0 112.307 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.07 129.09 51.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.27 147.44 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.557 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.81 158.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -6.42 49.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.55 -16.88 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.68 59.36 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -86.53 -76.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.78 133.1 3.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -135.05 143.18 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.2 m -52.03 -61.12 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.3 160.58 27.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.734 2.289 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.96 -31.45 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -66.44 -29.88 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.7 tp -82.01 -32.15 30.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.81 -40.43 88.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.58 -40.98 58.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.432 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.3 t60 -52.03 -47.25 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.811 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 21.2 mt -51.74 -32.29 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -23.33 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -66.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 438' ' ' HIS . 49.0 t -77.21 -62.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.624 HG11 HD22 ' A' ' 377' ' ' LEU . 21.9 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -98.16 116.35 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.6 134.2 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 27.35 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.36 -39.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.31 -40.56 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.77 25.83 5.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.517 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.32 140.33 29.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.82 143.91 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.48 139.52 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -69.81 -26.22 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.75 167.21 22.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 362' ' ' VAL . 22.3 t -84.06 -38.19 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.56 -28.65 47.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -43.88 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.624 HD22 HG11 ' A' ' 362' ' ' VAL . 23.0 tp -55.47 -31.63 62.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.36 -57.06 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -54.5 -30.02 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -74.82 -49.0 22.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.49 -35.49 65.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.568 0.699 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.72 -43.88 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.368 -0.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -121.02 99.05 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.36 156.88 22.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.0 t -82.35 129.38 63.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.06 35.42 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.628 2.219 . . . . 0.0 112.313 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 65.4 t -91.34 -64.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.9 m -69.46 -69.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.98 -10.22 6.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 165.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.0 136.35 53.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -128.54 133.85 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.67 25.75 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.54 142.54 23.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -85.02 -20.72 30.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.21 -17.3 61.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -97.92 -59.72 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.6 ppp? -51.8 -33.77 37.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 5.6 t -63.81 -34.83 78.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.72 -20.6 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -81.38 -43.83 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 405' ' ' MET . 98.3 t -65.25 -52.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.136 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -61.05 -34.18 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.11 -30.0 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.624 0.725 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -47.97 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.659 2.239 . . . . 0.0 112.313 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.54 131.37 43.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.4 147.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.75 159.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -92.92 -6.41 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.8 m -109.78 -75.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.7 p -76.77 -16.62 59.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 53.94 16.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.48 -75.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 129.33 126.37 2.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.11 144.35 50.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -56.95 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -101.79 160.6 26.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.654 2.236 . . . . 0.0 112.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.17 -38.24 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -79.77 -35.05 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -59.48 -45.19 92.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.25 -34.71 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.629 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.9 t60 -62.9 -34.0 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.35 -28.36 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.58 -17.47 25.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -95.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.629 HG21 ' CE1' ' A' ' 438' ' ' HIS . 74.2 t -67.96 -66.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.03 121.4 41.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.69 131.77 35.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.92 26.73 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.17 -40.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.59 -38.91 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.86 26.82 5.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 137.96 32.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 141.64 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -126.02 143.38 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -68.25 -33.43 74.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.18 149.15 52.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 79.9 t -78.25 -31.57 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -38.39 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 48.7 tp -53.26 -36.56 61.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -52.67 -46.39 67.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 382' ' ' LEU . 1.2 mtt-85 -65.6 -27.36 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -76.18 -58.19 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -57.09 -27.19 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 379' ' ' ARG . 10.1 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.7 mttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.74 -48.88 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.351 -0.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.67 101.5 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.0 t -108.6 150.58 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.82 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.31 128.5 67.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.35 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.6 t -105.51 -64.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.1 -69.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 131.64 -14.14 5.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.43 166.84 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -124.0 140.29 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.01 148.5 46.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.13 25.41 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 142.29 21.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -7.69 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.68 -25.14 28.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -90.75 -56.39 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.74 -30.98 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 t -65.31 -36.2 83.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.03 -12.33 36.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -91.62 -36.8 13.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 405' ' ' MET . 90.4 t -76.94 -51.5 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -64.77 -27.71 69.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -25.58 46.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -47.18 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.1 136.27 48.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.5 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.122 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.538 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.7 t -52.37 159.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -93.71 -6.46 46.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 m -109.53 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.38 -14.78 59.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.83 52.47 20.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -74.96 -76.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.5 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.68 116.03 2.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.481 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -114.95 143.48 45.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -54.94 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.51 160.1 27.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -41.58 4.13 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.258 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.55 -17.03 59.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -86.6 -9.53 55.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 422' ' ' CYS . 19.3 tp -93.3 -40.66 10.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.493 ' HA ' HD12 ' A' ' 439' ' ' ILE . 1.2 p-10 -65.02 -35.41 81.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.32 72.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 442' ' ' VAL . 18.8 t60 -75.67 -43.88 45.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 436' ' ' ASN . 45.3 mt -51.5 -31.19 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -91.81 -33.13 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.34 -67.0 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.8 t -76.01 -62.61 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.696 HG11 HD22 ' A' ' 377' ' ' LEU . 22.0 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.857 0.361 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.94 112.59 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.2 t -53.95 133.61 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.62 29.23 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -132.19 -44.2 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.7 p -114.87 -32.46 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.34 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -96.82 142.32 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.12 131.81 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 377' ' ' LEU . 49.9 m-85 -117.25 131.87 56.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -61.0 -26.65 67.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.04 171.83 13.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.68 HG22 HG21 ' A' ' 362' ' ' VAL . 72.8 t -86.66 -36.48 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.76 -27.12 58.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -26.24 30.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.696 HD22 HG11 ' A' ' 362' ' ' VAL . 16.7 tp -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.99 -50.8 67.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.4 OUTLIER -63.75 -26.58 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -70.87 -55.23 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -53.62 -32.42 51.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 379' ' ' ARG . 29.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.602 0.715 . . . . 0.0 110.939 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.77 -45.97 0.39 Allowed 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.33 -0.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.37 98.34 6.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 157.28 21.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.3 t -82.43 129.33 63.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -22.58 31.81 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.719 2.279 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.02 -68.17 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 32.6 m -63.04 -69.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.74 -12.35 5.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.81 169.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 131.92 50.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -120.83 142.68 49.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -98.16 25.37 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.41 158.24 42.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -23.31 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -69.03 -53.91 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -60.61 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.92 -34.04 39.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.2 t -65.12 -34.56 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -88.84 -20.74 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . 0.437 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 79.0 t60 -82.27 -47.57 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 96.2 t -62.12 -53.52 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -62.53 -31.98 72.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -27.8 35.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . 0.437 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 29.7 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.54 0.686 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -44.31 2.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.32 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 137.23 51.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.497 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -131.14 145.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.718 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.23 159.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.38 -6.39 50.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -111.08 -75.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -75.28 -16.55 60.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.02 45.84 32.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -71.27 -75.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.497 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 127.51 121.16 2.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -122.57 141.81 51.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.54 -57.02 11.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.844 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -97.94 160.74 27.72 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.674 0.749 . . . . 0.0 110.831 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.34 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -37.26 61.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -56.91 -28.42 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 422' ' ' CYS . 42.1 tp -86.94 -36.35 18.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.601 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.32 -59.24 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.66 98.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.514 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.73 -41.22 61.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.4 mt -54.11 -41.94 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -9.73 49.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -71.8 -50.5 29.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.84 -50.65 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -118.34 127.41 53.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.05 135.65 57.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 28.51 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.3 -46.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.0 p -112.45 -33.07 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.51 32.4 6.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -98.16 134.79 40.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.3 mm -87.44 145.97 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.484 ' CD1' HD13 ' A' ' 377' ' ' LEU . 50.2 m-85 -129.79 131.52 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -61.32 -29.52 69.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.23 163.31 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 41.1 t -79.16 -31.19 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.5 -29.05 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -82.93 -25.87 31.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.6 tp -78.08 -25.85 47.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.99 -54.08 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.744 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.5 OUTLIER -59.11 -25.85 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -72.91 -54.12 9.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -52.37 -39.67 61.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 379' ' ' ARG . 12.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.521 0.677 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.7 -42.42 0.75 Allowed 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.349 -0.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -123.59 97.99 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.96 157.25 20.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -82.33 129.13 64.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.61 37.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.237 . . . . 0.0 112.355 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.9 -66.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 29.1 m -64.75 -69.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.65 -12.95 5.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.04 171.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.333 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -128.97 135.43 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.92 148.22 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -104.99 23.53 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 155.27 37.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -19.39 25.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -74.22 -24.68 59.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -88.86 -59.92 2.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.6 -32.91 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -64.67 -48.31 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.49 -19.91 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -80.35 -48.98 12.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 405' ' ' MET . 97.5 t -64.91 -59.08 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -52.51 -37.16 56.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.5 t -52.97 -29.09 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.812 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.61 0.719 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -46.11 1.33 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.54 132.85 53.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.66 146.89 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.169 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.68 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.86 159.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.96 -6.38 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.5 m -109.52 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.18 -16.73 58.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 57.65 8.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -83.92 -76.1 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.13 128.14 2.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -128.25 139.82 52.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.6 t -52.01 -54.65 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 160.6 25.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.17 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -53.4 -34.89 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -61.41 -31.79 71.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 422' ' ' CYS . 63.5 tp -77.85 -31.47 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.04 -37.29 86.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.42 -34.16 54.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.655 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -63.94 -36.92 85.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.74 0.305 . . . . 0.0 110.804 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 79.0 mt -72.8 -25.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -20.53 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -96.86 -64.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.655 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -66.13 -68.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -109.08 132.63 53.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.3 t -69.85 133.87 47.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.89 26.26 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.12 -38.59 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.76 -36.47 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.35 -17.82 23.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -51.99 132.2 32.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.332 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.65 147.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 377' ' ' LEU . 53.2 m-85 -131.76 125.06 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -62.83 -34.49 77.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.17 155.7 33.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.12 -27.15 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.96 -43.97 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -34.36 77.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.7 tp -66.14 -30.69 71.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.5 -57.14 14.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.609 ' HA ' HD12 ' A' ' 382' ' ' LEU . 9.6 mtt180 -57.23 -30.59 64.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -69.33 -56.29 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -51.94 -32.83 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 379' ' ' ARG . 7.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.81 -42.79 0.7 Allowed 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.626 -1.823 . . . . 0.0 112.317 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.05 99.55 6.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 154.79 28.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 26.7 t -82.42 129.67 62.22 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.83 24.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.296 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 96.7 t -84.75 -72.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 48.6 m -56.46 -67.78 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.03 4.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.55 170.67 13.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -121.84 133.64 54.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -128.78 139.54 52.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 26.6 6.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.27 151.33 30.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -89.25 -16.52 31.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.5 -24.08 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -90.43 -59.67 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.589 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.56 -32.72 29.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.5 t -64.27 -46.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -78.56 -20.43 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -79.93 -49.68 11.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 405' ' ' MET . 95.3 t -63.01 -58.73 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -51.98 -37.66 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -28.21 32.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.558 0.694 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -47.37 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.64 135.65 49.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.06 146.93 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.05 159.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.24 -6.4 47.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -75.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.1 p -77.65 -17.0 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.38 58.63 7.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -85.34 -75.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 128.72 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -128.6 139.27 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 m -51.93 -55.55 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 160.6 25.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 -47.09 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -54.39 -33.26 58.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -62.35 -36.16 81.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.627 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.9 tp -72.17 -29.9 64.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.95 -44.81 95.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.82 -35.65 91.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.641 ' CE1' HG21 ' A' ' 442' ' ' VAL . 32.3 t60 -63.11 -34.63 78.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.02 -25.94 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.47 -17.76 25.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -100.37 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -68.31 -67.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 377' ' ' LEU . 7.5 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.842 0.353 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -106.4 128.9 54.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 8.5 t -62.1 134.91 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 26.19 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.28 -39.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -121.71 -38.8 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.88 30.18 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.38 137.05 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.97 147.98 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -133.09 135.95 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.26 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.05 158.12 45.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.91 -25.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.08 -34.07 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -77.94 -34.56 51.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 362' ' ' VAL . 24.1 tp -60.87 -35.26 76.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -55.7 -42.41 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -66.82 -46.65 74.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -61.22 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -51.92 -31.0 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.567 0.699 . . . . 0.0 110.872 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.1 Cg_endo -69.75 -48.9 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.358 -0.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -123.68 100.0 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.91 157.58 21.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -84.08 129.27 59.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -24.39 29.83 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.673 2.248 . . . . 0.0 112.358 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.17 -65.02 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.2 m -69.37 -69.1 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.24 -11.34 5.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 167.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.11 121.01 33.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -110.67 136.86 49.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 24.26 5.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 153.18 33.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -89.19 -18.94 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.07 -25.45 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt-85 -88.46 -59.39 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.66 -33.74 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.8 t -64.88 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -88.56 -20.55 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -82.11 -46.8 13.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 405' ' ' MET . 90.5 t -62.88 -52.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -25.55 45.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 5.4 mptt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.561 0.696 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -38.42 7.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.47 136.31 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.8 145.87 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.097 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.686 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.94 159.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -6.52 50.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.4 m -111.35 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -74.9 -16.43 60.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.93 43.28 30.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -68.26 -76.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.26 120.82 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -121.63 143.35 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -53.77 45.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.46 160.67 25.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -48.37 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.725 2.284 . . . . 0.0 112.31 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -53.15 -37.47 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -56.88 -26.47 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 422' ' ' CYS . 40.6 tp -88.9 -35.52 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.48 -59.38 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.78 -39.75 98.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.76 -41.41 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.735 0.303 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.2 mt -54.21 -41.75 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.31 -9.54 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.83 -52.81 15.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.04 -51.33 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.721 HG21 HD22 ' A' ' 377' ' ' LEU . 29.3 m . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.41 118.08 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.24 133.51 52.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -96.0 26.59 4.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.2 -38.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.0 p -119.72 -41.23 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.63 22.81 6.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.25 137.41 32.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.321 . . . . 0.0 110.86 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.62 138.34 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -122.5 128.39 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -58.23 -29.5 65.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.29 171.45 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 -36.82 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -52.29 -42.29 63.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -26.2 62.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.721 HD22 HG21 ' A' ' 362' ' ' VAL . 41.7 tp -77.63 -26.11 50.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -67.6 -53.7 25.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.809 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -61.02 -26.17 67.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.73 -54.64 8.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -53.4 -34.79 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 379' ' ' ARG . 39.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.5 mttt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.54 0.686 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.75 -41.39 0.92 Allowed 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.722 -1.783 . . . . 0.0 112.35 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -124.96 98.41 5.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.8 t -112.47 156.38 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.41 129.19 64.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.62 37.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.723 2.282 . . . . 0.0 112.34 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -94.82 -65.0 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.56 -69.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.64 -12.41 5.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.39 168.38 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -126.9 134.81 50.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.1 144.46 49.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.52 23.5 10.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.53 155.82 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -89.29 -20.9 23.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.69 -24.71 61.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -88.66 -59.75 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.7 -33.57 34.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.7 t -64.79 -46.51 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.838 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -77.49 -19.81 55.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -81.2 -51.06 8.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 405' ' ' MET . 98.1 t -61.16 -54.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.156 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -58.72 -35.8 73.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -30.07 24.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.565 0.698 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -118.5 138.17 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.525 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.79 146.56 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.131 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.692 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.94 159.04 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.75 -6.52 48.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.27 -75.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -76.9 -17.27 59.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.0 61.98 4.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -89.19 -76.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.525 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.78 133.29 3.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -136.47 137.06 39.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -55.87 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.16 160.57 26.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.62 0.724 . . . . 0.0 110.838 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.22 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.335 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -34.73 58.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -62.14 -30.4 71.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 422' ' ' CYS . 69.0 tp -80.28 -33.59 37.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.689 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -61.16 -41.81 97.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -68.68 -35.61 80.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -62.96 -46.3 88.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.0 mt -51.44 -35.17 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.63 -21.17 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.8 -66.94 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.19 -59.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.841 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -85.84 123.91 31.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -57.45 135.89 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -96.62 30.62 2.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.81 -41.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.51 -33.57 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.74 24.55 7.3 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 129.59 43.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 370' ' ' ILE . 4.4 mp -87.7 148.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.68 132.67 48.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.31 -27.0 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.19 175.44 9.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.2 -27.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.77 -44.19 96.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.9 -25.85 67.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.92 -25.8 37.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -64.77 -44.58 89.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.02 62.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -76.97 -48.38 18.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -52.41 -35.42 51.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.929 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 2.6 mtmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.72 -43.76 0.58 Allowed 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.344 -0.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -120.92 102.17 8.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 6.1 p -113.88 153.39 29.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -82.36 129.45 63.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.633 0.73 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -20.82 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.248 . . . . 0.0 112.331 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.74 -69.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.03 -68.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.88 18.33 3.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 172.18 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -124.38 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -127.39 138.62 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.72 25.71 4.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 152.38 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -14.18 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -32.99 50.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.24 -57.81 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.87 -32.75 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 81.1 p -65.9 -48.88 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.32 -18.45 60.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -83.1 -51.33 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 95.7 t -63.4 -58.79 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -31.59 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -25.17 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.594 0.711 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.36 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.304 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.25 135.95 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.93 146.38 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.739 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.09 159.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -92.68 -6.44 49.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 -75.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.4 p -76.88 -17.27 59.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 62.13 4.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.11 -76.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.341 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.46 135.57 3.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.15 135.71 34.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.345 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -57.17 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 160.58 27.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -47.88 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.87 -32.73 54.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -61.51 -30.3 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 422' ' ' CYS . 53.7 tp -80.34 -36.24 34.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.73 -38.77 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.39 -34.76 63.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.463 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.4 t60 -65.99 -49.07 69.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.7 mt -51.62 -32.37 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -91.68 -24.9 19.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -77.19 -66.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 438' ' ' HIS . 59.8 t -75.3 -63.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.84 127.36 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.81 134.32 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -98.45 31.71 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.12 -45.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.2 p -114.02 -34.07 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.53 27.74 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.478 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -96.54 134.2 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 31.0 mm -87.47 147.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 377' ' ' LEU . 39.1 m-85 -131.6 131.01 42.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -32.47 70.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 170.66 15.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.82 -28.22 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -55.02 -45.88 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -46.39 75.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 371' ' ' PHE . 21.2 tp -52.13 -30.33 25.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -53.7 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -62.12 -31.76 72.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -70.43 -51.4 29.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -52.21 -31.07 30.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.96 179.905 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.508 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.9 mttt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.74 -47.53 0.31 Allowed 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.343 -0.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -117.87 98.31 6.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . 0.5 ' HG ' ' N ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -111.86 157.49 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.1 t -82.35 129.15 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -15.3 36.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.0 -65.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.74 -69.52 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.52 -12.81 5.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 168.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -124.92 132.86 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.9 134.92 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -95.66 25.31 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.12 151.68 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -89.26 -17.49 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -23.12 56.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -91.35 -59.33 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.572 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -51.73 -33.9 36.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.2 t -65.08 -35.39 80.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -88.46 -20.1 25.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . 0.401 ' CD2' ' HE2' ' A' ' 412' ' ' HIS . 79.5 t60 -82.52 -45.64 14.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 405' ' ' MET . 94.9 t -64.14 -53.2 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -34.54 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 4.1 t -51.98 -30.13 23.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . 0.401 ' HE2' ' CD2' ' A' ' 408' ' ' HIS . 20.8 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.55 0.69 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.09 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.346 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -119.43 137.86 53.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.35 146.57 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.73 158.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.24 -6.31 50.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -75.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.6 p -75.8 -17.37 59.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.38 60.95 5.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -88.84 -76.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.63 135.31 3.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -136.73 137.94 40.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 40.6 p -52.24 -47.93 65.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -110.41 160.52 28.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.6 64.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -57.82 -25.85 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 45.6 tp -87.71 -27.69 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.4 t30 -63.88 -38.55 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.24 45.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.515 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -60.89 -41.4 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.5 mt -53.88 -41.94 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.093 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.91 -9.03 47.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.98 -49.22 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.88 -51.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.702 HG21 HD22 ' A' ' 377' ' ' LEU . 21.7 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.31 119.67 23.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.3 t -54.9 133.81 48.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.34 29.6 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.69 -40.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 23.8 p -117.28 -30.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.59 6.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -99.56 141.31 32.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.4 mm -93.66 143.7 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.5 m-85 -128.93 128.34 43.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -29.53 70.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.53 155.05 49.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.76 -29.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -55.4 -32.22 62.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -82.98 -37.42 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.702 HD22 HG21 ' A' ' 362' ' ' VAL . 21.2 tp -63.07 -31.73 72.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.52 -39.95 92.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 382' ' ' LEU . 43.4 mtt180 -73.95 -26.88 60.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -76.82 -48.07 19.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.51 ' HZ3' HD21 ' A' ' 377' ' ' LEU . 11.5 mttp -53.06 -32.5 47.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 379' ' ' ARG . 28.9 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.521 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.582 0.706 . . . . 0.0 110.899 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.77 -47.66 0.3 Allowed 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.314 -0.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -117.24 98.89 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 57.2 p -112.85 155.8 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.37 129.26 64.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.61 36.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.244 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.99 -64.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.54 -69.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.27 -11.67 5.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 169.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -127.91 133.7 49.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.8 145.61 48.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 23.83 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 154.97 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -89.22 -19.52 25.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -24.89 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.66 -59.79 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.585 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.63 -33.13 31.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 t -64.79 -47.19 79.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.57 -20.37 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -80.61 -51.88 8.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 405' ' ' MET . 99.0 t -60.71 -55.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -56.89 -36.86 70.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.12 -30.07 24.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.533 0.682 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.88 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.743 2.295 . . . . 0.0 112.35 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -97.34 130.25 44.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.483 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.89 147.29 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.683 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -92.74 -6.35 49.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.7 m -110.34 -75.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.37 -16.31 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.99 50.67 26.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -76.49 -76.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.331 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.483 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 128.13 127.14 2.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -54.68 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 160.67 25.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.28 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.31 -36.44 61.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -59.08 -32.75 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -77.23 -35.26 55.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.86 -28.17 69.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -84.34 -31.56 24.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -64.56 -47.57 78.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 48.0 mt -51.69 -34.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -21.52 20.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.44 -66.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.57 -61.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.496 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.1 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.841 0.353 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.93 140.63 30.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 366' ' ' ILE . 18.8 t -74.43 140.85 44.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.96 28.49 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . 0.435 HD12 ' SG ' ' A' ' 364' ' ' CYS . 2.6 mp -134.93 -46.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.2 p -112.55 -31.38 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.78 26.09 10.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.46 135.07 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -86.01 145.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.49 ' CD1' HD13 ' A' ' 377' ' ' LEU . 24.7 m-85 -126.34 147.22 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -65.46 -42.95 91.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -123.28 169.98 10.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.08 -29.8 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -63.51 -45.68 89.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -26.13 68.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.496 HD22 ' CG1' ' A' ' 362' ' ' VAL . 15.3 tp -78.99 -27.81 43.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.942 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -49.71 73.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.422 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -65.44 -24.96 67.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -74.33 -54.58 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.479 ' HE3' HD21 ' A' ' 377' ' ' LEU . 14.3 mttt -51.9 -30.18 23.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.577 0.703 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.6 Cg_endo -69.77 -48.39 0.27 Allowed 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.658 -1.809 . . . . 0.0 112.345 -0.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -115.11 103.72 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 47.7 p -115.24 155.46 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.858 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 11.9 t -82.34 129.18 64.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.62 29.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.36 -57.29 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.4 m -76.83 -69.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.39 -12.21 6.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 171.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.89 133.64 47.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.49 141.58 51.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 23.96 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 152.73 32.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 -13.74 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.88 -22.77 49.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -59.03 2.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.591 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.6 -33.47 33.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 t -65.02 -48.53 73.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -75.42 -19.79 59.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -81.36 -49.69 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 405' ' ' MET . 98.9 t -64.77 -60.08 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -52.02 -35.24 46.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 -28.9 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.986 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.57 0.7 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -48.41 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.24 . . . . 0.0 112.349 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.64 138.41 52.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.77 146.5 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.132 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.69 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.78 158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -92.3 -6.5 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -110.07 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.2 p -75.84 -17.37 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.61 61.09 5.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -88.62 -76.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.54 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.75 135.58 3.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.91 139.75 39.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -49.93 68.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.31 160.56 26.59 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.31 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -53.55 -37.88 63.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.17 -26.25 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 422' ' ' CYS . 55.8 tp -88.36 -26.29 22.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.8 t30 -61.63 -49.8 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -67.44 -39.72 91.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -51.87 -41.14 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.9 mt -53.84 -42.2 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -9.11 50.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 -43.47 54.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.03 -50.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.569 ' CG1' HD22 ' A' ' 377' ' ' LEU . 14.2 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.23 134.22 54.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.065 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.82 133.56 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.03 28.11 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.24 -39.83 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 25.8 p -120.1 -33.3 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.65 35.18 4.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -104.55 138.14 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.31 148.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 377' ' ' LEU . 28.3 m-85 -131.62 129.82 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -29.21 46.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -141.67 -179.85 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.33 -28.15 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -55.72 -58.6 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -56.9 -29.4 62.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.831 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.569 HD22 ' CG1' ' A' ' 362' ' ' VAL . 40.7 tp -75.76 -27.55 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.63 -49.61 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -70.49 -25.91 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -71.71 -44.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -58.3 -25.65 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.8 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 1.4 mttp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.594 0.711 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.4 Cg_endo -69.81 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.353 -0.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.96 103.29 10.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 92.5 p -109.0 156.37 19.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.6 t -82.35 128.83 65.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -10.84 29.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.734 2.289 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.38 -67.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 57.7 m -59.57 -68.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.82 17.67 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.25 172.82 8.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.366 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 139.51 50.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -127.76 131.4 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 23.64 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.58 138.98 18.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -81.53 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.73 -23.38 29.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.55 -56.75 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.68 -31.44 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -63.44 -54.79 31.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -73.59 -19.32 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -79.19 -47.74 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 405' ' ' MET . 96.0 t -67.19 -57.41 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -52.03 -36.24 49.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.2 t -53.15 -28.8 27.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.546 0.688 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -46.84 1.08 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.88 136.09 50.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.502 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -128.45 147.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.79 158.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -92.3 -6.43 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.35 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -75.82 -17.08 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.78 56.27 10.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -83.23 -76.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.502 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.38 128.58 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.449 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.97 142.02 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 p -51.99 -50.42 61.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.98 160.61 26.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.63 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.78 -38.22 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.45 -27.83 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 422' ' ' CYS . 56.9 tp -82.23 -33.22 29.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.608 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -60.12 -40.16 88.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.88 -36.11 61.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.03 -44.66 94.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 436' ' ' ASN . 12.2 mt -51.53 -38.02 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -21.38 23.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -64.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 52.3 t -84.54 -59.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.4 m 59.99 33.18 21.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 8.9 p -144.51 74.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -108.8 65.12 0.25 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.61 174.98 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.862 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.2 m -91.61 117.15 29.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.47 -175.67 38.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.49 HG21 HD22 ' A' ' 377' ' ' LEU . 35.4 m -97.51 166.01 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.353 . . . . 0.0 111.122 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -134.73 118.61 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.2 t -53.86 135.72 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.39 29.88 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.72 -43.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 9.0 p -118.32 -35.55 3.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.84 27.37 6.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -89.11 138.68 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.75 143.8 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 377' ' ' LEU . 51.2 m-85 -129.03 132.54 47.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.8 ptt-85 -58.81 -28.49 66.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -136.99 -178.25 5.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.9 -33.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -57.48 -51.53 69.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -57.48 -26.67 61.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 362' ' ' VAL . 27.3 tp -84.37 -26.38 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -38.88 90.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -76.6 -26.17 54.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -71.55 -50.25 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -53.13 -29.58 31.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 379' ' ' ARG . 24.0 mt -76.39 -32.83 58.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -29.59 62.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.97 149.27 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.18 160.15 14.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -111.68 79.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 54.22 85.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.941 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -178.33 159.57 1.15 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.59 0.709 . . . . 0.0 110.948 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.77 -43.82 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 -0.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -119.1 97.78 5.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.951 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.5 t -112.85 156.51 22.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.1 t -82.38 129.29 63.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -19.29 36.29 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.27 -66.28 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.69 -69.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.29 -11.92 5.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.42 169.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.04 132.27 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.23 146.93 48.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.43 25.88 10.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 151.39 31.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -89.21 -15.52 33.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -77.48 -24.2 50.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mmt-85 -90.55 -59.72 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.65 -31.91 27.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.7 t -64.26 -43.22 95.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.88 -20.92 41.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.16 -49.42 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 405' ' ' MET . 98.2 t -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -52.05 -36.57 50.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -30.12 24.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -85.95 -43.7 12.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.9 t0 60.89 77.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -96.46 93.92 1.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.5 160.34 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.82 -34.28 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 75.07 -110.71 3.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -61.27 160.51 22.81 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -43.12 2.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.719 2.279 . . . . 0.0 112.33 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.97 133.94 55.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -127.27 146.96 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.684 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.22 159.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.34 48.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -75.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.6 p -77.12 -17.09 58.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.11 59.16 7.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -85.94 -75.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 126.98 2.78 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.52 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.13 138.93 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.4 t -52.03 -55.24 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.15 160.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -48.21 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.333 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.84 -32.36 44.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -63.91 -35.52 80.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.684 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.6 tp -73.81 -34.27 64.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.55 -35.98 81.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.36 58.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -70.19 -50.19 42.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.764 0.316 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 50.3 mt -51.72 -33.34 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.56 -24.62 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -75.76 -66.85 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.73 -62.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -82.7 -169.89 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.0 t 63.37 92.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -172.8 68.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 170.81 15.68 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -32.9 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.3 8.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.503 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 86.3 p -154.71 161.48 41.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.87 168.94 15.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.835 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -145.71 -165.28 11.27 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.1 p -173.5 179.98 1.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 3.8 m -112.96 60.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -179.93 175.65 46.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.93 159.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.173 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.66 128.13 40.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.71 133.47 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -97.48 29.75 3.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.537 HD13 ' CD2' ' A' ' 384' ' ' HIS . 2.6 mp -134.16 -43.57 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 24.2 p -116.26 -27.32 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 92.13 37.09 6.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -101.28 134.72 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.32 143.39 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 41.8 m-85 -125.08 159.44 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -84.22 -27.22 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -137.49 -176.83 4.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 18.7 m -90.3 -30.42 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.83 -44.7 88.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.66 -25.96 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 371' ' ' PHE . 52.2 tp -82.44 -29.74 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.26 -45.23 77.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -26.05 68.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -81.71 -43.15 18.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -51.95 -37.92 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 52.5 mt -58.68 -33.22 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.8 m -63.46 -27.58 69.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.537 ' CD2' HD13 ' A' ' 366' ' ' ILE . 40.2 m-70 -78.97 66.59 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.08 149.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 129.29 56.57 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -170.5 50.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.947 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -177.14 159.58 1.44 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.905 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.71 -48.03 0.29 Allowed 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 -1.799 . . . . 0.0 112.393 -0.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -114.25 96.59 5.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 p -113.38 155.57 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 19.2 t -82.48 129.36 63.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.659 0.743 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -28.46 25.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.82 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.52 -68.92 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.62 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 168.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -126.47 132.49 51.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.26 140.07 53.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.07 23.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.44 151.32 30.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -89.23 -9.08 52.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.17 -24.48 37.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.29 -56.85 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.564 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -53.21 -34.82 58.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 17.2 t -65.74 -30.09 70.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -92.77 -20.79 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -84.07 -46.54 11.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 405' ' ' MET . 93.9 t -62.69 -52.81 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -64.15 -30.12 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -26.58 39.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -88.45 -46.06 9.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.94 101.04 10.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 76.6 121.28 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.9 p -177.04 109.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.62 150.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.11 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -131.41 -97.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 160.6 60.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -46.69 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -110.79 136.41 49.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.1 147.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.159 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.86 159.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.57 -6.4 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 16.8 t -109.98 -75.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.26 -16.88 59.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.75 57.47 8.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -84.21 -76.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.67 128.8 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -128.63 140.2 51.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.3 t -52.01 -57.86 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.45 160.51 26.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.353 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -31.1 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 422' ' ' CYS . 59.7 tp -72.52 -37.89 68.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.81 -31.7 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -79.53 -33.47 34.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -64.02 -48.13 77.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.3 mt -51.61 -32.94 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -91.58 -24.03 19.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -66.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.8 -60.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -79.11 -170.42 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.9 m 51.94 70.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -151.93 172.46 31.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 95.09 0.54 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.723 2.282 . . . . 0.0 112.32 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.53 106.28 15.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.13 139.43 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.474 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 52.7 p -156.34 136.62 12.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 14.9 p -176.7 106.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 134.63 122.43 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.29 125.81 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p -160.85 127.89 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -139.84 146.45 17.96 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.513 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.0 p -96.25 141.25 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -112.39 129.09 56.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 6.5 t -59.97 138.77 57.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.8 28.88 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.0 mt -132.54 -41.37 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.1 p -116.94 -33.09 4.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.42 29.49 7.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.66 138.57 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.737 0.304 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 44.4 mm -89.34 144.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -128.29 137.84 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -67.1 -31.29 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.17 151.65 49.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.7 t -72.3 -29.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -58.3 -37.77 75.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -78.36 -27.06 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.513 HD22 ' CG1' ' A' ' 362' ' ' VAL . 38.4 tp -71.54 -28.17 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.26 -55.97 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -55.15 -33.96 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -68.08 -50.56 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -53.67 -32.12 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 2.9 mt -70.39 -32.93 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 3.3 t -70.59 -28.36 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.38 -59.04 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.3 m -78.05 143.42 37.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -145.81 165.8 27.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.533 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -103.61 82.24 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.951 0.405 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER -172.33 159.61 4.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.592 0.711 . . . . 0.0 110.896 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.74 -40.05 1.19 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.313 -0.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -123.64 96.7 5.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.7 t -113.14 156.77 22.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.8 t -82.36 129.36 63.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -19.88 35.47 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.717 2.278 . . . . 0.0 112.366 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 69.7 t -91.63 -64.49 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.8 m -69.08 -69.05 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.67 -10.98 6.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 164.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.71 55.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.33 139.22 53.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.74 28.0 5.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.16 144.72 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -89.27 -9.14 51.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.62 -24.17 33.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -92.65 -58.72 2.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.623 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.3 ppp? -51.91 -35.06 44.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 3.4 t -61.5 -33.66 74.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -91.27 -20.98 21.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -80.74 -39.37 27.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 405' ' ' MET . 96.9 t -68.04 -51.1 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -58.12 -36.04 72.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 1.5 t -52.09 -30.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -88.99 -48.33 7.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.28 175.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 108.62 46.45 0.97 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.71 177.53 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 64.8 t -127.13 101.1 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -75.85 -90.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -77.32 160.59 75.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -47.1 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -109.13 135.63 49.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.05 147.03 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.668 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.73 159.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -92.85 -6.41 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.66 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -76.83 -16.67 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 57.82 8.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.506 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -84.38 -76.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.57 128.89 2.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.91 139.46 52.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -53.59 39.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.832 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -105.23 160.68 25.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -47.74 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.703 2.269 . . . . 0.0 112.387 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.9 -33.1 55.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -63.82 -31.74 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 422' ' ' CYS . 58.2 tp -76.76 -36.86 56.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -60.23 -36.43 77.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.15 57.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.459 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -65.98 -48.08 72.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.9 mt -51.92 -35.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -91.61 -16.98 26.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -83.35 -66.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 438' ' ' HIS . 97.6 t -74.71 -63.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -78.59 59.26 2.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.34 133.92 48.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -168.61 -73.98 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -23.25 30.94 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 0.0 112.296 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 30.7 t -102.72 149.38 24.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 m -131.14 -172.14 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 CA-C-O 119.161 -0.8 . . . . 0.0 112.488 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 50.6 p -138.42 146.36 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.28 155.67 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 135.82 110.89 1.09 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.37 117.38 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.827 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 53.8 p -74.44 164.96 25.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 175.34 165.28 31.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.556 HG21 HD22 ' A' ' 377' ' ' LEU . 26.9 m -103.72 170.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.12 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -132.85 119.92 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.4 ' SG ' HD12 ' A' ' 366' ' ' ILE . 3.7 t -55.37 133.1 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.23 29.06 2.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.4 HD12 ' SG ' ' A' ' 364' ' ' CYS . 2.3 mp -131.4 -40.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.9 p -118.19 -39.96 3.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.44 26.0 5.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 134.77 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.6 mm -89.3 137.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.4 ' CD1' HD13 ' A' ' 377' ' ' LEU . 58.7 m-85 -121.72 128.07 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.498 ' H ' ' NE ' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -58.72 -27.06 64.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.01 172.54 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 -34.82 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.18 -30.88 62.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -80.98 -26.05 36.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.916 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 362' ' ' VAL . 40.6 tp -76.71 -25.95 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -73.68 -53.09 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -54.07 -29.94 46.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.7 OUTLIER -62.21 -37.23 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 20.2 m -74.78 -32.16 61.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -52.44 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 96.5 p -132.73 138.58 47.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -133.85 179.79 17.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -133.38 79.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 110.895 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.3 ptpt -174.1 159.54 2.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.553 0.692 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.76 -45.6 0.41 Allowed 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 -1.782 . . . . 0.0 112.372 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.13 100.12 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 14.9 p -113.32 155.68 24.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 21.0 t -82.4 129.41 63.31 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -31.54 20.02 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.337 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.72 -66.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 22.2 m -67.05 -67.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.29 -11.93 6.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 168.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.927 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 132.35 50.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 25.38 5.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.08 42.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -89.24 -22.3 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -54.83 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -55.72 -58.93 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -53.62 -33.83 56.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -66.44 -29.26 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -93.85 -20.77 19.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.61 -46.64 11.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 405' ' ' MET . 93.5 t -62.85 -53.43 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -63.33 -30.35 71.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -26.69 40.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -88.19 -49.21 7.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 179.89 1.0 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.56 7.52 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.5 t -165.85 151.46 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.879 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.62 145.85 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.77 -108.42 2.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -55.81 157.48 7.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -48.26 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.47 136.71 53.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.538 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.92 146.67 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.643 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.79 158.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.49 -6.33 50.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.98 -75.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 29.2 p -76.27 -17.11 59.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.76 62.25 4.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -89.31 -76.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.858 0.361 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.538 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.8 134.14 3.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -136.95 135.83 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -54.69 26.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.82 160.43 26.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.577 0.703 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.65 2.233 . . . . 0.0 112.366 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.54 -35.8 61.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -60.1 -28.81 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 422' ' ' CYS . 54.4 tp -84.48 -30.44 25.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.1 t30 -63.77 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -82.75 -33.75 23.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -60.88 -46.9 88.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 436' ' ' ASN . 5.8 mt -51.55 -33.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -23.41 19.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.69 -61.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -81.64 -173.23 4.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.7 m 58.19 178.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 127.34 178.08 15.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 102.58 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.722 2.281 . . . . 0.0 112.301 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.2 p -164.2 113.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.894 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.8 m -94.91 162.88 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.159 -0.8 . . . . 0.0 112.44 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.99 -39.18 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 6.7 t 55.79 88.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.31 -144.7 15.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t 57.08 -179.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.83 -173.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.05 -139.05 2.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 374' ' ' VAL . 28.2 m -92.22 149.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.13 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.62 118.99 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.09 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 35.1 t -52.71 133.04 36.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 30.58 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.453 HG21 ' CG ' ' A' ' 384' ' ' HIS . 2.8 mp -131.14 -39.83 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 19.9 p -121.33 -35.97 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 106.06 24.85 6.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -93.64 139.06 31.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.19 143.77 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.59 ' CD1' HD13 ' A' ' 377' ' ' LEU . 40.9 m-85 -130.73 129.28 42.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -33.06 71.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -129.99 150.9 51.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 362' ' ' VAL . 61.9 t -79.2 -37.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -53.15 -31.16 41.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -36.69 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 371' ' ' PHE . 42.1 tp -57.67 -36.32 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.06 -55.85 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.619 ' HA ' HD12 ' A' ' 382' ' ' LEU . 81.6 mtt180 -58.76 -34.3 71.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -67.16 -59.49 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -54.48 -28.82 47.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 379' ' ' ARG . 14.3 mt -69.32 -29.79 67.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.36 -26.17 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.453 ' CG ' HG21 ' A' ' 366' ' ' ILE . 1.8 m-70 -51.93 -74.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 6.2 p -123.26 123.92 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -179.91 -52.24 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -90.42 96.56 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -178.29 159.55 1.16 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.77 -42.46 0.75 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.394 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -124.35 100.33 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.54 156.91 22.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.43 129.36 63.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -19.57 35.79 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.08 -66.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 28.2 m -65.05 -69.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.06 -11.64 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.14 172.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -129.39 135.25 48.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.59 146.99 47.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 22.47 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 158.71 42.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -89.26 -22.11 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.48 -32.67 68.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.04 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.551 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.8 -32.59 31.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.824 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 77.3 p -66.79 -47.62 71.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -75.64 -18.89 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -83.78 -54.02 5.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 405' ' ' MET . 95.5 t -60.52 -60.03 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -51.88 -38.33 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -30.01 24.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -83.96 -36.58 23.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.41 86.34 3.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 164.12 98.71 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.51 157.59 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 110.833 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 28.3 t -85.31 -66.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 97.69 -113.85 4.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -69.26 157.38 89.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.44 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -116.81 137.51 52.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.54 146.53 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.646 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.57 158.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -92.52 -6.39 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.95 -75.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.33 -17.05 59.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.66 61.9 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.448 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -89.06 -76.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 137.17 136.45 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.488 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -140.17 140.12 35.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.72 -56.92 14.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.97 160.57 26.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -48.07 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.66 -37.08 62.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -59.32 -25.9 64.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 422' ' ' CYS . 62.6 tp -86.87 -37.1 18.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -55.13 -38.63 68.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.73 -42.01 32.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.6 t60 -51.97 -48.96 64.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.85 -29.35 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.59 -20.91 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -84.36 -66.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.6 t -72.92 -55.45 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -91.45 45.96 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.13 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -174.82 71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 172.27 12.91 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.722 2.281 . . . . 0.0 112.348 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 30.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 p -130.8 157.58 42.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.528 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.35 169.25 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.15 151.88 50.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 164.34 178.6 37.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.17 174.06 6.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.5 m -103.25 -176.82 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -177.25 91.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.509 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.1 m -92.48 159.49 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.26 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.2 t -56.12 133.58 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -97.27 27.48 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.46 -39.08 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.66 -40.23 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.31 25.7 5.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.26 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.334 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 46.6 mm -99.64 143.99 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 377' ' ' LEU . 52.9 m-85 -127.14 141.56 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -26.28 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -136.33 173.56 11.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.05 -31.43 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.26 -27.24 68.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 -40.63 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.51 HD22 ' CG2' ' A' ' 362' ' ' VAL . 38.9 tp -63.3 -27.94 69.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -64.83 -54.58 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.425 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -56.59 -26.88 56.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -81.28 -42.05 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -54.38 -35.69 63.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.9 mt -67.9 -25.99 65.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -26.44 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -75.43 81.42 2.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.37 168.08 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -52.31 146.16 16.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.453 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 -169.64 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 110.86 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -134.07 159.34 72.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.571 0.701 . . . . 0.0 110.903 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.64 -48.76 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.371 -0.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -123.64 99.81 6.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.27 156.68 22.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 22.5 t -84.75 129.43 56.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.575 0.702 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.9 19.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.703 2.269 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.51 -67.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.53 -67.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 121.98 12.9 5.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 165.45 23.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -116.7 135.26 53.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.21 133.97 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.33 24.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.45 143.5 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -21.27 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.91 -19.43 61.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -95.33 -59.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.86 -34.25 40.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.1 t -65.01 -34.43 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.37 -20.42 24.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -82.8 -45.38 14.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 94.5 t -65.47 -58.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -53.91 -37.26 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.97 24.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -83.14 -31.98 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -130.56 101.05 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -88.77 -125.08 2.43 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.8 m -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.879 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 9.6 m -135.89 146.74 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -78.33 -94.15 0.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 160.66 9.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.613 0.72 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -47.51 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.724 2.282 . . . . 0.0 112.311 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -109.6 135.86 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.512 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.11 146.59 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.593 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -52.06 159.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -92.54 -6.49 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.85 -75.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.842 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.31 -17.03 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.92 55.65 11.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -82.24 -76.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.512 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 131.2 128.89 3.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.499 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -128.55 142.05 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 8.1 t -52.04 -57.5 9.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -100.81 160.6 26.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -47.87 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.316 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.55 -38.18 66.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.42 -31.03 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 422' ' ' CYS . 60.2 tp -80.86 -36.01 31.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.65 -32.45 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -80.86 -39.83 12.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.525 ' CE1' HG21 ' A' ' 442' ' ' VAL . 22.7 t60 -53.05 -48.33 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.833 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.61 -28.16 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -91.56 -15.14 29.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -93.71 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.525 HG21 ' CE1' ' A' ' 438' ' ' HIS . 97.8 t -69.71 -65.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -84.32 54.7 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.7 t -91.21 -172.97 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.6 173.17 22.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 118.45 5.69 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.367 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.0 t -150.97 105.73 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.91 172.83 11.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.901 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.516 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 65.1 m -148.2 83.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -171.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -87.68 -157.46 31.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.515 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.93 127.46 47.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.835 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.4 t -165.81 137.04 3.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 170.11 -169.38 42.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 377' ' ' LEU . 7.2 p -127.08 140.68 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 370' ' ' ILE . . . -100.47 118.71 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 9.5 t -52.39 134.0 34.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.9 27.06 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.457 HG21 ' CG ' ' A' ' 384' ' ' HIS . 2.7 mp -126.95 -38.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 8.1 p -120.18 -35.48 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 31.47 5.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.59 139.62 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 363' ' ' ALA . 36.5 mm -87.87 141.97 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 377' ' ' LEU . 38.8 m-85 -125.66 132.78 52.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -34.76 69.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 154.43 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.67 -33.15 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -53.26 -32.68 49.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -38.36 27.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.517 HD22 ' CG1' ' A' ' 362' ' ' VAL . 50.6 tp -53.25 -37.99 62.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -52.72 -49.43 65.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 382' ' ' LEU . 70.4 mtt180 -65.63 -26.56 67.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -75.54 -58.89 3.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -55.23 -28.64 54.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.4 mt -68.98 -27.43 65.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 21.8 m -83.51 -26.75 29.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.457 ' CG ' HG21 ' A' ' 366' ' ' ILE . 2.4 m-70 -52.47 -33.06 42.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -37.52 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.98 -125.81 7.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 57.62 74.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -176.53 159.53 1.66 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.2 Cg_endo -69.83 -39.64 1.29 Allowed 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.343 -0.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -124.02 101.61 7.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 68.9 p -112.07 152.96 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.1 t -82.37 129.08 64.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.0 37.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.98 -54.4 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.32 -69.09 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.42 -9.98 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 166.9 0.69 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 130.61 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -118.53 158.78 24.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 22.81 12.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.79 133.28 15.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -79.17 -22.79 44.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -74.11 -22.16 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -61.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.619 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.4 ppp? -51.75 -30.08 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 t -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -92.62 -21.0 20.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -81.02 -26.57 36.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 405' ' ' MET . 98.8 t -83.91 -61.15 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -51.93 -35.64 46.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.7 t -52.07 -30.05 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -79.7 -42.35 24.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.34 116.09 9.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -158.18 36.24 0.52 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.536 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.8 m -155.56 179.51 9.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.03 141.71 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -133.44 -76.1 0.1 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -58.98 160.67 10.56 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.555 0.693 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -45.86 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.673 2.249 . . . . 0.0 112.371 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.07 137.23 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.99 147.07 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.143 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.1 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -92.92 -6.41 48.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -109.37 -75.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.08 -16.85 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.97 58.37 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -85.07 -76.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.84 129.32 2.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.02 140.4 51.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -57.16 10.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.44 160.6 25.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -47.5 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -29.81 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -67.04 -37.5 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.657 HD11 ' HA ' ' A' ' 422' ' ' CYS . 65.7 tp -71.52 -36.59 71.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -57.83 -36.46 72.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.56 -36.5 48.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.669 ' CE1' HG21 ' A' ' 442' ' ' VAL . 22.9 t60 -61.33 -37.84 84.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.5 -22.74 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -19.85 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.03 -66.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.669 HG21 ' CE1' ' A' ' 438' ' ' HIS . 96.4 t -59.2 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.058 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -82.15 67.07 8.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.79 121.33 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -174.16 -166.75 32.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 134.56 28.3 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.354 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.94 -72.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -83.39 176.56 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.512 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 3.4 m 62.58 46.88 5.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 13.6 p -153.81 142.72 21.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 167.71 104.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 29.4 t -78.93 136.63 37.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.3 t -162.59 112.53 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.95 71.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.673 ' CG2' HD22 ' A' ' 377' ' ' LEU . 33.7 m -90.13 131.49 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 111.152 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -90.76 138.97 31.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.12 140.17 52.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.76 26.18 4.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.69 -51.67 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.9 p -108.54 -25.08 11.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.84 43.03 5.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -111.24 131.8 54.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -85.93 146.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.6 m-85 -128.21 127.46 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -53.34 -32.44 49.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.15 160.15 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.15 -39.44 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -54.46 -33.31 59.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -75.98 -26.0 56.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.673 HD22 ' CG2' ' A' ' 362' ' ' VAL . 45.3 tp -77.2 -27.5 53.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -67.54 -50.78 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -64.01 -24.85 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.6 -53.66 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -62.73 -22.17 66.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 379' ' ' ARG . 0.6 OUTLIER -51.43 -64.92 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.67 -41.07 8.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 51.44 38.75 22.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.0 p -95.31 -58.86 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.03 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -139.85 74.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER -173.88 159.6 2.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.571 0.701 . . . . 0.0 110.884 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.65 -46.48 0.36 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.367 -0.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -122.81 98.06 5.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 29.7 p -113.59 155.57 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.42 129.46 63.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -30.14 22.87 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.371 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.86 -65.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.7 m -69.04 -67.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.44 -11.08 6.43 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.11 169.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -125.29 133.85 52.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -125.61 135.76 52.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 23.11 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.48 151.58 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -89.28 -11.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.6 -23.83 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.863 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.31 -56.14 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.7 ppp? -53.94 -35.56 61.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.7 t -65.94 -26.93 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.4 -21.25 18.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -84.74 -45.86 11.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 405' ' ' MET . 88.2 t -62.86 -51.96 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -65.39 -31.79 73.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -30.22 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -80.21 -36.22 35.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.73 119.66 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -142.18 50.09 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 94.1 p -165.08 118.86 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.3 -58.25 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 94.68 -88.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 155.15 41.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.18 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.73 2.286 . . . . 0.0 112.307 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.07 129.09 51.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.505 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.27 147.44 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.557 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.81 158.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -6.42 49.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.55 -16.88 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.68 59.36 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -86.53 -76.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.78 133.1 3.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -135.05 143.18 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 2.2 m -52.03 -61.12 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.3 160.58 27.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.734 2.289 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.96 -31.45 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -66.44 -29.88 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 422' ' ' CYS . 57.7 tp -82.01 -32.15 30.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.81 -40.43 88.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.58 -40.98 58.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.432 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.3 t60 -52.03 -47.25 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.811 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 21.2 mt -51.74 -32.29 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -23.33 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -66.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 438' ' ' HIS . 49.0 t -77.21 -62.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -82.7 -171.88 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.5 t 61.86 81.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -179.42 -179.62 48.76 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -28.33 25.49 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.708 2.272 . . . . 0.0 112.293 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 28.8 t -68.69 101.83 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.3 m -158.53 104.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.847 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.485 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.27 113.33 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.795 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.2 172.55 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -135.86 152.48 21.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.39 156.71 29.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.895 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 75.9 p -129.6 156.38 44.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.34 171.0 12.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.624 HG11 HD22 ' A' ' 377' ' ' LEU . 21.9 t -91.02 128.5 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -98.16 116.35 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.6 134.2 55.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 27.35 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.36 -39.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.31 -40.56 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.77 25.83 5.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.517 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.32 140.33 29.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.82 143.91 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.48 139.52 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -69.81 -26.22 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.75 167.21 22.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 362' ' ' VAL . 22.3 t -84.06 -38.19 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.56 -28.65 47.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -43.88 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.624 HD22 HG11 ' A' ' 362' ' ' VAL . 23.0 tp -55.47 -31.63 62.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.36 -57.06 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -54.5 -30.02 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -74.82 -49.0 22.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.49 -35.49 65.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 8.9 mt -72.65 -25.99 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 5.9 t -86.21 -26.12 25.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -34.06 40.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.72 165.12 31.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 112.07 22.31 5.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.506 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -153.11 92.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -179.27 159.53 0.95 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.568 0.699 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.72 -43.88 0.57 Allowed 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.368 -0.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -121.02 99.05 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.36 156.88 22.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.0 t -82.35 129.38 63.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.06 35.42 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.628 2.219 . . . . 0.0 112.313 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 65.4 t -91.34 -64.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.9 m -69.46 -69.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 128.98 -10.22 6.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 165.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.0 136.35 53.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -128.54 133.85 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.67 25.75 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.54 142.54 23.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -85.02 -20.72 30.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.21 -17.3 61.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -97.92 -59.72 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.6 ppp? -51.8 -33.77 37.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 5.6 t -63.81 -34.83 78.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.72 -20.6 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -81.38 -43.83 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 405' ' ' MET . 98.3 t -65.25 -52.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.136 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -61.05 -34.18 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.11 -30.0 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -82.64 -41.36 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.66 127.47 32.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -152.43 -40.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 47.3 t -146.61 -70.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 98.36 -91.02 1.08 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -79.3 153.72 76.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.624 0.725 . . . . 0.0 110.83 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -47.97 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.659 2.239 . . . . 0.0 112.313 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.54 131.37 43.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.4 147.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.75 159.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -92.92 -6.41 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.8 m -109.78 -75.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.7 p -76.77 -16.62 59.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 53.94 16.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.48 -75.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 129.33 126.37 2.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.11 144.35 50.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -56.95 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -101.79 160.6 26.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.654 2.236 . . . . 0.0 112.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.17 -38.24 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -79.77 -35.05 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -59.48 -45.19 92.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.25 -34.71 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.629 ' CE1' HG21 ' A' ' 442' ' ' VAL . 23.9 t60 -62.9 -34.0 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.35 -28.36 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.58 -17.47 25.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -95.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.629 HG21 ' CE1' ' A' ' 438' ' ' HIS . 74.2 t -67.96 -66.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -83.64 55.35 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.97 -37.56 11.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -163.4 -165.87 21.27 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.389 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 8.3 t -162.07 74.87 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -174.29 153.57 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.189 -0.784 . . . . 0.0 112.493 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 12.1 p -122.18 149.33 43.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.922 0.391 . . . . 0.0 110.824 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.79 166.89 16.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.812 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -160.43 128.79 2.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.16 169.15 21.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.855 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 4.7 p -168.15 134.64 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 178.57 139.28 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.22 147.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.03 121.4 41.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.69 131.77 35.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.92 26.73 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.469 HG21 ' CG ' ' A' ' 384' ' ' HIS . 4.1 mt -127.17 -40.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.59 -38.91 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.86 26.82 5.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 137.96 32.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 141.64 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -126.02 143.38 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -68.25 -33.43 74.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.18 149.15 52.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 79.9 t -78.25 -31.57 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -38.39 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 48.7 tp -53.26 -36.56 61.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -52.67 -46.39 67.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 382' ' ' LEU . 1.2 mtt-85 -65.6 -27.36 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -76.18 -58.19 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -57.09 -27.19 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 379' ' ' ARG . 10.1 mt -64.63 -29.16 70.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.48 -26.2 23.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.469 ' CG ' HG21 ' A' ' 366' ' ' ILE . 1.1 m-70 -52.01 118.77 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.6 t -179.23 93.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -134.01 105.97 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -179.22 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.7 mttt -153.41 161.07 30.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.74 -48.88 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.351 -0.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.67 101.5 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.0 t -108.6 150.58 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.82 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.31 128.5 67.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.35 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.6 t -105.51 -64.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.1 -69.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 131.64 -14.14 5.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.43 166.84 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -124.0 140.29 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.01 148.5 46.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.13 25.41 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 142.29 21.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -7.69 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.68 -25.14 28.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -90.75 -56.39 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.74 -30.98 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 t -65.31 -36.2 83.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.03 -12.33 36.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -91.62 -36.8 13.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 405' ' ' MET . 90.4 t -76.94 -51.5 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -64.77 -27.71 69.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -25.58 46.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.33 -26.41 55.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.24 -29.8 24.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -158.77 93.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.6 -38.82 2.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.374 . . . . 0.0 110.858 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.13 148.66 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -54.13 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 160.6 37.91 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -47.18 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.1 136.27 48.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.5 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.122 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.538 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.7 t -52.37 159.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -93.71 -6.46 46.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 m -109.53 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.38 -14.78 59.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.83 52.47 20.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -74.96 -76.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.5 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.68 116.03 2.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.481 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -114.95 143.48 45.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -54.94 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.51 160.1 27.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -41.58 4.13 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.258 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.55 -17.03 59.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -86.6 -9.53 55.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 422' ' ' CYS . 19.3 tp -93.3 -40.66 10.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.493 ' HA ' HD12 ' A' ' 439' ' ' ILE . 1.2 p-10 -65.02 -35.41 81.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.32 72.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 442' ' ' VAL . 18.8 t60 -75.67 -43.88 45.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 110.866 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 436' ' ' ASN . 45.3 mt -51.5 -31.19 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -91.81 -33.13 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.34 -67.0 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 438' ' ' HIS . 99.8 t -76.01 -62.61 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.35 -176.46 6.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.79 156.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.76 173.28 13.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 79.45 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.7 p -80.94 175.09 10.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.36 103.69 16.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.508 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.24 -170.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 2.1 t 62.36 166.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.71 101.29 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -132.35 36.13 3.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.877 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.98 84.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -148.27 155.18 26.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.696 HG11 HD22 ' A' ' 377' ' ' LEU . 22.0 t -101.34 138.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.94 112.59 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.2 t -53.95 133.61 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.62 29.23 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mt -132.19 -44.2 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.7 p -114.87 -32.46 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.34 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -96.82 142.32 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.12 131.81 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 377' ' ' LEU . 49.9 m-85 -117.25 131.87 56.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -61.0 -26.65 67.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.04 171.83 13.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.68 HG22 HG21 ' A' ' 362' ' ' VAL . 72.8 t -86.66 -36.48 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.76 -27.12 58.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -26.24 30.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.696 HD22 HG11 ' A' ' 362' ' ' VAL . 16.7 tp -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.99 -50.8 67.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.4 OUTLIER -63.75 -26.58 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -70.87 -55.23 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -53.62 -32.42 51.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 379' ' ' ARG . 29.1 mt -64.69 -30.49 71.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 36.1 m -86.43 -26.63 24.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -67.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.48 113.17 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -151.35 -77.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -120.02 81.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.918 0.389 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -166.34 159.55 12.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.77 -45.97 0.39 Allowed 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.33 -0.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.37 98.34 6.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 157.28 21.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 17.3 t -82.43 129.33 63.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -22.58 31.81 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.719 2.279 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.02 -68.17 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 32.6 m -63.04 -69.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.74 -12.35 5.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.81 169.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 131.92 50.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -120.83 142.68 49.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -98.16 25.37 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.41 158.24 42.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -23.31 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -69.03 -53.91 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -60.61 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.92 -34.04 39.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.2 t -65.12 -34.56 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -88.84 -20.74 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -82.27 -47.57 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 96.2 t -62.12 -53.52 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -62.53 -31.98 72.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -27.8 35.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -88.61 -35.78 16.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -54.25 130.35 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -173.64 39.43 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.462 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.9 t -168.56 -172.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.27 60.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -51.75 -28.47 23.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.91 160.5 27.13 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.54 0.686 . . . . 0.0 110.912 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -44.31 2.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.32 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 137.23 51.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.497 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -131.14 145.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.718 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.23 159.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.38 -6.39 50.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.6 m -111.08 -75.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -75.28 -16.55 60.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.02 45.84 32.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -71.27 -75.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.497 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 127.51 121.16 2.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -122.57 141.81 51.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.54 -57.02 11.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.844 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -97.94 160.74 27.72 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.674 0.749 . . . . 0.0 110.831 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.34 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -37.26 61.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -56.91 -28.42 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 422' ' ' CYS . 42.1 tp -86.94 -36.35 18.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.601 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.32 -59.24 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.66 98.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.514 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.73 -41.22 61.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.4 mt -54.11 -41.94 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -9.73 49.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -71.8 -50.5 29.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.84 -50.65 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -79.23 58.66 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.3 t -104.34 -28.1 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.13 -170.38 54.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 150.74 68.77 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.8 t -101.38 -36.84 8.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.5 p -118.66 -47.48 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.126 -0.819 . . . . 0.0 112.533 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.8 104.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.833 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.06 86.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -136.95 -124.28 2.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.429 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.5 p 54.94 -171.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.22 172.45 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -137.24 137.42 8.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.95 148.79 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -118.34 127.41 53.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -60.05 135.65 57.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 28.51 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.3 -46.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 22.0 p -112.45 -33.07 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 98.51 32.4 6.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -98.16 134.79 40.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 45.3 mm -87.44 145.97 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.484 ' CD1' HD13 ' A' ' 377' ' ' LEU . 50.2 m-85 -129.79 131.52 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -61.32 -29.52 69.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.23 163.31 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 41.1 t -79.16 -31.19 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.5 -29.05 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -82.93 -25.87 31.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.6 tp -78.08 -25.85 47.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -67.99 -54.08 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.744 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.5 OUTLIER -59.11 -25.85 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -72.91 -54.12 9.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -52.37 -39.67 61.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 379' ' ' ARG . 12.2 mt -60.88 -30.78 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.22 -26.74 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -28.9 43.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 9.8 t -109.26 123.99 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -66.53 -161.36 1.08 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -177.7 177.16 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.902 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER 64.18 155.43 0.12 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.521 0.677 . . . . 0.0 110.896 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.2 Cg_endo -69.7 -42.42 0.75 Allowed 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.349 -0.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -123.59 97.99 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.96 157.25 20.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -82.33 129.13 64.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -15.61 37.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.237 . . . . 0.0 112.355 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.9 -66.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 29.1 m -64.75 -69.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.65 -12.95 5.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.04 171.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.333 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -128.97 135.43 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.92 148.22 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -104.99 23.53 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 155.27 37.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -19.39 25.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -74.22 -24.68 59.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -88.86 -59.92 2.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.6 -32.91 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -64.67 -48.31 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.49 -19.91 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -80.35 -48.98 12.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 405' ' ' MET . 97.5 t -64.91 -59.08 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -52.51 -37.16 56.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.5 t -52.97 -29.09 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -83.1 -30.55 27.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.812 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -52.02 103.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 132.19 -151.5 19.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.1 t -108.46 -40.89 4.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 22.6 t 62.92 70.31 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -98.7 -37.4 4.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 160.59 26.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.61 0.719 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -46.11 1.33 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.54 132.85 53.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.516 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.66 146.89 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.169 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.68 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -51.86 159.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.96 -6.38 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.5 m -109.52 -75.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 28.0 p -77.18 -16.73 58.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.849 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 57.65 8.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -83.92 -76.1 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.13 128.14 2.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -128.25 139.82 52.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.6 t -52.01 -54.65 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 160.6 25.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.17 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -53.4 -34.89 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -61.41 -31.79 71.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 422' ' ' CYS . 63.5 tp -77.85 -31.47 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.04 -37.29 86.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -74.42 -34.16 54.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.655 ' CE1' HG21 ' A' ' 442' ' ' VAL . 24.2 t60 -63.94 -36.92 85.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.74 0.305 . . . . 0.0 110.804 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 79.0 mt -72.8 -25.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -20.53 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -96.86 -64.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.655 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -66.13 -68.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -86.49 54.66 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -32.23 21.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 164.72 74.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 160.09 50.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.65 2.233 . . . . 0.0 112.351 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -56.52 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.21 144.84 32.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.161 -0.8 . . . . 0.0 112.52 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 80.1 p -143.44 141.33 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 31.6 m -156.9 144.04 18.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -94.69 -156.69 32.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.5 m -132.93 101.56 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 110.891 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.18 163.71 12.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 138.95 172.12 12.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.431 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.33 141.35 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -109.08 132.63 53.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.3 t -69.85 133.87 47.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.89 26.26 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 384' ' ' HIS . 2.7 mp -128.12 -38.59 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.76 -36.47 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.35 -17.82 23.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -51.99 132.2 32.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.332 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.65 147.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 377' ' ' LEU . 53.2 m-85 -131.76 125.06 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -62.83 -34.49 77.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.17 155.7 33.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.12 -27.15 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.96 -43.97 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -34.36 77.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 371' ' ' PHE . 44.7 tp -66.14 -30.69 71.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.5 -57.14 14.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.609 ' HA ' HD12 ' A' ' 382' ' ' LEU . 9.6 mtt180 -57.23 -30.59 64.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -69.33 -56.29 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -51.94 -32.83 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 379' ' ' ARG . 7.3 mt -57.33 -32.47 66.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 45.4 m -72.42 -39.42 67.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.422 ' CD2' HD13 ' A' ' 366' ' ' ILE . 13.0 m-70 -52.89 -62.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 29.8 m -90.18 168.45 11.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 130.79 -19.38 4.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.5 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.12 82.28 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -169.47 159.55 7.3 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.7 Cg_endo -69.81 -42.79 0.7 Allowed 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.626 -1.823 . . . . 0.0 112.317 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.05 99.55 6.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 154.79 28.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 26.7 t -82.42 129.67 62.22 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.83 24.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.296 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 96.7 t -84.75 -72.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 48.6 m -56.46 -67.78 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.03 4.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.55 170.67 13.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -121.84 133.64 54.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -128.78 139.54 52.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 26.6 6.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.27 151.33 30.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -89.25 -16.52 31.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.5 -24.08 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -90.43 -59.67 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.589 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.56 -32.72 29.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.5 t -64.27 -46.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -78.56 -20.43 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -79.93 -49.68 11.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 405' ' ' MET . 95.3 t -63.01 -58.73 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -51.98 -37.66 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -28.21 32.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -89.57 -50.95 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 t0 72.2 -69.45 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 107.43 27.1 5.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 8.6 t -89.53 69.98 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.881 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.72 -25.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 151.28 -120.1 1.06 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 160.58 80.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.558 0.694 . . . . 0.0 110.932 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -47.37 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.64 135.65 49.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -129.06 146.93 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.05 159.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.24 -6.4 47.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -75.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.1 p -77.65 -17.0 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.38 58.63 7.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -85.34 -75.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.35 128.72 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -128.6 139.27 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 m -51.93 -55.55 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 160.6 25.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 -47.09 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -54.39 -33.26 58.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -62.35 -36.16 81.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.627 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.9 tp -72.17 -29.9 64.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.95 -44.81 95.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -65.82 -35.65 91.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.641 ' CE1' HG21 ' A' ' 442' ' ' VAL . 32.3 t60 -63.11 -34.63 78.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.02 -25.94 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.47 -17.76 25.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -100.37 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 438' ' ' HIS . 89.3 t -68.31 -67.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -89.38 50.27 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.2 t -76.29 134.92 39.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -104.56 175.85 22.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 167.39 24.54 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.665 2.243 . . . . 0.0 112.377 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -118.53 -44.03 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.6 m 53.66 73.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.134 -0.815 . . . . 0.0 112.503 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.5 t -174.57 152.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 110.815 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.94 139.19 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 106.77 150.75 17.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.05 169.84 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 t -171.79 149.65 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 178.84 150.53 8.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 377' ' ' LEU . 7.5 p -115.33 136.33 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.115 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -106.4 128.9 54.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 8.5 t -62.1 134.91 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.09 26.19 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.28 -39.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -121.71 -38.8 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.88 30.18 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.38 137.05 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.97 147.98 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -133.09 135.95 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.26 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.05 158.12 45.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.91 -25.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.08 -34.07 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -77.94 -34.56 51.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 362' ' ' VAL . 24.1 tp -60.87 -35.26 76.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -55.7 -42.41 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -66.82 -46.65 74.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -61.22 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -51.92 -31.0 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 1.9 mt -89.77 -25.97 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.4 m -62.46 -25.85 68.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.84 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -57.39 179.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.23 92.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 129.96 -147.15 17.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -169.23 1.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.879 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER -137.57 159.47 69.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.699 . . . . 0.0 110.872 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.1 Cg_endo -69.75 -48.9 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.358 -0.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -123.68 100.0 6.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.91 157.58 21.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -84.08 129.27 59.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -24.39 29.83 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.673 2.248 . . . . 0.0 112.358 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.17 -65.02 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 17.2 m -69.37 -69.1 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.24 -11.34 5.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 167.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.11 121.01 33.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -110.67 136.86 49.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 24.26 5.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 153.18 33.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -89.19 -18.94 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.07 -25.45 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 6.3 mmt-85 -88.46 -59.39 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.66 -33.74 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.8 t -64.88 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -88.56 -20.55 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -82.11 -46.8 13.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 405' ' ' MET . 90.5 t -62.88 -52.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -25.55 45.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -83.95 -25.17 30.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.79 148.59 5.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -59.3 -171.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 6.3 t -61.99 167.99 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.828 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.84 -25.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 68.16 -92.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.478 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -92.52 160.54 34.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.561 0.696 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -38.42 7.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.47 136.31 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.8 145.87 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.097 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.686 ' HA ' HD11 ' A' ' 435' ' ' LEU . 6.9 t -52.94 159.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -6.52 50.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.4 m -111.35 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.5 p -74.9 -16.43 60.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.93 43.28 30.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -68.26 -76.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 126.26 120.82 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -121.63 143.35 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -53.77 45.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.46 160.67 25.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -48.37 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.725 2.284 . . . . 0.0 112.31 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -53.15 -37.47 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -56.88 -26.47 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 422' ' ' CYS . 40.6 tp -88.9 -35.52 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' A' ' 439' ' ' ILE . 0.1 OUTLIER -51.48 -59.38 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -62.78 -39.75 98.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -51.76 -41.41 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.735 0.303 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.2 mt -54.21 -41.75 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.31 -9.54 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.83 -52.81 15.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.04 -51.33 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -78.1 59.39 2.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 33.5 t -97.43 122.23 40.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 168.92 174.74 37.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.492 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -39.88 5.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 6.5 t -169.91 120.29 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.2 m -148.27 31.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 6.7 p -87.91 131.8 34.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 162.96 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.871 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -174.37 39.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.531 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.29 117.84 31.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.22 146.93 15.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -144.54 163.9 27.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.721 HG21 HD22 ' A' ' 377' ' ' LEU . 29.3 m -98.63 161.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -128.41 118.08 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.24 133.51 52.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -96.0 26.59 4.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.2 -38.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 7.0 p -119.72 -41.23 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.63 22.81 6.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.25 137.41 32.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.321 . . . . 0.0 110.86 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.62 138.34 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -122.5 128.39 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -58.23 -29.5 65.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.29 171.45 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 -36.82 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -52.29 -42.29 63.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -26.2 62.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.721 HD22 HG21 ' A' ' 362' ' ' VAL . 41.7 tp -77.63 -26.11 50.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -67.6 -53.7 25.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.809 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -61.02 -26.17 67.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -72.73 -54.64 8.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -53.4 -34.79 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 379' ' ' ARG . 39.7 mt -57.93 -28.34 64.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.8 m -77.43 -37.76 50.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -52.57 -51.22 60.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.3 m -111.37 123.39 50.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -79.06 -141.71 2.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -179.24 172.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.958 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 11.5 mttt 64.19 155.48 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.54 0.686 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.1 Cg_endo -69.75 -41.39 0.92 Allowed 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.722 -1.783 . . . . 0.0 112.35 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -124.96 98.41 5.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.8 t -112.47 156.38 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.41 129.19 64.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.62 37.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.723 2.282 . . . . 0.0 112.34 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 60.8 t -94.82 -65.0 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.56 -69.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.64 -12.41 5.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.39 168.38 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -126.9 134.81 50.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.1 144.46 49.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.52 23.5 10.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.53 155.82 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -89.29 -20.9 23.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.69 -24.71 61.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -88.66 -59.75 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.7 -33.57 34.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.7 t -64.79 -46.51 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.838 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -77.49 -19.81 55.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -81.2 -51.06 8.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 405' ' ' MET . 98.1 t -61.16 -54.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.156 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -58.72 -35.8 73.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -30.07 24.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -86.4 -47.99 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.13 -58.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 68.8 -160.49 52.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.7 112.74 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 110.9 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.34 116.07 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.101 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -108.42 -69.26 0.66 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -90.29 157.51 44.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -118.5 138.17 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.525 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.79 146.56 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.131 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.692 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.94 159.04 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.75 -6.52 48.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.27 -75.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.4 p -76.9 -17.27 59.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.0 61.98 4.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -89.19 -76.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.525 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.78 133.29 3.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -136.47 137.06 39.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -55.87 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.16 160.57 26.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.62 0.724 . . . . 0.0 110.838 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.22 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.335 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -34.73 58.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -62.14 -30.4 71.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 422' ' ' CYS . 69.0 tp -80.28 -33.59 37.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.689 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -61.16 -41.81 97.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -68.68 -35.61 80.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -62.96 -46.3 88.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 436' ' ' ASN . 8.0 mt -51.44 -35.17 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.63 -21.17 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.8 -66.94 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.19 -59.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -78.59 -172.26 2.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 39.1 m 53.73 76.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -70.82 -167.2 7.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.515 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 125.72 12.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.34 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -67.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.91 -175.56 3.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.454 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.33 134.0 9.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.888 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 8.1 t -135.58 162.08 33.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -164.99 162.79 35.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.8 p -164.71 179.2 6.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.6 p -169.71 157.78 7.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.11 133.09 3.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 30.8 m -90.87 126.32 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -85.84 123.91 31.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.5 t -57.45 135.89 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -96.62 30.62 2.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 384' ' ' HIS . 2.9 mp -133.81 -41.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.51 -33.57 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 104.74 24.55 7.3 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 129.59 43.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 370' ' ' ILE . 4.4 mp -87.7 148.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.68 132.67 48.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.31 -27.0 63.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.19 175.44 9.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.2 -27.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.77 -44.19 96.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.9 -25.85 67.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.92 -25.8 37.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -64.77 -44.58 89.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.02 62.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -76.97 -48.38 18.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -52.41 -35.42 51.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.86 -31.05 62.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 22.3 t -64.44 -34.13 77.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.4 ' CD2' HD13 ' A' ' 366' ' ' ILE . 13.2 m-70 -52.52 123.09 10.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.8 p -175.01 155.9 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 140.77 -156.98 25.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.508 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.54 178.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.413 . . . . 0.0 110.856 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 2.6 mtmm 64.12 155.5 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.9 Cg_endo -69.72 -43.76 0.58 Allowed 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.344 -0.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -120.92 102.17 8.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 6.1 p -113.88 153.39 29.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.5 t -82.36 129.45 63.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.633 0.73 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -20.82 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.248 . . . . 0.0 112.331 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.74 -69.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.03 -68.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.88 18.33 3.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 172.18 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -124.38 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -127.39 138.62 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.72 25.71 4.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 152.38 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -14.18 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -32.99 50.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.24 -57.81 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.2 ppp? -51.87 -32.75 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 81.1 p -65.9 -48.88 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.32 -18.45 60.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -83.1 -51.33 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 405' ' ' MET . 95.7 t -63.4 -58.79 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -31.59 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -25.17 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.83 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -89.33 9.2 26.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.82 -59.3 4.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.28 -127.21 34.7 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.95 -53.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.878 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 60.4 t 51.99 86.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -86.93 -148.37 12.83 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -53.05 157.42 2.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.711 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.36 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.304 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.25 135.95 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.534 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -125.93 146.38 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.739 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.0 t -52.09 159.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -92.68 -6.44 49.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 -75.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.4 p -76.88 -17.27 59.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 49.05 62.13 4.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.11 -76.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.341 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.534 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.46 135.57 3.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.15 135.71 34.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.345 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -57.17 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 160.58 27.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -47.88 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.87 -32.73 54.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -61.51 -30.3 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 422' ' ' CYS . 53.7 tp -80.34 -36.24 34.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.73 -38.77 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.39 -34.76 63.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.463 ' CE1' HG21 ' A' ' 442' ' ' VAL . 25.4 t60 -65.99 -49.07 69.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 54.7 mt -51.62 -32.37 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -91.68 -24.9 19.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -77.19 -66.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 438' ' ' HIS . 59.8 t -75.3 -63.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -83.23 -169.88 2.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 t 62.67 179.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.23 -179.39 25.98 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 128.69 16.42 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.704 2.27 . . . . 0.0 112.373 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.94 -65.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 60.2 p -70.93 113.46 8.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.465 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.53 155.74 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 0.0 110.84 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 12.9 t -159.22 157.74 31.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -161.96 110.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 75.3 m -161.35 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.861 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 75.7 m -142.99 94.49 2.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -158.99 132.26 3.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.483 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.85 144.09 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -114.84 127.36 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.81 134.32 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -98.45 31.71 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.12 -45.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 20.2 p -114.02 -34.07 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.53 27.74 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.478 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -96.54 134.2 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 31.0 mm -87.47 147.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 377' ' ' LEU . 39.1 m-85 -131.6 131.01 42.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -32.47 70.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 170.66 15.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.82 -28.22 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -55.02 -45.88 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -46.39 75.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 371' ' ' PHE . 21.2 tp -52.13 -30.33 25.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -53.7 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -62.12 -31.76 72.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -70.43 -51.4 29.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -52.21 -31.07 30.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . . . . . . . . . 4.5 mt -72.3 -38.38 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.96 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 48.2 t -66.04 -29.45 69.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.22 -48.92 77.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.5 p 54.96 -171.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 174.56 115.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.52 167.24 1.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.508 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 5.9 mttt 64.19 155.43 0.12 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 54.3 Cg_endo -69.74 -47.53 0.31 Allowed 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.343 -0.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -117.87 98.31 6.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.86 157.49 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.1 t -82.35 129.15 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -15.3 36.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.0 -65.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 26.9 m -65.74 -69.52 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.52 -12.81 5.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 168.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -124.92 132.86 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.9 134.92 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -95.66 25.31 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.12 151.68 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -89.26 -17.49 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -23.12 56.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -91.35 -59.33 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.572 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.0 ppp? -51.73 -33.9 36.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.2 t -65.08 -35.39 80.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -88.46 -20.1 25.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -82.52 -45.64 14.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 405' ' ' MET . 94.9 t -64.14 -53.2 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -34.54 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 4.1 t -51.98 -30.13 23.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -86.42 -45.15 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.2 t70 63.19 164.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 175.49 -169.79 42.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.491 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 6.3 t 58.8 -171.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.53 89.72 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -94.27 -18.72 35.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.469 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -79.52 157.35 74.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.55 0.69 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.09 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.346 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -119.43 137.86 53.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.35 146.57 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.651 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.73 158.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.24 -6.31 50.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -75.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.6 p -75.8 -17.37 59.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.38 60.95 5.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -88.84 -76.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.63 135.31 3.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -136.73 137.94 40.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 40.6 p -52.24 -47.93 65.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -110.41 160.52 28.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -38.6 64.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -57.82 -25.85 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 422' ' ' CYS . 45.6 tp -87.71 -27.69 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.4 t30 -63.88 -38.55 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.24 45.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.515 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -60.89 -41.4 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.5 mt -53.88 -41.94 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.093 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.91 -9.03 47.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.98 -49.22 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.88 -51.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -82.28 56.17 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 t -115.87 132.95 56.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.09 -72.97 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -34.8 13.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.7 p -164.53 164.38 21.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.7 t -148.98 121.11 8.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.154 -0.803 . . . . 0.0 112.484 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 41.8 t -161.76 152.13 17.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 130.67 36.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.842 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 176.62 57.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.1 t -170.94 -173.55 1.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.369 . . . . 0.0 110.872 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.48 165.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 141.06 80.76 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.702 HG21 HD22 ' A' ' 377' ' ' LEU . 21.7 m -92.65 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -130.31 119.67 23.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 5.3 t -54.9 133.81 48.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.34 29.6 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.69 -40.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 23.8 p -117.28 -30.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.59 6.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -99.56 141.31 32.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 51.4 mm -93.66 143.7 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 377' ' ' LEU . 47.5 m-85 -128.93 128.34 43.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -29.53 70.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.53 155.05 49.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.76 -29.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -55.4 -32.22 62.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -82.98 -37.42 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.702 HD22 HG21 ' A' ' 362' ' ' VAL . 21.2 tp -63.07 -31.73 72.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.52 -39.95 92.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 382' ' ' LEU . 43.4 mtt180 -73.95 -26.88 60.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -76.82 -48.07 19.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.51 ' HZ3' HD21 ' A' ' 377' ' ' LEU . 11.5 mttp -53.06 -32.5 47.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 379' ' ' ARG . 28.9 mt -60.3 -33.59 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.14 -26.75 65.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.807 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -76.54 86.09 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.71 95.17 5.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 173.66 -168.71 41.67 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.539 ' H ' ' NE ' ' A' ' 398' ' ' ARG . 1.1 tt0 63.26 170.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.521 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.0 OUTLIER 64.07 155.49 0.12 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.582 0.706 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.8 Cg_endo -69.77 -47.66 0.3 Allowed 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.314 -0.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -117.24 98.89 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 57.2 p -112.85 155.8 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 16.5 t -82.37 129.26 64.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.61 36.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.244 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.99 -64.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.54 -69.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 130.27 -11.67 5.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 169.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . 0.539 ' NE ' ' H ' ' A' ' 387' ' ' GLU . 1.4 mpt_? -127.91 133.7 49.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.8 145.61 48.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 23.83 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.43 154.97 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -89.22 -19.52 25.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -24.89 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.66 -59.79 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.585 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.8 ppp? -51.63 -33.13 31.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 t -64.79 -47.19 79.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -76.57 -20.37 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -80.61 -51.88 8.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 405' ' ' MET . 99.0 t -60.71 -55.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -56.89 -36.86 70.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.12 -30.07 24.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -84.9 -38.67 19.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.33 172.72 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -131.75 -38.43 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.3 m -94.52 122.15 36.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.14 -26.57 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 109.25 -86.83 0.46 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -82.49 153.67 68.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.533 0.682 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.88 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.743 2.295 . . . . 0.0 112.35 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -97.34 130.25 44.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.483 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -130.89 147.29 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.683 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.1 t -51.76 159.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -92.74 -6.35 49.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.7 m -110.34 -75.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 25.9 p -76.37 -16.31 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.99 50.67 26.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -76.49 -76.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.331 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.483 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 128.13 127.14 2.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -54.68 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 160.67 25.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.28 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.31 -36.44 61.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -59.08 -32.75 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 422' ' ' CYS . 64.6 tp -77.23 -35.26 55.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.86 -28.17 69.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -84.34 -31.56 24.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -64.56 -47.57 78.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 48.0 mt -51.69 -34.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -21.52 20.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.44 -66.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.57 -61.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -77.59 -170.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p 63.14 22.68 13.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.76 171.07 32.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 85.27 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.92 27.04 3.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 79.3 p -139.99 -51.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.481 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 2.1 m -146.98 -43.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.45 157.1 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -141.94 36.95 1.63 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 64.6 p -152.25 101.84 2.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 0.0 110.854 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.67 124.1 1.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.829 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.15 151.77 23.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.496 ' CG1' HD22 ' A' ' 377' ' ' LEU . 12.1 p -98.47 131.17 46.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.93 140.63 30.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 366' ' ' ILE . 18.8 t -74.43 140.85 44.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.96 28.49 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . 0.474 HG21 ' CG ' ' A' ' 384' ' ' HIS . 2.6 mp -134.93 -46.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 21.2 p -112.55 -31.38 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.78 26.09 10.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.46 135.07 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 370' ' ' ILE . 5.1 mp -86.01 145.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.49 ' CD1' HD13 ' A' ' 377' ' ' LEU . 24.7 m-85 -126.34 147.22 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -65.46 -42.95 91.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -123.28 169.98 10.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.08 -29.8 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -63.51 -45.68 89.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -26.13 68.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.496 HD22 ' CG1' ' A' ' 362' ' ' VAL . 15.3 tp -78.99 -27.81 43.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.942 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -49.71 73.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.422 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.0 OUTLIER -65.44 -24.96 67.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -74.33 -54.58 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.479 ' HE3' HD21 ' A' ' 377' ' ' LEU . 14.3 mttt -51.9 -30.18 23.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 379' ' ' ARG . 18.8 mt -72.01 -36.7 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.45 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.474 ' CG ' HG21 ' A' ' 366' ' ' ILE . 11.2 m-70 -51.98 137.94 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.86 100.98 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 153.77 90.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -179.37 167.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.912 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 0.1 OUTLIER 64.08 155.69 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.703 . . . . 0.0 110.883 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.6 Cg_endo -69.77 -48.39 0.27 Allowed 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.658 -1.809 . . . . 0.0 112.345 -0.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -115.11 103.72 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 47.7 p -115.24 155.46 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.858 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 11.9 t -82.34 129.18 64.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.62 29.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.36 -57.29 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 18.4 m -76.83 -69.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 129.39 -12.21 6.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 171.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.89 133.64 47.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.49 141.58 51.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 23.96 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 152.73 32.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 -13.74 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.88 -22.77 49.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -59.03 2.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.591 ' O ' HG23 ' A' ' 409' ' ' VAL . 5.1 ppp? -51.6 -33.47 33.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 t -65.02 -48.53 73.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -75.42 -19.79 59.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -81.36 -49.69 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 405' ' ' MET . 98.9 t -64.77 -60.08 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -52.02 -35.24 46.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 -28.9 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -82.61 -48.8 10.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.08 -172.94 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 113.24 -41.84 2.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 5.5 t -66.55 152.98 44.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 40.2 t -91.12 90.66 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -113.9 -82.16 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.505 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -63.35 157.49 63.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.57 0.7 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -48.41 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.24 . . . . 0.0 112.349 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.64 138.41 52.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -126.77 146.5 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.132 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.69 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.78 158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -92.3 -6.5 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -110.07 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 27.2 p -75.84 -17.37 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.61 61.09 5.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -88.62 -76.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.54 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 136.75 135.58 3.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.91 139.75 39.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -49.93 68.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.31 160.56 26.59 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.865 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.31 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -53.55 -37.88 63.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.17 -26.25 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 422' ' ' CYS . 55.8 tp -88.36 -26.29 22.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 439' ' ' ILE . 3.8 t30 -61.63 -49.8 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -67.44 -39.72 91.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -51.87 -41.14 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 436' ' ' ASN . 6.9 mt -53.84 -42.2 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -9.11 50.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 -43.47 54.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.03 -50.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -79.31 58.57 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.76 172.67 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -112.07 172.09 14.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.49 69.01 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.38 -60.33 3.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.0 t -135.84 131.97 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.497 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.52 177.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 0.0 110.866 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 7.9 m -153.98 170.43 21.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -157.14 82.19 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 73.2 m -108.66 -43.79 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.5 m 63.17 -179.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 153.17 -166.15 31.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.569 ' CG1' HD22 ' A' ' 377' ' ' LEU . 14.2 p -90.28 148.54 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.23 134.22 54.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.065 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.82 133.56 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.03 28.11 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.24 -39.83 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' CYS . . . . . . . . . . . . . 25.8 p -120.1 -33.3 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.65 35.18 4.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -104.55 138.14 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.31 148.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 377' ' ' LEU . 28.3 m-85 -131.62 129.82 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -29.21 46.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -141.67 -179.85 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.33 -28.15 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -55.72 -58.6 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -56.9 -29.4 62.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.831 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.569 HD22 ' CG1' ' A' ' 362' ' ' VAL . 40.7 tp -75.76 -27.55 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.63 -49.61 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 382' ' ' LEU . 0.3 OUTLIER -70.49 -25.91 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -71.71 -44.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -58.3 -25.65 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 379' ' ' ARG . 5.8 mt -83.57 -46.37 12.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -16.4 62.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.54 124.17 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.4 p -145.92 -42.44 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.35 79.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.55 165.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.371 . . . . 0.0 110.905 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.53 ' HA ' ' C ' ' A' ' 389' ' ' PRO . 1.4 mttp 64.18 155.58 0.12 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.594 0.711 . . . . 0.0 110.896 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 388' ' ' LYS . 53.4 Cg_endo -69.81 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.353 -0.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.96 103.29 10.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 92.5 p -109.0 156.37 19.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 12.6 t -82.35 128.83 65.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -10.84 29.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.734 2.289 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.38 -67.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 57.7 m -59.57 -68.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 120.82 17.67 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.25 172.82 8.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.366 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 139.51 50.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -127.76 131.4 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 23.64 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.58 138.98 18.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -81.53 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.73 -23.38 29.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.55 -56.75 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 409' ' ' VAL . 4.9 ppp? -51.68 -31.44 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.5 t -63.44 -54.79 31.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -73.59 -19.32 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -79.19 -47.74 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 405' ' ' MET . 96.0 t -67.19 -57.41 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -52.03 -36.24 49.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.2 t -53.15 -28.8 27.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -84.64 -42.11 15.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -102.85 50.11 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 153.26 111.29 0.45 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 16.8 t 58.08 82.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.875 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.07 -69.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.72 -116.45 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.27 160.68 8.83 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.546 0.688 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -46.84 1.08 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.88 136.09 50.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.502 HG22 ' CA ' ' A' ' 428' ' ' GLY . 0.1 OUTLIER -128.45 147.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' A' ' 435' ' ' LEU . 7.2 t -51.79 158.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -92.3 -6.43 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.35 -75.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' CYS . . . . . . . . . . . . . 26.5 p -75.82 -17.08 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 48.78 56.27 10.09 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -83.23 -76.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.502 ' CA ' HG22 ' A' ' 421' ' ' ILE . . . 132.38 128.58 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.449 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.97 142.02 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 1.2 p -51.99 -50.42 61.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.98 160.61 26.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -47.63 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.78 -38.22 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -59.45 -27.83 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 422' ' ' CYS . 56.9 tp -82.23 -33.22 29.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.608 ' HA ' HD12 ' A' ' 439' ' ' ILE . 2.7 t30 -60.12 -40.16 88.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . -71.88 -36.11 61.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.03 -44.66 94.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 436' ' ' ASN . 12.2 mt -51.53 -38.02 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -21.38 23.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -64.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 52.3 t -84.54 -59.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -80.56 -175.19 5.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.21 160.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -175.19 -176.04 43.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 82.76 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.665 2.243 . . . . 0.0 112.344 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.82 121.84 15.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 -61.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.483 -179.983 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_